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Endoplasmic Reticulum (ER) is the site for secretory and transmembrane protein 
synthesis and maturation. Disrupted ER homeostasis activates a cascade of ER-to-nucleus 
signaling pathways termed the Unfolded Protein Response (UPR) to alleviate ER stress 
and restore ER homeostasis. Causal links between ER stress and a variety of human 
diseases have been suggested. However, as physiological ER stress is subtle and hard to 
detect relative to pharmacologically induced ER stress, the significance of ER stress and 
UPR activation in the pathogenesis of these disorders remains controversial.  
 
To this end, our lab developed a Phos-tag based SDS-PAGE method to sensitively detect 
the phosphorylation of UPR sensors (IRE1!/PERK), a direct indicator of ER stress levels 
and UPR activation. This method was verified and showed to quantitatively monitor UPR 
activation in cells expressing misfolded proteins. More significantly, this assay revealed 
delicate changes in IRE1! phosphorylation in mouse tissues under basal or stimulated 
physiological conditions that could not be visualized with a regular SDS-PAGE gel. 
Using this powerful tool in a screen for anti-diabetic reagents, we showed that 
phenformin, an anti-diabetic drug, stimulated the IRE1! and PERK pathways in both 
AMPK- and ER stress-dependent manners, revealing a novel crosstalk between UPR and 
metabolic pathways. 
 
To further expand our understanding of physiological ER stress, we turned to a model of 
chronic ER stress and UPR activation. Specifically, we generated a mouse model 
deficient for SEL1L, a core factor in ER associated degradation (ERAD). Animals with 
SEL1L deficiency in B cells (SEL1LCD19) exhibited severely impaired B cell 
development. Unexpectedly, the developmental defect in SEL1L-null B cells was 
independent of ER stress-mediated cell death, as UPR sensor phosphorylation and 
chaperone induction were not detected. Additional data supported a model that the 
phenotypic defect was due to a block in degradation of VpreB, a key component for a 
critical checkpoint during B cell developmental. In addition, our method, for the first time, 
showed an uncoupling between the activation status of UPR sensors and downstream 
targets in B cell to plasma cell differentiation.  
 
 
Taken together, our Phos-tag gel has proven to be a sensitive and reliable tool for 
investigating physiological ER stress. We believe this method will be critical in further 
understanding and elucidating the physiological role of mammalian ER quality control 
system, and may provide insights into future diagnosis for ER-associated conformational 
diseases. !
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CHAPTER 1. INTRODUCTION AND LITERATURE 
REVIEW 
 
1.1 ENDOPLASMIC RETICULUM  
Endoplasmic reticulum (ER) is a eukaryotic organelle consisted of interconnected 
networks of tubules, flattened cisternae and nuclear envelope, which share a common 
luminal space (Hu et al., 2011). The ER network dynamically interacts with other cellular 
organelles such as nucleus, Golgi, and mitochondria, functions as the site for protein 
synthesis, lipid production and calcium storage (Shibata et al., 2006). 
 
There are two types of ER in most cell types classified by their morphology -rough ER 
(rER) and smooth ER (sER). Ribosomal particles attach to the outer surface of certain ER 
sub-compartment synthesizing nascent peptides into its lumen. These ER subdomains 
attached with ribosomes exhibit a rough appearance under electron microscope and thus 
defined as rER. Meanwhile, the ones in the absence of ribosomal particle attachment 
showing a smooth structure are determined as sER (Shibata et al., 2006).   
 
In addition to their morphological differences, rER and sER perform distinct biological 
functions. rER is the first unit in the factory of transmembrane and secretory protein 
synthesis (CARO and PALADE, 1964). The translation complex of ribosome and mRNA 
encoding ER protein is directed to rER surface with the assistance of signal recognition 
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particle  (SRP). SRP binding to the hydrophobic signal sequence on the terminus of 
nascent peptide arrests translation. Subsequently, SRP-ribosome-mRNA complex is 
directed to ER surface by docking to SRP receptor on the ER membrane. Release of SRP 
from the complex results in resumed translation, followed by insertion of growing 
polypeptide into ER lumen through translocons such as Sec61(Akopian et al., 2013; 
Nicchitta, 2002). Besides SRP dependent co-translational targeting, post-translational ER 
localization of newly synthesized polypeptides can also be achieved with the assistance 
of chaperones (Rapoport et al., 1999). Alternately, cis-ER targeting sequence on the 
untranslated mRNA can promote ER location of the translation complex in an SRP-
independent pathway (Kraut-Cohen and Gerst, 2010). Proteins synthesized into rER 
lumen are then folded, modified, transported to Golgi for further modification and 
ultimately incorporated into plasma membrane/lysosomal vesicles or secreted into extra-
cellular space.  
 
Despite the common luminal space connected to rER, sER does not participate in protein 
synthesis. Rather, sER majors in phospholipids and steroid synthesis, providing material 
for membrane reparation and hormone production, and is highly abundant in hormone-
producing cells (Black et al., 2005). In addition, sER is also the compartment for dynamic 
cellular calcium storage (Meldolesi and Pozzan, 1998). Particularly, a specialized sER – 
Sarcoplasmic reticulum found in muscle serves as the sink and source of free calcium. 
Voltage-dependent calcium pump releasing calcium from Sarcoplasmic reticulum 
couples excitation signals to the initiation of muscle contraction in stimulated muscle 
cells (Wray and Burdyga, 2010).  
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1.2 PROTEIN HOMEOSTASIS AND ER STRESS 
rER network (which will be referred as ER for simplicity in the rest of the chapters) is 
responsible for about one-third of cellular protein synthesis, mostly secretory and integral 
membrane protein in all eukaryotic cells (Kaufman, 1999). Proteins destined for plasma 
membrane, lysosomal or extracellular space are processed in this organelle in a distinct 
way compared to those synthesized in the cytosol: ER proteins are synthesized at higher 
rates in the oxidizing environment, and bears more modification to create structural 
complexity (Stephens and Nicchitta, 2008). Without correct conformation, proteins are 
retained in ER, and cannot proceed to Golgi for further sorting and decoration. 
 
An array of chaperones and foldases participate in the sophisticated folding cycles for 
correct conformation, covalent modification and multimer assembly. Many of the general 
folding chaperones (Hsp70 and Hsp90) and co-chaperones (Hsp110 and Hsp40) belong 
to the heat shock protein family. The most well-studied heat shock chaperone is Hsp70 
family member BIP (also known as glucose-related protein 78, GRP78), which facilitates 
folding of a broad range of newly synthesized peptides by various mechanisms: BIP 
ensures translocation and keeps the synthesized part soluble before generation of the 
complete polypeptides(Nguyen et al., 1991; Vogel et al., 1990). It also holds early-
produced subunit in prevention for aggregation, until displaced by the rest subunits for 
complex assembly (Hendershot, 1990).  
 
Lectin chaperones such as calnexin (CXN) and calreticulin (CRT) specialize in 
glycoprotein folding. A large portion of ER client peptides co-transitionally obtain N-
!(!!!
glycosylation on asparagine (N) at the N-X-T/S (X is any amino acid) motif, which rarely 
occurs on cytosolic proteins. The glycan modification consists of two N-
acetylglucosamine, nine mannose and three glucose, and are sequentially processed by 
ER glycosidase and mannosidase, to generate various barcodes representing different 
folding status (Ruddock and Molinari, 2006). ER exportation of folded proteins requires 
complete removal of glucose from the original triglucosylated oligosaccharide by 
glucosidases I and II. However, the trimmed glucose-free, mannose-rich glycan on non-
natively folded proteins can be reglucosylated by the folding sensor UDP-
glucose:glycoprotein glucosyltransferase (UGGT) (Ritter and Helenius, 2000). Lectin 
chaperones calnexin (CXN) and calreticulin (CRT) specifically recognize the 
monolglucosylated glycan tag, prolong retention of associated cargos in the ER and 
promote their entry/re-entry into the folding cycles (Hebert et al., 1995; Helenius and 
Aebi, 2004). Terminally misfolded polypeptides are removed from de- and re-
glucosylation circulation. These misfolded cargos are targeted to the ER degradation 
system, once the N-glycan is dismantled by mannosidase (Jakob et al., 2001; 1998; 
Nakatsukasa et al., 2001).  
 
Another feature of ER folding is the formation of structure-stabilizing disulfide bond, 
which is enabled by the reducing environment in ER.  Disulfide bonds occur between two 
cysteine residues on the same or two individual peptides catalyzed by members of PDI 
(protein disulfide isomerase) family (Wilkinson and Gilbert, 2004). The example of 
immunoglobulin indicates that disulfides serve to stabilize subunits of multimer 
complexes, affecting their folding and secretion (Elkabetz et al., 2008; Vinci et al., 2004). 
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In addition, a PDI family member, ERp57 assists non-native disulfide bonds in the 
cysteine-rich unstructured regions of its substrates, allowing formation of temporary 
intermediates that facilitate final folding processes (Jessop et al., 2007).  
 
Despite various folding machineries, protein folding is by nature a slow and inefficient 
process, with many peptides repetitively trapped into the low-energy pits on the folding-
energy landscape before achieving their native conformation.  Many physiological and 
pathological stimuli, such as sudden burst of protein synthesis and secretion, genetic 
mutation on critical amino acids, virus infection, depletion of chaperone co-factor 
calcium, interrupt with folding processes and induce large amount of misfolded protein 
accumulation. In fact, even under basal condition, a considerable fraction of polypeptides 
are terminally misfolded and never reach their native state. Misfolded proteins 
accumulated in the ER may cause ER stress, which is deleterious for the folding of other 
peptides. Alternatively, they escape the ER folding checkpoint, execute dominant 
negative effects, and become toxic to the tissues. To solve the problem, cells developed 
two major quality control pathways- the ER-associated degradation (ERAD) pathway, 
and the unfolded protein responses (UPR) pathway, to enhance folding capacity, ensure 
qualified protein functions, prevent exportation of failed products and degrade potential 
toxic misfolded peptides. Efficient ERAD at basal conditions, and the adaptive UPR upon 
stress challenges are required for maintenance of the healthy ER environment. 
Remarkably, these two machineries inter-regulate each other under various physiological 
and pharmacological conditions, synergistically alleviate ER stress and contribute to ER 
homeostasis (Travers et al., 2000).   
!*!!!
1.3 ERAD 
Timely removal of the failed folding products prevent unnecessary occupation of 
chaperones and folding space in the ER. The system eliminating terminally misfolded ER 
proteins is collectively termed as ER-associated degradation (ERAD) pathway. ERAD 
pathway has an invert pyramid structure formed by a variety of chaperones and glycan-
binding adaptors, a limited number of E3 complexes, and one shared terminal proteasome 
degradation complex. Glycan-binding adaptors recognize misfolded proteins through yet 
unclear mechanisms, and deliver substrates to the ERAD central organizer- E3 complexes 
on the ER membrane for dislocation and ubiquitination. In both yeast and metazoans, 
there are different ERAD pathways defined by the E3 central organizers, responsible for 
distinct but overlapping ranges of substrates. Regardless of the specific E3 complex, all 
misfolded proteins end up being extracted by P97/cdc48p AAA ATPase and ultimately 
degraded by the cytosolic p26 proteasome (Smith et al., 2011). 
 
1.3.1 Substrate recognition  
The first step in ERAD is substrate recognition. Based on experiments using model 
ERAD substrates, several theories of recognition and delivery have been established. The 
most detailed mechanism is “glycan-clock” model revealed by the study of luminal 
glycosylated proteins. The Glc3Man9GlcNAc2 modification on glycoproteins can be 
trimmed by mannosidase upon prolonged retention in ER, removing the branch A 
terminal mannose. Exposed alpha-1,6 mannose prevents re-glucosylation which is 
required for re-association with calnexin/calreticulin chaperone system (Parodi, 2000). 
Hence, polypeptides are released from folding cycle and can be recognized as 
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degradation substrates by glycan-binding protein (lectin adaptors) such as Yos9p/OS-
9/XTP3-B (Quan et al., 2008). Mannosidase EDEM1 (Htm1p in yeast) has been shown to 
act upstream of the lectins to generate such glycan marker(Quan et al., 2008) or promote 
disassociation of polypeptide from calnexin (Oda et al., 2003). However, this glycan 
signal model doesn’t explain the whole story, as non-glycosylated proteins are also 
degraded by ERAD machinery comprised of ER lectin and EDEM1 (Shenkman et al., 
2013). Thus, alternative model has been proposed in which ERAD target misfolded 
proteins by direct binding to structural features exposed only in misfolded conditions. 
This strategy has been seen in many cases of quantity regulation of ER located enzymes 
in response to metabolite levels. The structure of HMG-CoA, the rate-limiting enzyme in 
cholesterol synthesis, changes upon cholesterol binding, and is recognized as misfolded 
protein by E3 ligase in yeast, or by specialized adaptors Insig-1 and Insig-2 in 
mammalian cells (Shearer and Hampton, 2005; Song et al., 2005). Investigation of the 
major histocompatibility class I (MHC-I) protein reveals another model in which virus 
hijacked ERAD pathway. In the human cytomegalovirus-infected cells, antigen 
presenting molecule MHC-I is recruited to ERAD by virus transmembrane adaptors 
US11 and US2 for dislocation and degradation, allowing virus to escape from immune 
defending system (Lilley and Ploegh, 2004; Rehm et al., 2002). Despite the in vitro 
results, we still know little about how endogenous misfolded proteins are distinguished 
from folding intermediates. The underlying mechanism by which degradation is initiated 
remains to be a puzzling but interesting question. 
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In addition to ERAD specific adaptors, housekeeping chaperones may also participate in 
substrate recognition. Binding of BIP to the ERAD substrates increases their solubility 
and prevents aggregation formation (Kabani et al., 2003; Nishikawa et al., 2001).  GRP94 
associates with OS-9 to deliver misfolded alpha-antitrypsin to E3 complex (Christianson 
et al., 2008). The disulfide isomerases (PDIs) participate in retro-translocation of bacteria 
and virus antigens (Schelhaas et al., 2007; Tsai et al., 2001). The fact that folding and 
degradation machineries share common components suggests a possible role of these 
chaperones as gatekeepers, recruiting terminally misfolded proteins to ERAD while 
preventing degradation of peptides in folding process. However, this hypothesis requests 
further studies. 
 
1.3.2 Dislocation 
ERAD targeted misfolded proteins are spatially separated from cytosolic proteasome by 
ER membrane. Thus, efficient dislocation system is required to retro-transport large and 
sometimes covalently modified ER luminal and membrane-integral peptides without 
disrupting ER membrane integrity. Reducing disulfide bonds by PDIs may be needed to 
breakdown large multimers into individual molecules before dislocation (Tsai et al., 
2001). Pores or channels consisted of transmembrane proteins warrant misfolded peptide 
retro-translocation. Two major candidate channel proteins are Sec61 and the Derlin 
family members (Bagola et al., 2011).  
 
Sec61, the translocon for protein synthesis obtains ideal properties as a candidate ERAD 
channel. However, research regarding the involvement of Sec61 as dislocation channel 
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has reached controversial conclusions. In the human cytomegalovirus-hijacked ERAD 
system, co-immunoprecipitation of MHC-1 and US2 virus adaptor recovers Sec61, 
indicating a physical interaction between Sec61 and ERAD substrates (Wiertz et al., 
1996). Mutation of Sec61p significantly delays degradation of ERAD model substrate 
CPY* (mutated luminal yeast carboxypeptidase ycsY) in yeast (Plemper et al., 1997). 
However, real-time fluorescence-based detection shows that blockage of Sec61 has no 
effect on in vitro reconstituted substrate retrotranslocation (Wahlman et al., 2007). 
Hence, more studies are needed to establish the function of Sec61 in ERAD. 
 
Transmembrane Derlin-1/VIMP complex has been shown to associate with both 
misfolded polypeptides and p97 (Ye et al., 2004) and to be indispensable for retro-
translocation of mutant !-1 antitrypsin (Greenblatt et al., 2011). This idea that Derlin-1 is 
the dislocation channel in ERAD machinery is also supported by the real-time assay 
detecting in vitro retrotranslocation (Wahlman et al., 2007). Deletion of Derlin-1 causes 
misfolded protein accumulation and thus leads to ER stress (Ye et al., 2004). 
 
Substrate dislocation is facilitated by the AAA (ATPases Associated with diverse cellular 
Activities) ATPase p97, its yeast homolog cdc48, as well as their binding partners UFD1 
and NPL4 in the cytosol (Braun et al., 2002). Cdc48/p97 complex binds both 
ubiquitinated and non-ubiquitinated substrates in an ATP dependent manner. ATP 
hydrolysis provides energy for the extraction of aberrant polypeptides into the cytosol 
(Ye et al., 2003).  
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1.3.3 Core organizers of ERAD – E3 complex 
E3 complexes ubiquitinate misfolded substrates, and deliver them to the cytosol for 
degradation. They are the core organizers defining distinct ERAD pathways. Reported 
E3s include Hrd1p and Doa10p in yeast, and many more in metazoans, such as HRD1, 
GP78, TRC8, RMA1 and TEB4. Depending on the topology (luminal protein or 
transmembrane protein) and the location of lesion (in the luminal, transmembrane or 
cytosolic domains), substrates can be sorted by adaptors for particular E3 complexes. For 
example, secretory substrates are mainly targeted to ERAD-L pathway defined by HRD1 
in both mammalian and yeast cells (Bernasconi et al., 2010; Christianson et al., 2012). 
However, the categorization is not always clear-cut, as GP78 is shown to degrade both 
luminal and transmembrane proteins at equal extents (Christianson et al., 2012).     
 
Among the known E3 complexes, the most well characterized E3 complex is the 
Hrd1/SEL1L complex, which is evolutionally conserved through yeast to mammals. At 
the center of this complex is HRD1, the E3 ubiquitin ligase with six transmembrane 
segments and a cytosolic catalytic ring (Kikkert et al., 2004). Ubiquitination by HRD1 is 
selectively facilitated by E2 ubiquitin-conjugating enzyme, UBC6e in mammals (Mueller 
et al., 2008) and Ubc7p in yeast (Bazirgan et al., 2006). Mammalian UBC6e has a 
transmembrane region and a cytosolic catalytic domain, while in yeast, Ubc7p is a 
soluble protein in cytosol, and requires ubiquitin binding protein Cue1p for membrane 
anchoring and full-length ubiquitination (Bagola et al., 2013; Metzger et al., 2013).  
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The central adaptor in HRD1 E3 complex is SEL1L and its yeast counterpart Hrd3p 
(Mueller et al., 2006), which nucleate, stabilize and bring ERAD target proteins to the 
complex. Both SEL1L and Hrd3p are type I ER transmembrane proteins with a large 
luminal domain and a small proline-rich tail in the cytosol (Biunno et al., 2006). The 
luminal domain contains multiple tetratricopeptide repeats, a feature commonly found on 
interaction hubs for assembly of macromolecular complexes (Mittl and Schneider-
Brachert, 2007). SEL1L nucleates the whole complex by interacting with multiple ERAD 
components including HRD1, Derlin1/2, p97, OS-9, XTP3-B, ancient ubiquitous protein 
1 (AUP1), UBXD8 and several housekeeping chaperones (Christianson et al., 2012; 
Mueller et al., 2006; 2008). Dramatic decrease of Hrd1p protein is resulted from Hrd3p 
deletion in yeast (Gardner et al., 2000) while mammalian HRD1 in SEL1Li (RNAi) cells 
skews to smaller fractions in sucrose gradient assay (Iida et al., 2011). Vice versa, 
silencing HRD1 rapidly reduces mammalian SEL1L (Iida et al., 2011). These findings 
together point out the fact that SEL1L and HRD1 critically optimize the stability of the 
ERAD complex. As the substrate loading dock for HRD1 ubiquitination, SEL1L/Hrd3p 
recruits misfolded proteins by binding to lectins such as mammalian OS-9 and XTP3-B 
(Christianson et al., 2008) and yeast Yos9p (Gauss et al., 2006a). Direct binding of 
ERAD targets by SEL1L/Hrd3p is also possible. For instance, N-terminal fraction of 
Hrd3p interacts with CPY* connecting it to membrane-associated Cdc48p (Gauss et al., 
2006b). Interestingly, SEL1L is heavily glycosylated on its luminal domain. This 
modification may be necessary for its binding to lectin adaptors OS-9, XTP3-B as well as 
mannosidase EDEM1 (Cormier et al., 2009).  
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1.3.4 Physiological significance of ERAD 
ERAD eliminates the misfolded proteins preventing them from forming potentially toxic 
aggregation. Various knockout mouse models have demonstrated the physiological 
importance of ERAD as housekeeping machinery. Deletion of HRD1, SEL1L or 
VCP/p97 causes embryonic lethality (Francisco et al., 2010; Müller et al., 2007; 
Yagishita et al., 2005). Remarkably, only SEL1L but not HRD1 null embryos showed 
retarded growth, suggesting HRD1-independent roles of SEL1L in development 
(Francisco et al., 2010; Yagishita et al., 2005). On the other hand, knockout of different 
Derlin family members results in various outcomes: Derlin-1 deficiency is embryonic 
lethal, Derlin-2 deficiency impairs protein dislocation in chondrocytes, while Derlin-3 
deficient mice appear normal (Dougan et al., 2011; Eura et al., 2012).  
 
Animals with conditional knockout or genetic mutations were generated and examined to 
understand tissue-specific ERAD functions related to human diseases. The importance of 
SEL1L in pancreas is not only demonstrated by the developmental blockage of 
embryonic pancreatic epithelial cells in SEL1L-/- mice, but also proved by the 
observation that haploid insufficiency of SEL1L predisposes mice to "-cell degeneration 
and insulin deficiency upon high-fat diet (Francisco et al., 2011; Li et al., 2010b). R155H 
or A232E mutations on VCP/p97 cause pathology in muscle, brain and bones in mice, 
fully resembling syndromes of human IBMPFD (inclusion body myopathy associated 
with Paget’s disease of bone and frontotemporal dementia) (Custer et al., 2010). In 
nature, progressive loss of ERAD occurs with aging, contributing to pathogenic protein 
accumulation and organ dysfunction. In the nerve system, E3 enzyme HRD1 degrades 
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amyloid precursor protein to prevent APP aggresome formation-mediated neuron 
apoptosis. Significant decrease of HRD1 is detected in patients’ brain neurons, which 
likely initiates pathogenesis of Alzheimer’s disease (AD) (Kaneko et al., 2010). The 
animal and human studies establish the biological significance of ERAD pathway in 
physiological and pathological context, particularly in the tissues with high protein 
synthesis rates, or cells expressing error-prone polypeptides. Hence, it is not surprising 
that high levels of ERAD components such as SEL1L are detected in secretory organs 
such as salivary tissues, colon, stomach and pancreas (Biunno et al., 2006). 
 
Despite the protective effect on normal cells, ERAD may also be involved in 
carcinogenesis. In vitro experiments reveal two novel SEL1L variants, p28 and p38, 
secreted by human breast cancer cells in response to ER stress. The functional relevance 
of the new variants remains unclear (Cattaneo et al., 2011). Analysis of human pancreatic 
adenocarcinoma and breast cancer suggests a negative correlation between SEL1L levels 
and tumor outcomes (Cattaneo et al., 2003; Orlandi et al., 2002). Overexpression of 
SEL1L dramatically reduces proliferation and anchorage-independent colony formation 
of breast cancer cells, implicating that SEL1L may inhibit tumor transition (Orlandi et al., 
2002). On the contrary, proteasome inhibitors blocking the downstream of ERAD trigger 
myeloma cell apoptosis, and thus have been proposed as potential anti-cancer drugs. 
More loss-of- and gain-of-function studies are needed for the comprehensive 
understanding of individual ERAD players in tumorgenesis and treatment before they can 
be aimed as therapeutic targets and/or diagnostic markers. 
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1.4 UNFOLDED PROTEIN RESPONSE 
The Unfolded Protein Response (UPR) is the collection of signaling cascades that 
communicate ER with other cellular organelles when accumulated misfolded protein 
causes ER stress. Thus it is also termed as ER stress response (Fig. 1.1). Mammalian 
UPR is mainly initiated by three ER stress sensors, IRE1! (Inositol-requiring enzyme 1 
!), PERK (PKR-like endoplasmic reticulum kinase) and ATF6 (Activating transcription 
factor 6). The sensors initiate downstream transcriptional, translational and post-
translational events to reduce nascent peptide loading, increase folding machinery and 
degrade misfolded proteins. IRE1! and PERK are type I transmembrane proteins with 
kinase activities for both autophosphorylation and phosphorylation of downstream targets. 
In addition, IRE1! has an RNase domain adjacent to its kinase domain to promote 
synthesis of a key transcription factor XBP1s, which exhibits mainly pro-survival 
functions by transcriptionally increasing the UPR genes. The third member ATF6 is a 
type II transmembrane-anchored transcription factor, upregulating the UPR genes 
synergistically with XBP1s (Walter and Ron, 2011). Short-term activation of these 
pathways has been implicated as an adaptive response, which protects cells against acute 
or mild stress. However, prolonged UPR activation induces apoptosis under severe stress 
conditions (Tabas and Ron, 2011). Mechanistic and physiological details of each pathway 
will be discussed below. 
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Figure 1.1 Three major UPR pathways in mammals are shown. Homeostatic alterations in 
the ER result in the accumulation of unfolded or misfolded proteins, and these induce 
dissociation of BiP and subsequently permit activation of three ER membrane sensors: 
IRE1a, PERK and ATF6. (a) IRE1a undergoes dimerization or oligomerization, and 
trans-autophosphorylation, activating its cytosolic endoRNase activity. IRE1a then 
removes a 26-base intron from Xbp1 mRNA to generate a potent transcription factor 
XBP1s (XBP1 spliced) that translocates into the nucleus and regulates a diverse array of 
genes. In addition, activated IRE1a could selectively degrade particular mRNAs. (b) 
Activated PERK phosphorylates Ser51 on the translation initiation factor eIF2a to 
attenuate global translation, but also preferentially upregulates the translation of selected 
mRNAs including ATF4, C/EBPa, and C/EBPb. ATF4 activates the expression of the 
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UPR target genes involved in amino acid biosynthesis, the anti-oxidant response, and 
apoptosis, whereas C/EBPa and C/EBPb activate genes regulating glucose production 
and lipogenesis in the liver. (c) Activated ATF6 translocates to the Golgi, where it is 
cleaved by the proteases S1P/S2P, yielding the mature transcription factor ATF6(N), 
which then activates the transcription of the UPR target genes. (Adopted from Sha, H., 
He, Y., Yang, L. and Qi, L. (2011) Stressed out about obesity: IRE1!-XBP1 in metabolic 
disorders. Trends Endocrinol Metab 22, 374–381) 
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1.4.1 IRE1 PATHWAY 
Overview of IRE1  
Inositol-requiring enzyme 1 (IRE1) initiates the most evolutionally conserved branch out 
of the three UPR pathways. Ire1p was first identified as an indispensable gene for yeast 
growth on inositol-deficient medium (Nikawa and Yamashita, 1992). It is a 
transmembrane kinase critical for transcriptional induction of ER-resident protein genes, 
such as KAR2 and PDI1 (Cox et al., 1993; Mori et al., 1993). Later, the Walter group 
discovered that Ire1p also contained site-specific endonuclease activity to splice HAC1 
mRNA in collaboration with tRNA ligase. The spliced HAC1 mRNA encodes a basic-
leucine zipper (bZIP) transcription factor, Hac1p which is the master regulator of Ire1p-
induced ER-resident chaperones under ER stress (Cox and Walter, 1996; Sidrauski and 
Walter, 1997; Sidrauski et al., 1996).  
 
In mammalian cells, researchers have identified two isoforms of IRE1- IRE1! and 
IRE1", both of which display kinase and RNase domains highly conserved to yeast Ire1p. 
The splicing target for mammalian IRE1 is Xbp1, the ortholog of yeast HAC1 gene. 
Interestingly, IRE1! also splices yeast HAC1 mRNA in vitro, demonstrating the 
structural and functional conservativeness of this protein(Tirasophon et al., 2000; 1998).  
IRE1! is universally found in almost all mammalian tissues while IRE1" is uniquely 
expressed in gut epithelial cells (Bertolotti et al., 2001). Meanwhile, mammalian 
counterpart of the tRNA ligase has not been found yet. However, in vitro exon-exon 
ligation of mammalian XBP1 mRNA can be achieved by adding yeast and amphioxus 
!%,!!!
tRNA ligases, suggesting similar ligation mechanism may be applied in mammals 
(Iwawaki and Tokuda, 2011).  
 
Current work regarding to IRE1 pathway mainly focuses on IRE1!. IRE1! is a type I 
transmembrane protein consisted of a luminal fraction, a 20 amino acid transmembrane 
segment and a cytosolic domain with non-conventional RNase activity and kinase 
activity. It is the most well characterized UPR sensor. Currently major theories on IRE1! 
activation include binding of misfolded proteins to the grooves formed by dimer luminal 
domains, disassociation of inhibitory chaperone BIP, and composition changes of ER 
membrane lipid content. Upon activation, the IRE1! RNase domain cleaves its cytosolic 
mRNA targets for either targeted upregulation of the transcription factor XBP1s or 
downregulation of nascent peptide loading into the ER. In specialized conditions, the 
kinase domain may phosphorylate associating adaptors and kinases, branching out to 
modulate various stress response pathways. 
 
Mechanisms of IRE1 activation  
In the past decade, researchers have been interested in mapping out the detailed 
mechanisms by which Ire1/IRE1! is activated by ER stress and/or other physiological 
and pathological stimuli. In vitro studies and crystal structure analyses have greatly 
advanced our understanding of how different domains of IRE1! sense the surrounding 
misfolded proteins, and/or contribute to its activation.     
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It is natural to believe that the Ire1p/IRE1! luminal domain exposed directly to the 
misfolded/unfolded peptides plays a key role in initiating the kinase and RNase activities 
on the cytosolic side. Crystal structure of yeast Ire1 core luminal domains shows that Ire1 
luminal domains form dimers, together to create a central groove reminiscent of the 
peptide binding groove on the major histocompatibility complex (MHC) (Credle et al., 
2005). In vitro experiments demonstrate that an endogenous misfolded ER protein CYP* 
as well as synthesized basic and hydrophobic peptides directly bind into the Ire1p core 
luminal domains and activate the UPR signaling, which provide direct evidence for the 
peptide-binding model (Gardner and Walter, 2011). However, crystal structure of human 
IRE1! raises questions against the application of direct binding model in mammalian 
cells, as the diameter of luminal groove formed by human IRE1! is too narrow to 
accommodate amino acid chains (Zhou et al., 2006).  
 
BIP-binding model was brought up by the analysis of the IRE1! linker region, which 
reveals dynamic BIP binding to an IRE1! luminal site next to the dimerization domain 
(Bertolotti et al., 2000). In this model, BIP associates with IRE1! under basal conditions 
to inhibit its activation. Under ER stress condition, misfolded proteins compete with 
IRE1! for BIP association. The resulting depletion of BIP from IRE1! allows IRE1! 
luminal domain dimerization and/or oligomerization as well as its subsequent activation 
(Bertolotti et al., 2000). However, a mutant Ire1p, Ire1bipless lacking the BIP binding 
segment, can still form oligomers and splice HAC1 mRNA, suggesting that BIP binding 
is not required for the responsiveness of yeast Ire1p to ER stress. Instead, elevated basal 
foci formation and delayed deactivation of Ire1bipless after drug washout are observed, 
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comparing to wild type Ire1. Hence, it is more likely that the association of BIP raises the 
threshold of IRE1! activation by sequestering inactive Ire1 molecules and preventing 
oligomerization, rather than directly modulating its activity (Pincus et al., 2010).  
 
Regardless, following the direct or indirect initiation by misfolded proteins are IRE1 
trans-autophosphorylation and dimerization/oligomerization. The occurring orders for the 
two events are not full appreciated yet. Transient dimer/oligomers may be stabilized by 
misfolded protein bindings, allowing subsequential trans-autophosphorylation on the 
adjacent IRE1! activation loops (Ali et al., 2011). Phosphorylation on the activation loop 
in turn leads to conformational changes of IRE1! cytosolic domains, further boosting 
oligomer formation and splicing. The IRE1 oligomerization in both yeast and mammals 
has been demonstrated by various methodologies including crystal structure analysis 
(Korennykh et al., 2009), sucrose gradient centrifugation (He et al., 2012; Hetz et al., 
2006), native SDS-PAGE (Hetz et al., 2006; Liu et al., 2002) and direct observation of 
fluorescent-IRE1! cluster formation (Kimata et al., 2007; Li et al., 2010a), and is shown 
to be critical for full IRE1 activation. However, it is likely that dimer rather than the 
oligomer is the basic functional unit, as loss of foci formation only delays but does not 
block the downstream UPR signaling (He et al., 2012).  
 
Besides misfolded protein binding and BIP binding models, lipid content change is 
another potential mechanism to activate IRE1! and other UPR sensors. The lipid content 
model has attracted great attention, as UPR has been frequently linked to lipid 
dysregulation in metabolic diseases such as obesity, diabetes and atherosclerosis (Fu et 
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al., 2011; Ozcan et al., 2004; 2006). Manipulation of lipid composition, particularly 
increasing the lipid saturation level in ER has been shown to activate IRE1, in both yeast 
and mammalian cells, which can be alleviated by adding various unsaturated lipids 
(Ariyama et al., 2010; Pineau et al., 2009). The fact that the chemical chaperone 4-phenyl 
butyrate (4-PBA) attenuates saturated the lipid-induced UPR suggests that misfolded 
protein accumulation is the direct reason for the UPR activation. Increased saturated fat 
in the ER likely disrupts calcium homeostasis, impairs functions of calcium-binding 
chaperones, and thus causes accumulation of misfolded proteins (Fu et al., 2011). A 
similar mechanism has also been proposed to mediate the cholesterol-induced UPR (Feng 
et al., 2003). Interestingly, an in vitro study using IRE1! mutant lacking its luminal 
domain demonstrates that IRE1! activation by ER lipid saturation level can be solely 
attributed to its transmembrane domain, implicating that IRE1! can directly sense lipid 
composition on the ER membrane (Volmer et al., 2013).  
 
Fine-tuning of IRE1 activation by interacting protein adaptors 
IRE1! activation is a highly regulated process which can be much more complicated than 
the models presented above. In fact, IRE1! activation can be facilitated or suppressed by 
multiple ancillary components on the cytosolic side in addition to the ER-derived signals.  
The repertoire of IRE1! fine-tuning adaptors, collectively named IRE1! interactome, 
may vary in different tissues and modulate IRE1! activation in tissue- and/or stimulus-
specific manners. 
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Studies in cell culture models reveal several positive IRE1! regulators, such as BH3-only 
proteins PUMA and BIM (Rodriguez et al., 2012), and BCL-2 family members BAX and 
BAD (Hetz et al., 2006), physically interacting with IRE1! cytosolic domains. Knockout 
or knockdown of these cofactors impairs IRE1! activation in response to 
pharmacological ER stress. Recently, our lab identified the non-muscle myosin heavy 
chain IIB (NMHCIIB) as a novel IRE1! interacting protein, necessary for IRE1! foci 
formation and full induction of XBP1s (He et al., 2012). Interaction of NMHCIIB as well 
as other cytoskeleton related proteins (unpublished data) suggest a possible role for the 
cytoskeleton system and motor proteins in the regulation of IRE1! under ER stress.  
Negative regulators of IRE1! have also been identified. An ER-resident protein BAX 
inhibitor-1 (BI-1) forms a stable complex with IRE1! and suppresses IRE1!-XBP1 
pathway in fly and mouse models (Castillo et al., 2011; Lisbona et al., 2009). ERAD 
component ubiquitin specific protease (USP) 14 binds the cytosolic region of inactive 
IRE1!, preventing its activation by ER stress (Nagai et al., 2009). Scaffold protein 
RACK1 (receptor for activated C-kinase) mediates complex formation between IRE1! 
and protein phosphatase 2A (PP2A), promoting dephosphorylation and inactivation of 
IRE1! in " cells upon prolonged glucose or ER stress stimulations (Qiu et al., 2010). 
These inhibitory adaptors together with BIP desensitize or deactivate IRE1!, eliminating 
unnecessary activation when the stress is mild or removed.  
 
In addition to protein modulators, small compounds may facilitate IRE1! activation as 
well. A study by the Ron group showed that flavonol quercetin bound to the pocket of the 
dimer interface formed by yeast Ire1 kinase-RNase domains, potentiated Ire1p RNase 
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activity in response to ADP (Wiseman et al., 2010). The effect is likely due to enhanced 
dimerization rather than oligomerization upon compound binding.  Even though 
quercetin is derived from plant, this study opens up the possibility that endogenous 
mammalian metabolites may interact and activate/potentiate IRE1! under metabolic 
stresses. 
 
Activation of IRE1 leads to XBP1 splicing and folding capacity induction for 
adaptation 
Activated IRE1 signals ER stress to the nucleus by splicing mRNA of a key UPR 
transcriptional factor Xbp1 in metazoans and HAC1 (Xbp1 ortholog) in yeast in a 
spliceosome independent manner. In yeast, the intron of HAC1 mRNA pairs with 5’ UTR 
forming secondary structure that hinges translation elongation (Rüegsegger et al., 2001). 
Ire1p RNase domain cleaves both HAC1u 5’ and 3’ splice junctions at the conserved G of 
the seven-residue stem-loop, to release the 252-nucleotide intron (Sidrauski and Walter, 
1997). After removal of the intron, the two adjacent exon fragments are ligated by tRNA 
ligase Rlg1, yielding a mature HAC1i mRNA, which can be translated into a functional 
transcription factor upregulating the entire yeast UPR transcriptome (Sidrauski et al., 
1996).  
 
In metazoans, IRE1! splices 26 nucleotides from the Xbp1u mRNA to generate the 
spliced form - Xbp1s, causing a frame shift to avoid the premature stop codon, and 
producing a stable bZIP transcription factor with DNA binding domain (DBD) and 
transactivation domain (TAD) (Yoshida et al., 2001). Overall XBP1s positively 
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influences transcription as an activator. Its activity can be positively or negatively 
affected by various post-translational modulations.  Disruption of PI3K subunits p85! 
and p85" by insulin signaling promotes interaction between XBP1s and p85!/ p85". 
Binding of p85!/" enhances nuclear translocation of XBP1s, and thus increases XBP1s-
mediated transcriptional activation (Park et al., 2010; Winnay et al., 2010). On the other 
hand, XBP1s can be SUMOylated by PIAS2 (protein inhibitor of activated STAT 2). 
Addition of small ubiquitin-like modifiers (SUMOylation) on two lysine residues of 
XBP1s transactivation domain downregulates its transcriptional activity (Chen and Qi, 
2010). In addition, Xbp1 mRNA (Xbp1u) can be constitutively translated to an 
incomplete transcription factor lacking the last fraction of TAD. XBP1u has a very short 
half-life and reduce XBP1s protein level by forming degradation-prone complex with 
XBP1s (Yoshida et al., 2006).  
 
The major downstream targets of XBP1s include ER-resident chaperones and foldases, 
lipid synthesis enzymes and ERAD components. These genes synergistically assist 
folding processes, increase ER capacity and enhance degradation of misfolded protein, 
together functioning as adaptation to restore ER homeostasis and promote cell 
survival(Walter and Ron, 2011). However, recent studies also indicate that a high level of 
XBP1s may be pro-apoptotic and detrimental to cell survival (Allagnat et al., 2010; Zeng 
et al., 2009).   
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Activation of IRE1 leads to RIDD 
Recent work has uncovered more substrates for IRE1! endonuclease domain. Unlike 
XBP1, cleavage of these ER associated mRNA by IRE1! doesn’t produce functional 
protein; rather contribute to the reduction of peptide loading into ER.  This non-specific 
decay of ER cargo mRNA termed as regulated IRE1! dependent degradation (RIDD) 
was fist discovered in drosophila S2 cells, where in response to DTT, a subset of mRNA 
get degraded by IRE1! endonuclease activity depending on their ER localization and 
amino acid sequence. (Hollien and Weissman, 2006). Later, similar phenomena were 
observed in mammalian cells, likely in a cell- or tissue specific manner (Hollien et al., 
2009; Lipson et al., 2008; Oikawa et al., 2007; Tirasophon et al., 2000). RIDD has been 
shown to degrade CD59 in Hela cells (Oikawa et al., 2007), insulin transcript in 
pancreatic " cells (Lipson et al., 2008) and mRNA of itself as feedback control in COS-1 
cells (Tirasophon et al., 2000). A sequence consensus CUGCAG has been proposed as a 
common substrate recognition and cleavage motif for both Xbp1 mRNA splicing and 
RIDD (Oikawa et al., 2010). 
 
Mechanistically, RIDD and Xbp1 splicing seem to be differentially regulated. Forced 
activation of IRE1! RNase domain by ATP analogue circumventing ER stress results in 
only Xbp1 splicing but not decay of other mRNA substrates (Hollien et al., 2009). The 
alternate endoribonuclease outcomes may depend on different IRE1! kinase activation 
modes (Han et al., 2009). Besides ER cargo reduction, RIDD can degrade mRNA for pro-
survival chaperones, which complicates the physiological significance of IRE1! 
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activation, and raises the question whether prolonged IRE1! RNase activity also 
contributes to apoptosis under stressed conditions (Han et al., 2009).  
 
Activation of IRE1 initiates multiple signaling pathways through its interactome   
Interactome of IRE1! not only fine-tunes its activity but also diversify its physiological 
outputs. Activated IRE1! crosstalks to a variety of kinases involving in alarm signaling 
pathways such as JNK/ASK1 (Nishitoh et al., 2002; Urano et al., 2000), MAPK kinases 
p44 (ERK) and p38(Nguyên et al., 2004). Adaptor protein TRAF2 binds IRE1! cytosolic 
domain coupling IRE1! signaling with ASK1 (apoptosis signal-regulating kinase 1) 
(Nishitoh et al., 2002) and JNK (cJun-N terminal kinase) activation (Urano et al., 2000). 
In vitro and vivo evidences suggest versatile outcomes of IRE1!-JNK signaling pathway: 
JNK activation by IRE1! controls ER-stress induced autophagy and apoptosis in cell 
model, and suppresses insulin receptor substrate (IRS) to in part mediate insulin 
resistance in obese animals (Ozcan et al., 2009; 2004; Urano et al., 2000). The IRE1!-
TRAF2-ASK1 axis seems to be required for ER-stress caused JNK activation and neuron 
cell death in polyglutamine aggregation-induced human neurodegenerative disorders 
(Nishitoh et al., 2002). In addition, IRE1! leads to I#B kinase (IKK) activation, which 
promotes phosphorylation, disassociation and degradation of Nf#B repressor I#B (Hu et 
al., 2006). Both JNK and IKK-Nf#B pathways may promote IRE1!-induced 
inflammatory responses via upregulating an array of inflammatory genes as an alternative 
result of IRE1! activation in addition to XBP1s-mediated ER expansion (microarray data 
in our lab). Besides the above examples, interactomic screening in our and other labs 
revealed far more interacting proteins with various known or possible functions. The 
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biological significance of these adaptor proteins requests further investigation, which will 
enhance our understanding of both mechanistic and physiological aspects of the UPR 
sensor IRE1!. 
 
1.4.2 PERK PATHWAY 
PERK is a metazoan type I transmembrane ER-resident protein with kinase activity on its 
cytosolic fraction. PERK luminal region shows structural similarity in despite of limited 
sequence homology to IRE1!. In addition, a BIP binding domain and a dimerization 
interface are also found in the luminal fragment of PERK (Bertolotti et al., 2000; Ma et 
al., 2002). Thus it has been proposed that BIP prevents PERK 
dimerization/oligomerization, and retains monomeric PERK in an inactive status in a 
similar manner as it desensitizes IRE1!. This hypothesis is supported by the fact that 
luminal domains of IRE1! and PERK are shown to be inter-switchable without 
disrupting their sensibility to ER stress (Liu et al., 2000). However, whether PERK 
luminal dimer also directly binds to misfolded ER protein is still unknown. 
 
Following activation by misfolded proteins are PERK oligomerization and trans-
autophosphorylation on its activation loop. Phosphorylation on the loop enhances affinity 
of PERK with its kinase target eIF2! (Marciniak et al., 2006). Activated PERK regulates 
protein translation by directly phosphorylating eukaryotic translation initiation factor 2 ! 
(eIF2!) on its serine 51 residue (Harding et al., 1999). Phosphorylation of eIF2! by 
PERK attenuates global protein translation, to reduce ER burden and promote survival 
under ER stress conditions (Harding et al., 2000; Scheuner et al., 2001; Yan et al., 2002).  
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Moreover, phosphorylated eIF2! enhances translation of selective proteins in despite of a 
general inhibitory effect. The most well characterized protein produced by this 
mechanism is ATF4 (Activating transcription factor 4), whose 5’ UTR contains two extra 
untranslated open reading frame (uORF). Ribosome scanning starts at the first uORF 
(uORF1), efficiently proceeds to the inhibitory second uORF (uORF2) and thus preclude 
translation of ATF4 under non-stressed condition. ER-stress induced phosphorylation on 
eIF2! delays ribosome re-initiation favoring translation start site at ATF4 over uORF2 
after scanning uORF1 (Lu et al., 2004a).  
 
ATF4 results in upregulation of additional transcription factors such as ATF3 (Activating 
transcription factor 3) and CHOP (C/EBP-homologous protein, also named as 
GADD153), which together with ATF4 promote expression of genes in the categories of 
metabolism, inflammation, redox regulation and apoptosis (Jiang et al., 2004; Wek et al., 
2006; Whitney et al., 2009) (unpublished data from our lab). Of note, CHOP is a bZIP 
transcription factor that upregulates pro-apoptotic genes such as carbonic anhydrase VI 
(CAVI) (Sok et al., 1999), death receptor 5 (DR5) (Yamaguchi and Wang, 2004), 
Tribbles homolog 3 (TRB2) (Ohoka et al., 2005), and downregulates pro-survival protein 
BCL2 (Matsumoto et al., 1996; McCullough et al., 2001). It is the first identified and the 
most well studied pro-death UPR gene under prolonged or severe ER stress. 
 
Activation of PERK-eIF2! pathway can be attenuated at different levels by various 
mechanisms. eIF2!-ATF3 upregulates GADD34, a substrate-specific regulatory 
component in a phosphatase complex that dephosphorylates eIF2! as a negative feedback 
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(Jiang et al., 2004).  P58ipk a transcriptional target of XBP1s, interacts with PERK and 
suppresses its kinase activity during prolonged ER stress (Yan et al., 2002). Signaling 
pathways triggered by other initiators can also negatively regulate PERK downstream 
pathways. For example, priming cells with toll-like receptor TLR activators inhibits 
translation of ATF4, without affecting upstream PERK activation (Woo et al., 2009).  
 
Recent investigations have identified additional PERK targets: PERK phosphorylates 
NRF2, releases it from sequestration by cytoskeletal anchor, KEAP1 for nuclear 
translocation. NRF2 functions as a cyto-protective PERK target, as loss of NRF2 impairs 
cell viability in chronic ER stressed condition(Cullinan et al., 2003). PERK also activates 
GSK3"  (glycogen synthase kinase 3 ") in an eIF2!-independent way to promote 
degradation of p53, suggesting GSK3" as another direct PERK kinase target (Baltzis et 
al., 2007). Whether there exist more PERK targets and/or regulatory adaptors remains to 
be tested. Compared to IRE1!, the relative low level of endogenous PERK expression 
has been an obstacle for immunoprecipitation-based screening. More efficient 
immunoprecipitation methods and more sensitive mass-spectrometric tools will greatly 
assist our understanding of PERK activation and its downstream events.   
 
1.4.3 ATF6 PATHWAY 
ATF6 is a type II transmembrane ER stress sensor also added to the UPR family since 
metazoan cells. Activation of ATF6 depends on regulated intramembranous proteolysis 
(RIP), a process known to regulate SREBP in cholesterol homeostasis (Ye et al., 2000). 
The luminal domain of ATF6 is also indispensable for ER stress responses(Chen et al., 
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2002a). However, how ATF6 luminal domain senses unfolded proteins is less understood, 
as its luminal domains shares little homology with its counterparts on IRE1! and PERK. 
The finding of multiple BIP binding sites provides one explanation of stress sensing: 
ATF6 is retained in an inactive status in ER by binding of BIP in unchallenged conditions, 
and translocates to Golgi via transport vesicles upon BIP depletion by misfolded protein 
(Shen et al., 2002). The ER-to-Golgi transportation is likely directed by two Golgi 
localization signals (GLSs) on its luminal domain, as ATF6 with only GLS but not BIP 
binding site is constitutively delivered to Golgi (Shen et al., 2002).  
 
Once in the Golgi apparatus, ATF6 is cleaved by two proteases, site-1 protease (S1P) and 
site-2 protease (S2P) sequentially to remove its luminal domain and transmembrane 
anchor respectively (Haze et al., 1999; Ye et al., 2000). The cleavage process releases a 
50-kDa N-terminal cytosolic domain of ATF6 (ATF6N) as a b-ZIP Transcription factor. 
ATF6N migrates into the nucleus and preferentially binds to ER stress-response element 
(ERSE) featured by the consensus motif CCAAT-N9-CCACG at the promoter regions of 
the downstream target genes(Yamamoto et al., 2004). One important target for ATF6 is 
the transcription factor XBP1 (Yoshida et al., 2001), which prefers binding sites with 
UPR-response element (UPRE, TGACGTGG/A) over ERSE. In addition to their specific 
binding elements, ATF6 and XBP1s can both interact with ATTGG-N-CCACG, the 
ERSE-II motif (Yoshida et al., 2001), and together induce ER chaperones and ERAD 
genes in collaboration with other transcription factors for the recovery of ER homeostasis.  
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Recent studies have added several ATF6-like ER transmembrane bZIP transcription 
factors as new members of UPR initiators. Reported novel UPR initiators include Luman, 
CREBH and OASIS, which share the similar RIP-dependent activation mechanism as 
ATF6. Luman is stimulated by pharmacological blockage of ER-to-Golgi flux and 
activates transcription of genes with ERSE consensus (Liang et al., 2006; Raggo et al., 
2002). CREBH is a liver-specific transcription factor required for acute phase responses 
(APR) upon cytokine- and antigen- induced ER stress (Zhang et al., 2006a). OASIS 
increases BIP and suppresses cell death in astrocytes undergoing ER stress challenge 
(Kondo et al., 2005). Taken together, the cell type-specific UPR sensors suggest 
differential UPR pathways optimized for specialized cellular adaptation in response to 
distinct physiological stimuli. 
 
1.4.4 Physiological and pathological UPR 
The unfolded protein response has (UPR) been wildly associated with multiple human 
diseases such as obesity and diabetes, inflammation, neurodegeneration, and cancer, and 
is considered to play a causal role in many disease settings. Addressing the mechanisms 
underlying the UPR activation and its crosstalk with other signaling pathways is of pivot 
significance for the treatment of these pathological disorders.  
 
UPR in obesity and diabetes 
Obesity and diabetes has been an increasing health threat to human society ever since we 
gradually switch to high-energy food consumption and contemporary life style. The 
absorption, utilization and synthesis of glucose need to be coordinately regulated by 
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metabolic tissues such as liver, fat, pancreas, and hypothalamus to achieve glucose 
homeostasis. Disruption of glucose homeostasis leads to diabetes and damages to various 
tissues. Abnormality in insulin production, secretion and responsiveness is one of the 
most prevailing causes for elevated glucose, which can be closely linked to UPR 
modulation.   
 
In 2004, the study by Hotamisligil group first proposed UPR as the intermediating link to 
couple obesity and type II diabetes (Ozcan et al., 2004). Ever since then, accumulating 
evidence has suggested ER stress in metabolic tissues especially liver and adipose tissue 
as a potential therapeutic target for metabolic disorders.  In obese animals, the activation 
of IRE1!-JNK axis in liver and fat desensitizes insulin receptor by phosphorylating 
insulin receptor substrate-1 (IRS-1). Loss of XBP1 predisposes mice to high-fat diet 
induced obesity and glucose intolerance likely due to increased ER stress in metabolic 
tissues (Ozcan et al., 2004). Oral treatment of chemical chaperones attenuates ER stress 
in these tissues, and restores insulin sensitivity and glucose homeostasis in ob/ob mice 
(Ozcan et al., 2006). Interestingly, partial loss of IRE1!-XBP1 downstream target GRP78 
protect mice against diet-induced obesity and insulin resistance, which may be due to 
compensatory ER capacity expansion under adaptive UPR (Ye et al., 2010).  
 
Wolcott-Rallison syndrome (WRS) is an early onset type I diabetic diseases commonly 
treated with insulin supplementation. Genetic mapping suggests that mutations on PERK 
gene may be responsible for the manifestations of WRS (Delépine et al., 2000). PERK-
eIF2! is required for translational control, protecting pancreatic " cells against heavy ER 
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burden caused by fast insulin production in large quantity. Several mouse models support 
the role of PERK-eIF2! pathway in pancreatic development and degeneration: Ser51Ala 
eIF2! mutant mice die after birth with pancreatic " cell deficiency (Hetz et al., 2006; 
Scheuner et al., 2001), while PERK-/- mice are born with normal pancreas, but later 
exhibit gradual pancreatic " cells loss and progressive diabetes (Harding et al., 2001; 
Zhang et al., 2002). At cellular and molecular level, PERK deficiency causes a 
remarkable suppression of insulin mRNA, resulting in significant insulin level drop in 
both pancreas and serum of PERK-deficient animals (Zhang et al., 2006b). Meanwhile, 
loss of PERK impairs ER protein trafficking and exportation, which leads to enlarged ER 
and retention of proinsulin (Gupta et al., 2010).   
 
Although the translational regulation by PERK-eIF2! is essential for the ER homeostasis 
and " cell survival, its prolonged activation under pathological ER stress may cause 
oxidative stress and cell apoptosis through CHOP induction. Investigations of Chop-/- 
mice on diabetic backgrounds suggest that compensatory insulin production induces ER 
stress and PERK-eIF2!-CHOP pathway, which may contribute to the " cell loss at the 
late stage of type II diabetes (Song et al., 2008). Development of pancreatic " cell and 
optimal insulin secretion also require IRE1! target XBP1. " cell-specific XBP1 knockout 
reduces islet area, blocks pro-insulin process and causes hyperglycemia and glucose 
intolerance. IRE1! is hyperactivated as compensatory feedback for XBP1 deficiency, and 
cleaves " cell mRNA including Insulin mRNA, to partially mediate the insulin 
insufficiency in " cell-specific XBP1 knockout mice (Lee et al., 2011).   
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Later studies also reveal significant contribution of UPR into the maintenance of 
balanced hepatic gluconeogenesis and lipid synthesis. Translational control by PERK-
eIF2! pathway is required for perinatal gluconeogenesis. Neonates containing Ser51Ala 
eIF2! mutant fail to induce hepatic gluconeogenesis gene PEPCK and die from 
hypoglycemia (Kim et al., 2008; Ron and Walter, 2007; Scheuner et al., 2001). 
Meanwhile, XBP1 protein is upregulated by carbohydrate consumption to promote key 
genes in lipogenesis (Lee et al., 2008). Hepatic XBP1 deficiency results in 
hypocholesterolemia and hypotriglyceridemia (Lee et al., 2008). Contrast to the 
phenotype in XBP1 deficient mice, liver-specific IRE1! knockout mice develop 
hepatosteatosis, which can be further aggravated by pharmacological ER stress (Zhang et 
al., 2011). Phosphorylation of eIF2! promotes lipogenic genes in vitro, whereas 
attenuation of eIF2! in vivo reduces adipogenic genes in liver, enhances glucose 
homeostasis and prevents hepatosteatosis (Oyadomari et al., 2008). This finding together 
with the PERK activation observed in obese mouse liver suggests PERK-eIF2! as the 
alternative mechanism mediating hepatosteatosis and type II diabetes in addition to the 
IRE1!-XBP1 pathway (Iwawaki et al., 2004; Ozcan et al., 2004).  
 
In the central nerve system, hypothalamus controls the appetite in response to adipocyte 
or gut hormones. Leptin is an adipokine acting on a subset of hypothalamic neurons to 
suppress food intake and increase energy expenditure. UPR activation have been 
observed in hypothalamus in obese animals, and is associated with diet-induced leptin 
insensitivity. Genetic or pharmacological manipulation that enhances ER capacity 
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significantly attenuates ER stress and increases leptin sensitivity in the hypothalamus 
(Ozcan et al., 2009; Zhang et al., 2008).  
 
UPR in immunity 
UPR pathways, especially the IRE1!-XBP1 branch, regulate multiple developmental or 
differentiation processes in both adaptive and innate immunity. Xbp1 mRNA is highly 
expressed in pre-pro-B cells and plasma cells, tightly regulated by B cell specific 
activator proteins (Reimold et al., 1996). In the XBP-1/RAG-2-/- chimeric mice, XBP1-/- 
hematopoietic cells develop to B and T lymphocytes successfully. However, XBP1-/- B 
cells expressed very low levels of immunoglobulin upon in vitro lipopolysaccharide 
stimulation, and fail to defend against polyoma virus, a B-cell-dependent antigen. Simply 
overexpressing XBP1 in wild-type B lymphocytes forced B cell to differentiated into 
plasma cells, evident by the increased plasma cell surface marker Syndecan-1, suggesting 
XBP1 is not only required but also sufficient for B cell to plasma cell differentiation 
(Reimold et al., 2001). Xbp1 mRNA in activated B cells is upregulated by cytokine IL-4 
pathway and transcription factor BLIMP-1, and then spliced by IRE1! for functional 
protein production (Iwakoshi et al., 2003; Lee et al., 2008; Shaffer et al., 2004). The 
resulting XBP1s protein boosts transcription of genes involved in ER and Golgi secretory 
pathways, expanding the ER volume and folding apparatus in anticipation for increasing 
immunoglobulin synthesis in plasma cells (Shaffer et al., 2004). In addition, XBP1fl/fl 
CD19+/Cre (XBP1CD19) conditional knockout mice are generated to advance our 
understanding of B cell-specific role of XBP1. XBP1CD19 mice are protected from 
chemical-induced lupus, an autoimmune disease, while having normal antibody-specific 
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memory B cells after immunization (Todd et al., 2009). Loss of IRE1!, the XBP1 
upstream regulator, impairs terminal plasma cell differentiation as expected, whereas 
surprisingly affects hematopoietic stem cell proliferation and early B cell development. 
IRE1! deficiency results in B cell developmental defect in bone marrow due to 
dysregulated VDJ recombination factors RAG1/2 and TdT, suggesting broader 
downstream events other than XBP1 splicing in a cell type specific manner (Zhang et al., 
2005).   
 
It was originally proposed that dramatic increase of immunoglobulin synthesis causes ER 
stress and initiates IRE1!-XBP1 pathway. However, several recent evidences have 
challenged this hypothesis: 1. XBP-1 induction is differentiation-dependent and remains 
normal in the mutant B cells without IgM secretion (Hu et al., 2009). 2. A dynamics 
study shows sequential waves of chaperone induction and ER expansion prior to 
immunoglobulin synthesis (van Anken et al., 2003). 3. Development of antibody-
secreting B cells are independent of the other two UPR branches, PERK and ATF6 
pathways, suggesting these two are not activated due to lack of ER stress (Aragon et al., 
2012; Gass et al., 2008; Zhang et al., 2005). These studies implicate an alternative model 
in which XBP1 is programmed to increase at transcriptional level upon differentiation 
and spliced with unchanged basal IRE1! activity, while the other pathways remain 
inactive with no overt ER stress. However, differential activation threshold or specialized 
regulatory interactome may also explain the different requirement among distinct UPR 
pathways. A more direct monitoring tool of ER stress level will greatly help to clarify this 
question.            
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UPR is critical for not only development of adaptive immune system but also the 
regulation of innate immunity. TLR2 and TLR4 specifically activate IRE1!-XBP1 but 
not the other two pathways in macrophages. TLRs-triggered XBP1 activation results in a 
distinct transcriptional profile compared to ER stress-induced transcriptome, and is 
required for optimal expression of cytokines such as IL-6, IL-1", TNF and IFN-" 
(Martinon et al., 2010; Smith et al., 2008; Zeng et al., 2010). In addition, constitutive 
XBP1 expression is observed in another innate immune cell type - dendritic cells (DCs) 
and essential for its survival. Both conventional and plasmacytoid DCs decreased in 
Chimeric mice lacking XBP1, while overexpression of XBP1 rescued the DC cell loss 
(Iwakoshi et al., 2007). This essential role of XBP1 in innate immune system is 
conserved in lower species, as C.elegans with a loss-of-function xbp1 mutant exhibit 
dilated ER and larval lethality when infected with Pseudomonas aeruginosa (Richardson 
et al., 2010). Interestingly, TLR signaling can also negatively regulate the UPR pathways. 
Pre-engagement of TLR3 and TLR4 directly suppresses ATF4-CHOP in a TRIF-
dependent manner but leaves PERK and eIF2! intact (Woo et al., 2009). Although the 
detailed mechanism remains unclear, this opposite TLR processes on IRE1! and PERK 
pathways may evolve to prevent CHOP-induced apoptosis while optimize cytokine 
production through XBP1 induction.  
 
XBP1 variants have been associated with human inflammatory bowel diseases (IBD) as 
genetic risk factors. Mice with intestinal epithelial cell (IEC)-specific XBP1 deletion 
spontaneously develop enteritis and are more susceptible to colitis. The phenotypes 
originate from the role of XBP1 in Paneth cell homeostasis and epithelium in response to 
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proinflammatory IBD inducers (Kaser et al., 2008). The gastrointestinal IRE1" is also 
required to protect mice from weight loss and death under dextran sodium sulfate (DSS)-
induced colitis.  Significant increase of BIP protein in IRE1"-/- mice suggests high levels 
of ER stress (Bertolotti et al., 2001). However, whether ER stress is the direct mediator of 
phenotypic changes in IRE1"-/- requires further investigations. 
 
UPR in neuron diseases 
Neuronal degenerative diseases are late onset aging-associated diseases usually coupled 
with disruption of proteostasis (Balch et al., 2008). Increasing evidence implicates that 
the impaired ERAD and ER stress are common causes for a number of neuron diseases 
including Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), 
and Huntington’s disease (Cornejo and Hetz, 2013; Duennwald and Lindquist, 2008; 
Holtz and O'Malley, 2003). However whether UPR promotes pathogenic progress or 
protects cells against diseases is still an open question. Mouse hippocampal cell HT22 
primed with low level of ER stress are resistant to oxidative glutamate toxicity, a process 
believed to trigger neuronal loss by extracellular glutamate. Mechanistically, this 
cytoprotection protection is mediated by pre-emptive conditional eIF2! phosphorylation 
(Lu et al., 2004b). Ectopic expression of the IRE1! downstream target XBP1s attenuates 
dopaminergic neuron cell death and protects mice against chemical-induced Parkinson’s 
disease (Sado et al., 2009). The protective role of XBP1 is also supported by studies of 
the Alzheimer’s disease using taupathies or A"-overexpressing fly models (Casas-Tinto 
et al., 2011; Loewen and Feany, 2010). 
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On the contrary, neuron-specific XBP1 deletion enhances the degradation of SOD1mut 
aggregation by lysosome-mediated autophagy pathway, and protects mice against ALS 
(Hetz et al., 2009). In addition, the IRE1!-ASK1 pathway has been shown to mediate 
neuron cell death in both SOD1 mutation-related ALS and polyglutamine-induced 
Huntington’s disease (Nishitoh et al., 2002; 2008). Pharmacological ER suppressors have 
been proposed as potential treatment for ALS (Vaccaro et al., 2013). The controversial 
results point to a complicated relation between ER stress/UPR and neuron diseases. The 
UPR pathway may influence clinical outcomes of neuron degeneration in a disease-
specific way.  
 
Unlike most neuron diseases originating from genetic or environmental disadvantages, 
Prion disease is a unique case of neuron dysfunction caused by infectious misfolded 
protein that transforms normal PrPC to non-degradable pathogenic PrPSc. Several studies 
using model systems report ER chaperone induction in prion disease, suggesting 
occurrence of ER stress and UPR (Hetz et al., 2003; 2005). However, upstream ER stress 
markers such as phosphorylated PERK and eIF2! are not detected in human prion 
specimen, and only increase slightly in prion-infected mice (Unterberger et al., 2006). 
Mice specifically lacking brain XBP1 show normal stress responses upon prion infection 
and similar levels of neural loss and survival curve compared to WT controls, which rules 
out the role of XBP1 in prion disease (Hetz et al., 2008). It would be interesting to 
examine prion infection and pathology in genetic mouse models with deficiency of 
individual UPR components for a comprehensive picture of the UPR in prion disease. 
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UPR in cancer 
Carcinogenetic progression allows cells escape growth restrictions for fast and unlimited 
proliferation. The high energy and oxygen demanding for rapid cell growth requires 
various intracellular and extracellular adaptive changes. One of the growth challenges for 
tumor cells is to adapt protein synthesis with decreasing environmental disadvantages 
such as energy deprivation and hypoxia. A Large portion of ER proteins bears 
glycosylation, which can be affected by carbohydrate insufficiency. Low ATP levels 
under energy deprivation also limits the chaperone function and thus impairs ER folding 
capacity. In addition, hypoxia induces oxidative stress, which is another source of ER 
stress. 
 
It is not surprising that increasing evidence shows abnormal upregulation of UPR or at 
least partial UPR pathways in tumor cells. The distal pro-survival UPR components – ER 
chaperones are frequently upregulated in various types of cancer. Induction of chaperones 
such as GRP78 and GRP94 was detected in human gastric tumor (Song et al., 2001), lung 
cancer(Tsai et al., 2013), fibroarcoma (Jamora et al., 1996), malignant breast cancer 
(Fernandez et al., 2000), hepatocarinoma (Shuda et al., 2003) and esophageal 
adenocarcinomas (Chen et al., 2002b). The master transcription factor XBP1s responsible 
for ER stress-mediated chaperone induction at the transcription level is found in breast 
cancer (Gomez et al., 2007; Lacroix and Leclercq, 2004) and lymphoma (Davies et al., 
2003; Maestre et al., 2009). Studies also report proximal UPR activation at the sensor 
level in cancer cells. IRE1! plays a key role in angiogenesis and tumor growth in human 
glioma (Drogat et al., 2007), while PERK activation by constitutive activated BCR-ABL 
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tyrosine kinase mediates drug resistance, and thus protects chronic myeloid leukemia 
against imatinib treatment (Kusio-Kobialka et al., 2012). However, direct evidence is 
lacking to demonstrate whether the prevalent chaperone induction in tumors is always 
initiated by ER stress.  
 
Efforts have been made to identify therapeutic drugs targeting to the protective UPR, 
such as proteasome inhibitors that suppress IRE1! activity and XBP1 production and 
cause myeloma cell apoptosis (Lee et al., 2003). Furthermore, UPR-targeted drugs can 
also be used in combination with immunotherapy. Epidermal growth factor (EGF) fused 
with cytotoxin SubA binds specifically to EGFR (Epidermal growth factor receptor) 
positive tumor and selectively cleaves GRP78 in glioma. Injection of the fusion protein 
delays tumor growth in xenograft mice, while the reagent per se can be well tolerated by 
the animals (Prabhu et al., 2012). 
 
Interestingly, although mild and prolonged UPR are thought to be protective for tumor 
growth and survival, several therapeutic drugs promote tumor-toxicity by upregulating 
apoptotic UPR. Nitric oxide-induced glioma cell death is abolished by siRNA knock 
down of IRE1! (Kim et al., 2010). Fenretinide and bortezomib activate eIF2!-ATF4 
signaling pathway which is indispensable for drug effects on neuroblastoma and 
melanoma cell lines (Armstrong et al., 2010). A recent high throughput screen selected a 
small molecular that specifically activated the apoptotic branch of the UPR (Flaherty et 
al., 2012). However what the mechanistic basis differentiates physiological outcomes 
upon UPR activation (adaptive v.s. apoptotic) in given tumor types remains a mystery. 
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Quantitative and comprehensive measurement of the UPR activation is needed to pave 
the foundation for our understanding of UPR pathways in cancer.  
 
1.5 RESEARCH AIMS AND DISSERTATION ORGANIZATION  
Countless studies report that the UPR causally associate with the pathogenesis of multiple 
human conformational diseases and thus are proposed as potential therapeutic targets for 
medicine development. However, different measuring methods can reach contradictory 
conclusions on ER stress levels and sources of the UPR activating signals. One of the 
major unsolved questions resulting in this dilemma is that the broad UPR downstream 
targets may be initiated not only by ER stress but also by crosstalk from other signaling 
pathways. In addition, individual UPR branches may have different sensitivity to ER 
misfolded protein accumulation at the sensor level. How to accurately define and 
quantitatively measure ER stress and UPR activation levels appears to be an obstacle for 
deeper understanding of the UPR in human diseases.  
 
Multiple genes are transcriptionally upregulated by UPR transcription factors such as 
XBP1s, ATF4 and ATF6. Q-PCR has been wildly used to measure the steady-state 
mRNA levels of these UPR factors, including but not limited to Bip, p58ipk, Chop, 
Erdj4, and Pdia6. Commercially available antibodies also provide the convenience to 
detect the protein levels of these chaperones. However, there are several drawbacks for 
using UPR downstream targets: first of all, their activation is not none or all. Situations in 
which only a subset of the UPR transcriptome is upregulated are not uncommon. 
Conclusions solely based on downstream targets may be misleading depending on the 
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genes of choices, while microarray may not be experimentally feasible for every 
specimen. Secondly, the UPR downstream targets are distal outcomes and hardly reflect 
the levels of ER stress quantitatively. Last but not the least, other signaling pathways 
unrelated to ER stress or UPR have been shown to induce the UPR targets, such as 
CHOP induction by insulin and growth factors(Brewer et al., 1997; Miyata et al., 2008), 
or ATF4 via TLR signaling (Woo et al., 2009). Thus, the downstream targets are not 
suitable as the sole UPR marker, and better to be displayed with other measurement.  
 
Xbp1 splicing by IRE1! has been another popular hallmark for the UPR activation. PCR 
products using primers designed around the splicing site are run on a high percentage 
agarose gel. Loss of 26 nucleotides fastens the migration of spliced Xbp1s mRNA and 
results in the separation from the unspliced form Xbp1u (Lin et al., 2007). Alternatively, 
enzyme digestion can be applied after PCR, as splicing deletes a digestion site for Pst I 
restriction enzyme on the human and mouse Xbp1 mRNA. Electrophoresis of digested 
PCR products yields a large band of Xbp1s and two smaller bands of Xbp1u, making the 
separation more obvious (Established by the David Ron lab). The splicing appears to be a 
good marker more closely related to the occurrence of ER stress, except that it is hard to 
collect enough mRNA from certain tissues.  
 
The Miura lab generated a transgenic mouse model for in vivo monitoring of ER stress 
(Iwawaki et al., 2004). The mice express an XBP-1-venus (green fluorescent protein) 
fusion protein in all tissues, which can be spliced by IRE1! RNase domain upon ER 
stress. The spliced indicator mRNA produces a florescent fusion protein, indicating the 
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ER stress levels in different tissues. This model can be of great use to investigate tissue 
specific ER stress under various physiological and pathological challenges. However, it is 
restricted for laboratory studies but not for clinical diagnosis.    
 
We believe that the most direct method to determine ER stress is at the UPR sensor level. 
Phosphorylation and oligomerization are the two events closely coupled with IRE1! and 
PERK activation. IRE1! oligomerization can be observed as foci under fluorescence 
microscope. But this process requires overexpression of GFP-tagged protein, which may 
not fully reflect endogenous situations. Antibodies are available for site-specific 
phosphorylation of IRE1! and PERK, even though we found the one for IRE1! doesn’t 
always work for endogenous protein. The phospho (Thr980)-PERK antibody from Cell 
Signaling Technology works very well. However PERK is shown as a smear under 
severe ER stress triggered by pharmacological reagents, thapsigargin and tunicamycin, 
suggesting more than one site being phosphorylated. We know little about the ER stress 
level, which the Thr980 phosphorylation is corresponding to. Slow migration of IRE1! 
and PERK on SDS-PAGE gels is often used to detect ER stress when phospho-antibodies 
are not available. However the migration can be too mild to detect, especially under mild 
physiological ER stress conditions. Thus, developing sensitive and quantitative methods 
is critical to enhance our understanding of ER stress and UPR in both in vitro and in vivo 
settings.      
 
This thesis dissertation is centered on the investigation of the physiological ER quality 
control system, particularly the UPR. Chapter 1 introduces the ER homeostasis, ER stress, 
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ER quality control machineries such as ERAD and UPR, UPR activation and its 
significance in conformational diseases. Chapter 2 focuses on the development of a Phos-
tag based method to quantitatively detect mild physiological UPR at sensor level in cell 
culture and mouse models. This method is based on alkoxide-bridged dinuclear metal 
(Zn2+ or Mn2+) embedded in the pockets of acrylamide-pendant Phos-tag molecule (Fig. 
1.2). The positively charged metals interact with negatively charged phosphate groups 
and delay the mobility of phosphorylated proteins (Kinoshita et al. 2006). Salt 
concentration in the buffer may affect the process of electrophoresis and cause band 
distortion between adjacent lanes. Therefore, cytosolic HSP90 (Heat Shock Protein 90), 
which has constant levels of phosphorylation under non-stressed and ER stress conditions, 
is used to reveal the basal position of each lane. A crosstalk between UPR and metabolic 
pathways is revealed by using this method and presented in Chapter 3. Chapter 4 presents 
a conditional ERAD deficient mouse model generated to investigate the tissue-specific 
influence of ER stress and physiological UPR. Contrast to original expectation, I identify 
an ER stress-independent role of ERAD in B lymphocyte development. Finally, Chapter 
5 summarizes the dissertation research and discusses possible future directions. Chapter 2 
and Chapter 3 have been published as on the PLoS ONE (2010) and the Journal of 
Biological Chemistry (2013) respectively. Chapter 4 will be continued by other lab 
members and published in the future. In addition to the above projects, I also take 
advantage of the Phos-tag based method to explore various mechanistic and physiological 
aspects of the UPR, which results in many interesting insights. These findings are 
organized into three appendixes:  Appendix A discusses proteostasis boundary reset by 
transcriptional upregulation of XBP1 during plasma cell differentiation with no overt 
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UPR activation. Appendix B reports a novel IRE1! interacting protein FARP1 
discovered in a proteomic screen from the lab. Appendix C presents the physiological 
oscillation of UPR at both sensor and target levels, picturing circadian patterns of UPR in 
various important organs. 
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Figure 1.2 Phos-tag molecules and phosphorylated compounds. Phos-tag molecule 
crosslinks to biotin beads or polyacrylamide gels and reversibly captures phosphorylated 
compounds, such as phosphorylated proteins.    
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CHAPTER 2. A PHOS-TAG-BASED APPROACH REVEALS 
THE EXTENT OF PHYSIOLOGICAL ENDOPLASMIC 
RETICULUM STRESS !
Published as: Yang, L., Xue, Z., He, Y., Sun, S., Chen, H., and Qi, L. (2010). A Phos-
Tag-Based Approach Reveals the Extent of Physiological Endoplasmic Reticulum Stress. 
PLoS ONE 5(7): e11621. 
 
2.1 ABSTRACT 
Cellular response to endoplasmic reticulum (ER) stress or unfolded protein response 
(UPR) is a key defense mechanism associated with many human diseases. Despite its 
basic and clinical importance, the extent of ER stress inflicted by physiological and 
pathophysiological conditions remains difficult to quantitate, posing a huge obstacle that 
has hindered our further understanding of physiological UPR and its future therapeutic 
potential. Here we have optimized a Phos-tag-based system to detect the activation status 
of two proximal UPR sensors at the ER membrane. This method allowed for a 
quantitative assessment of the level of stress in the ER. Our data revealed quantitatively 
the extent of tissue-specific basal ER stress as well as ER stress caused by the 
accumulation of misfolded proteins and the fasting-refeeding cycle. Our study may pave 
the foundation for future studies on physiological UPR, aid in the diagnosis of ER-
associated diseases and improve and facilitate therapeutic strategies targeting UPR in 
vivo. 
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2.2 INTRODUCTION 
ER homeostasis is tightly monitored by ER-to-nucleus signaling cascades termed UPR 
(Ron and Walter, 2007). Recent studies have linked ER stress and UPR activation to 
many human diseases including heart complications, neurodegenerative disorders, and 
metabolic syndrome (Kim et al., 2008; Ron and Walter, 2007). Indeed, chemical 
chaperones and antioxidants aiming to reduce ER stress and UPR activation have been 
shown to be effective in mouse models of obesity and type-1 diabetes (Back et al., 2009; 
Basseri et al., 2009; Malhotra et al., 2008). Despite recent advances, our understanding of 
UPR activation under physiological conditions is still at its infancy, largely due to the 
lack of sensitive experimental systems that can detect mild UPR sensor activation. 
 
The underlying mechanisms of UPR signaling and activation induced by chemical drugs 
such as thapsigargin (Tg) are becoming increasingly well-characterized (Ron and Walter, 
2007). Upon ER stress, two key ER-resident transmembrane sensors, inositol-requiring 
enzyme 1 (IRE1!) and PKR-like ER-kinase (PERK) undergo dimerization or 
oligomerization and trans-autophosphorylation via their C-terminal kinase domains, 
leading to their activation (Kim et al., 2008; Ron and Walter, 2007). Phosphorylation of 
IRE1! and PERK has been challenging, if not impossible, to detect under physiological 
conditions. The mobility-shift of IRE1! shown in many studies is very subtle and, as 
demonstrated in this study, may be inaccurate and misleading. In addition, commercially-
available phospho-specific antibodies (e.g. P-Ser724A IRE1! and P-Thr980 PERK) do 
not reflect the overall phosphorylation status of the proteins. Finally, use of these 
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antibodies, if successful, raises the question as to whether Ser724 of IRE1! or Thr980 of 
PERK is indeed phosphorylated under various physiological and disease conditions. 
 
Alternatively, many studies have used downstream effectors such as X-box binding 
protein 1 (XBP1) mRNA splicing, phosphorylation of eukaryotic translation initiation 
factor 2! (eIF2!), C/EBP homologous protein (CHOP) and various genes involved in 
protein folding and ER-associated degradation (ERAD) as surrogate markers for UPR 
activation. This method, albeit convenient, may be confounded by the possibility of 
integrating signals not directly related to stress in the ER. For example, the PERK 
pathway of the UPR is part of the integrated stress response that consists of three other 
eIF2! kinases (Ron and Walter, 2007). Activation of any of these kinases leads to eIF2! 
phosphorylation and induction of ATF4 and CHOP (Ron and Walter, 2007). A recent 
study also showed that ATF4 and CHOP can be regulated translationally in a PERK-
independent manner via the TLR signaling pathways (Woo et al., 2009). Furthermore, 
UPR target genes such as CHOP and ER chaperones can be induced by other signals, 
such as insulin and cytokines/growth factors (Brewer et al., 1997; Miyata et al., 2008). 
Thus, downstream UPR targets alone are not best suited for accurate assessment and 
evaluation of UPR status, especially under physiological and disease settings. 
 
Our previous study utilized the Phos-tag-based system (Kinoshita et al., 2006) to detect 
IRE1! phosphorylation mainly in Tg-treated culture cells (Sha et al., 2009). Here we 
have further modified the system to maximize the resolution of phosphorylation and 
extended the system to detect PERK phosphorylation. Strikingly, our system allows for 
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increased sensitivity in detecting UPR activation and more importantly, accurate 
quantitation of ER stress. This powerful tool allows us to quantitatively measure the 
extent of UPR or ER stress induced by various physiological conditions, including (a) the 
accumulation of misfolded proteins in HEK293T cells, (b) the basal feeding conditions in 
various adult tissues and (c) the fasting- feeding cycle in the pancreas. Our data reveal 
that many tissues and cell types constitutively display mild ER stress and more 
intriguingly, various acute physiological challenges increase ER stress by 2–3 fold over 
basal levels. 
 
2.3 MATERIALS AND METHODS 
Cells and reagents 
HEK293T and MEFs as described in (Sha et al., 2009) were maintained in DMEM 
supplemented with 10% FBS (Hyclone) and 1% penicillin/streptomycin. Tg (EMD 
Calbiochem) and stock CHX (Sigma) were dissolved in DMSO and ethanol, respectively. 
Cells were treated with Tg at indicated concentrations for the indicated times and 
immediately snap-frozen in liquid nitrogen. Phos-tag was purchased from NARD 
Institute (Japan). 
 
Protein lysates, Western blot and Phos-tag gels 
Whole cell or nuclear extraction was performed as we previously described (Chen and 
Qi, 2010; Sha et al., 2009). Lysate protein concentrations were measured using the 
Bradford assay (Biorad) and normalized to 0.5~2 µg/µl using SDS sample buffer. 
Samples were boiled for 5 min prior to loading onto a SDS-PAGE gel. 15–30 µg of 
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whole cell lysates or 1–10 µg of nuclear extracts were used in a mini SDS-PAGE. Phos-
tag gel was modified from our previous report (Sha et al., 2009) with the following 
running conditions: 100 V for 3 h for IRE1! using 25 µM Phos-tag and 15 mA for 15 
min followed by 5 mA for 9.5 h for PERK using 3.5 µM Phos-tag. To achieve optimal 
results, we always run IRE1! and PERK on separate gels using the following conditions. 
Membranes were routinely strip- reprobed for 2–4 times. The IRE1! blot in the Phos-tag 
gel was routinely reprobed with HSP90 (90 kDa vs. 110 kDa IRE1!) as a position 
control. 
Importantly, for both regular and phos-tag gels, gel-running was stopped when the 75 
kDa maker ran off the gel and same amounts of lysates were loaded. Therefore, the 
difference in separating the phosphorylated from the non-phosphorylated species between 
Phos-tag and regular gels was mainly attributable to the effect of Phos-tag incorporated. 
 
Antibodies for Western blot 
GRP78 (goat, 1:1,000), XBP1 (XBP1u/s-specific, rabbit, 1:1,000), CHOP (mouse, 1:500) 
and HSP90 (rabbit, 1:5,000) were purchased from Santa Cruz; p-eIF2!, eIF2!, IRE1! 
and (p)-PERK (rabbit) antibodies were purchased from Cell Signaling and used at 
1:1,000–2,000. Primary antibodies were diluted in 5% milk/TBST or 2% BSA/TBST and 
incubated with PVDF membrane overnight at 4°C. Secondary antibodies were goat anti-
rabbit IgG HRP, goat anti-mouse IgG HRP (Biorad) and donkey anti-goat IgG HRP 
(Jackson ImmunoResearch), all of which were used at 1:10,000. 
 
Mice and tissues 
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Wildtype C57BL/6 mice were purchased from the Jackson Laboratory or bred in our 
mouse facility. For some experiments, mice were injected with 40 µg CHX per g body 
weight (dissolved in 100 µl PBS) for 2 h before they were dissected. Epididymal white 
adipose tissues (WAT) and pancreas were harvested, snap-frozen in liquid nitrogen and 
stored at -80°C. All animal procedures have been described previously (Qi et al., 2006; 
2009) and were approved by the Cornell IACUC (#2007-0051). 
 
Plasmids and transfection 
NHK, wildtype and dominant negative E305Q/E578Q p97 (p97-QQ) plasmids were gifts 
from Qiaoming Long and Fenghua Hu (Cornell University), respectively. HEK293T were 
transfected with plasmids using polyethylenimine (PEI, Sigma) as we recently described 
(Chen and Qi, 2010). Cells were snap-frozen in liquid nitrogen 24 h post-transfection 
followed by Western blot. 
 
Phosphatase treatment 
100 µg cell lysates or tissue lysates were incubated with 2.5 µl calf intestinal phosphatase 
(CIP) or 0.5 µl $ phosphatase ($PPase, New England BioLabs- NEB) in 1X NEB buffer 3 
(100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT) or 1X PMP buffer (50 
mM HEPES, 100 mM NaCl, 2 mM DTT, 0.01% Brij35, NEB) with 1 mM MnCl2 at 37 
or 30°C for 45 or 30 min, respectively. Reaction was stopped by adding 5X SDS sample 
buffer, and the mixture were incubated at 90°C for 5 min. 
 
RNA extraction and Q-PCR 
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Total mRNA extractions were carried out using a combination of Trizol and RNeasy kit 
(Qiagen) for pancreas. RNAs were reverse transcribed using Superscript III kit 
(Invitrogen). For Q- PCR, cDNA was analyzed using the SYBR Green PCR system on 
the Roche 480 LightCycler (Roche). Reactions using samples with no RT and water were 
included as negative controls to ensure the specificity of the Q-PCR reaction. All Q-PCR 
data were normalized to ribosomal l32 gene in the corresponding sample. Primer 
sequences are listed in Supplementary material Table 2.1. 
 
 
 
Image quantification 
Quantification was performed using the NIH ImageJ software where band densities were 
calculated and subtracted from the background. Data are represented as mean ± SEM 
from several independent samples or experiments. 
 
Statistical analysis 
Results are expressed as mean ± SEM. Comparisons between groups were made by 
unpaired two-tailed Student t-test. P<0.05 was considered as statistically significant. All 
experiments were repeated at least twice. 
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2.4 RESULTS 
2.4.1 Visualization of sensor phosphorylation and quantitation of ER stress 
We optimized the separation of phosphorylated IRE1! and PERK proteins in a Phos-tag-
based Western blot (see Methods section and Figure 2.1). The mobility change of IRE1! 
and PERK was reversed by phosphatase treatment (Figure 2.2A). Strikingly, IRE1! and 
PERK hyperphosphorylation patterns were distinct (Figure 2.2A), reflecting various 
levels of phosphorylation upon activation. Dramatically, p-IRE1! exhibited one discrete 
slow-migrating band in the Phos-tag gels, a feature that allows for quantitation of the 
percent of p-IRE1! out of total protein (see below). Upon treatment with Tg, the percent 
of phosphorylated IRE1! out of total IRE1! protein increased from 30 min post-
treatment, peaked around 4 h and slightly decreased at 8–17 h, with nearly 30, 100 and 
80% IRE1! phosphorylated, respectively (Figure 2.2B–C). Similarly, PERK 
hyperphosphorylation increased at 30 min, peaked at 4 h and decreased after 8–17 h. In 
both cases, the dynamic patterns of IRE1! and PERK phosphorylation were either not 
discernible or less impressive in regular gels or using the phospho-specific antibody 
(Figure 1B and D). 
 
The temporal dynamic patterns of IRE1! and PERK phosphorylation as shown above 
indicate that hyperphosphorylation of UPR sensors correlates with the amount of stress in 
the ER. Further supporting this notion, hyperphosphorylation of IRE1! and PERK 
increased with Tg concentrations, peaking and subsequently plateauing at 38 nM Tg upon 
4 h treatment (Figure 1E). Demonstrating the sensitivity and quantitative nature of our 
method, !15% of IRE1! protein was phosphorylated upon 4 nM Tg treatment and 
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increased to !50% under 9 nM Tg (Figure 2.2E–F). In contrast, IRE1! phosphorylation 
was not visible using a regular gel system and phosphorylation of PERK was also much 
less impressive (Figure 2.2E). Thus, our method achieves both accuracy and sensitivity in 
detecting ER stress and UPR activation. We then went on to characterize the extent of ER 
stress under three physiological conditions. 
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Fig. 2.1 Immunoblots of p-Thr980 PERK, IRE1! (left) and total PERK (right) in 
different MEFs treated with or without Tg. (left) IRE1!-/- and PERK-/- MEFs were used; 
(right) wildtype (+/+), PERK-/- (-/-) and PERK-/- MEFs rescued with wildtype PERK (-
/- + wt). 
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Figure 2.2 Visualization and quantitation of ER stress under pharmacological stress. (A) 
Immunoblots of IRE1! (upper) and PERK (lower) proteins in Tg-treated MEFs treated 
with or without $PPase or CIP. (B and D) Immunoblots of IRE1! (B) and PERK (D) 
using the Phos-tag vs. regular gels. MEFs were treated with 75 nM Tg at indicated period 
of time. (C) Quantitation of percent of phosphorylated IRE1! in total IRE1! protein in 
Phos-tag gels shown in B. (E) Immunoblots of IRE1! and PERK in wildtype MEFs 
treated with Tg at indicated concentrations for 4 h. (F) Quantitation of percent of 
phosphorylated IRE1! in total IRE1! protein in Phos-tag gels in E. HSP90 and CREB, 
loading controls. Phos-tag gels are indicated with a bar at the left-hand side. ‘‘0’’ refers 
to the non- or hypophosphorylated forms of the protein whereas ‘‘p’’ refers to the 
phosphorylated forms of the protein. 
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2.4.2 Accumulation of misfolded proteins induces mild ER stress 
Although ER stress was initially characterized as induced by accumulation of unfolded 
proteins (Cox et al., 1993; Kozutsumi et al., 1988; Mori et al., 1993), it remains 
impossible to quantitate the levels of stress inflicted by accumulation of misfolded 
proteins in the ER. To this end, we ectopically expressed the terminally-misfolded a1-
antitrypsin (AT) genetic variant-null Hong Kong (NHK) (Figure 2.3A), a frequently 
mutated allele in human a1 AT deficiency (Sifers et al., 1988) or the dominant-negative 
mutant of p97 (p97- QQ) (Figure 2.3C), a member of the AAA-ATPase protein family 
involved in ERAD (Ye et al., 2001). In both cases, IRE1! and PERK were 
phosphorylated when compared to cells overexpressing control or wildtype proteins 
(Figure 2.3A and C), indicating the specificity of sensor activation in response to 
misfolded proteins. Interestingly, IRE1! phosphorylation nearly tripled in both cases 
reaching 20–30% (Figure 2.3B–D). Similar observations were obtained in Sel1L-
deficient MEFs (not shown), in which ERAD is defective (Francisco et al., 2010). Thus, 
our data revealed quantitatively the extent of ER stress induced by accumulation of 
misfolded proteins in the ER, a finding that was impossible using regular systems under 
similar running conditions (Figure 2.3A and C). 
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Figure 2.3 Accumulation of misfolded proteins induces mild ER stress. (A and C) 
Immunoblots of IRE1! and PERK in HEK293T cells transfected with the indicated 
plasmids for 24 h. NHK, the unfolded form of a1-antitrypsin; p97-QQ, dominant negative 
form of p97-WT. ER-dsRed and GFP, negative control plasmids. HSP90, a position and 
loading control. (B and D) Quantitation of percent of phosphorylated IRE1! in total 
IRE1! protein in Phos-tag gels shown in A, C. Values are mean ± SEM *, P<0.05 using 
unpaired two-tailed Student’s t-test. Representative data from at least three independent 
experiments shown. 
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2.4.3 Many tissues exhibit basal ER stress under feeding conditions 
We then analyzed the levels of basal ER stress in various tissues from adult mice under 
2h refeeding after 20h fasting. Intriguingly, many tissues exhibited slower electrophoretic 
mobility of IRE1! and PERK proteins (Figure 2.4A and 2.5A). The mobility shift of 
IRE1! and PERK was specific for phosphorylation as it was reversed by phosphatase 
treatment (Figure 2.4B and 2.5B); importantly, this was caused by signals from the ER as 
it was attenuated by I.P. injecting the mice with a protein translation inhibitor, 
cycloheximide (CHX) (Figure 2.4C). Quantitatively, phosphorylated IRE1! accounted 
for over 40% of total IRE1! protein in the pancreas and ~10% in most of the other tissues 
(Figure 2.4D). Our data is in line with an early finding in which the XBP1-GFP reporter 
mice exhibited basal UPR primarily in the pancreas (Iwawaki et al., 2004). Pointing to 
the complexity of tissue-specific UPR, IRE1! exhibited multiple slower migrating bands 
and PERK was beyond the detection limit in skeletal muscle (Figure 2.4A and 2.5A). The 
nature of these slower migrating bands in the IRE1! blot was not due to phosphorylation 
as they were resistant to phosphatase treatment (Figure 2.5C). 
 
 
 
 
!*&!!!
 
Figure 2.4. Many tissues exhibit basal ER stress under feeding conditions. (A) 
Immunoblots of IRE1! and PERK in various tissues of wildtype mice. WAT, white 
adipose tissues; Panc, pancreas; Muscle, gastrocnemius. HSP90, a position and loading 
control. (B–C) Immunoblots of IRE1! and PERK in tissue lysates treated with $PPase 
(B) or in pancreatic and WAT lysates prepared from mice injected with CHX (C). (D) 
Quantitation of percent of phosphorylated IRE1! in total IRE1! protein in various tissues 
shown in A. Values are mean ± SEM. Representatives of at least two independent 
experiments shown. 
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Figure 2.5 (A) Immunoblots of IRE1! (top) and PERK (bottom) in various tissues of 
wildtype mice under feeding conditions, an independent experiment from the one shown 
in Fig. 2.4 A. WAT, white adipose tissues; Panc, pancreas; Muscle, gastrocnemius. (B) 
Original Phos-tag whole-gel images for the data shown in Fig. 2.4B. Note the specificity 
of the antibody and the complete reverse of phosphorylation upon phosphatase treatment. 
(C) Immunoblots of IRE1! and PERK in muscle lysates treated with $PPase. The 
multiple bands of IRE1! in the muscle are not due to hyperphosphorylation and PERK 
protein levels are beyond detection limit. (D) Immunoblots of IRE1! and PERK in 
lysates extracted from different regions of the pancreas of 13-week-old wildtype mice 
under the 20 h-fasting (F) and 2 h-refeeding (R) conditions. The position of the pancreas 
is relative to the duodenum (proximal, middle or distal) - see the diagram on top. HSP90, 
a loading control. Phos-tag gels are indicated with a bar at the left-hand side. 
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2.4.4 Refeeding induces mild ER stress in the pancreas 
We then conducted an in-depth analysis of UPR activation during the fasting-refeeding 
process in the pancreas (20 hr fasting followed by 2 hr feeding). Indeed, refeeding 
significantly increased phosphorylation of both IRE1! and PERK (percent of p-IRE1! 
under fasting vs. refeeding: 8.7±4.3% vs. 29.5±5.4%; P<0.05) (Figure 2.6A–B). This 
effect was independent of the region of the pancreas sampled (Figure 2.5D). Supporting 
the importance of our method in analyzing mild physiological UPR, similar running 
conditions in regular gels resulted in a much less impressive mobility-shift for PERK 
(Figure 2.6A). This mild PERK phosphorylation was undetectable using the phospho-
PERK antibody (Figure 2.6A). In addition, although comparing to IRE1! from fasted 
animal tissues, IRE1! did exhibit a slightly slower mobility shift upon refeeding in 
regular gels after prolonged gel running conditions, this shift did not reflect the overall 
phosphorylation status of IRE1! as revealed by the Phos-tag gel (Figure 2.6A). 
Furthermore, phosphorylation of IRE1!, an immediate downstream effector of PERK, 
did not change (Figure 2.6A). Finally, while some UPR targets such as CHOP, ERDJ4 
and P58IPK were induced upon refeeding (Figure 2.6C), both the mRNA and protein 
levels of Grp78, an ER chaperone, were not altered (Figure 2.6A and C). Thus, our data 
demonstrated that the fasting- feeding cycle acutely stimulates mild UPR activation in the 
pancreas. 
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Figure 2.6. Fasting-refeeding induces mild ER stress in pancreas. (A) Immunoblots of 
lysates from the pancreas of wildtype mice either fasted or fasted followed by 2 h 
refeeding (refed). For the PERK blot, a mixture of all 6 samples treated with CIP were 
included as a control. For the p-PERK blot, Tg-treated MEF cell lysates with or without 
CIP treatment were included as a control. HSP90, a loading control. (B) Quantitation of 
the percent of phosphorylated IRE1! in pancreas under fasting and refeeding conditions 
shown in A (N = 4 mice per cohort). (C) Q-PCR analyses of UPR genes in the pancreas 
under either fasting or refeeding. Values are mean ± SEM. Xbp1t, total Xbp1; 
Xbp1s/Xbp1t, splicing efficiency. N = 3–4 mice. *, P<0.05 using unpaired two-tailed 
Student’s t-test. Representatives of at least two independent experiments shown. 
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2.5 DISCUSSION 
In summary, we have optimized a sensitive and simple Phos-tag-based system to 
quantitatively assess ER stress and UPR activation with the following major advantages: 
First, dynamic ranges of PERK and IRE1! phosphorylation can be more sensitively 
visualized compared to regular SDS-PAGE gels; this is particularly important for 
physiological UPR where ER stress can be so mild that traditional methods may no 
longer be accurate or reliable. Second, the major breakthrough of our method lies in the 
unique pattern of IRE1! phosphorylation in the Phos-tag gel, which allows for a 
quantitative assessment of ER stress. To our knowledge, this is the first demonstration of 
quantitation of ER stress under physiological or pathological settings (e.g. the fasting-
refeeding cycle or the accumulation of misfolded proteins). Finally, in comparison to 
using commercially-available phospho-specific antibodies (e.g. P-Ser724A IRE1! and P-
Thr980 PERK), our method not only provides a complete view of the overall 
phosphorylation status of IRE1! and PERK proteins, but also circumvents the issue of 
whether these specific residues are indeed phosphorylated under certain physiological 
conditions. 
 
Our data reveal that many tissues and cell types display constitutive basal UPR activity, 
presumably to counter misfolded proteins passing through the ER. This observation is in 
line with an early report demonstrating that under physiological conditions removal of 
these misfolded proteins in yeast requires coordinated action of UPR and ERAD (Travers 
et al., 2000). Taking it one step further, our data show that a fraction of mammalian 
IRE1! and PERK is constitutively active in many tissues, with ~10% IRE1! being 
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phosphorylated and activated. This low level of IRE1! activation and ER stress in many 
tissues may provide a plausible explanation for the inability of an earlier study to detect 
basal UPR in the XBP1s-GFP reporter mice (Iwawaki et al., 2004). We believe that this 
basal UPR activity, especially the IRE1!-XBP1 branch, is critical in maintaining ER 
homeostasis and providing quality control as supported by the embryonic lethality of 
IRE1! and XBP1- deficient mice (Masaki et al., 1999; Reimold et al., 2000; Ron and 
Walter, 2007; Wu and Kaufman, 2006; Zhang et al., 2005). It is noteworthy that in 
skeletal muscles, IRE1! exhibited multiple non-phosphorylated bands while PERK 
protein is beyond the detection limit. As the IRE1!-XBP1 pathway is active in adult 
skeletal muscles (Iwawaki et al., 2004), the role of UPR in myocytes is an interesting 
question as it may offer new insights into physiological UPR. 
 
As exocrine pancreatic acinar cells account for over 80% of the pancreatic mass, 
pancreatic ER stress observed under the fasting- feeding cycle likely reflects the acute 
elevation of protein synthesis in acinar cells in response to food intake (Morisset and 
Webster, 1972). Indeed, mice with XBP1 or PERK deficiency exhibit defective 
development of exocrine pancreas (Harding et al., 2001; Lee et al., 2005; Zhang et al., 
2002), suggesting an indispensable role for UPR in countering the fluctuating stress 
associated with food intake. While UPR is mildly active under fasting presumably to 
attenuate protein synthesis as previously suggested (Zhang et al., 2002), our data showed 
a 3-fold increase of IRE1! phosphorylation, i.e. UPR, to enhance ER homeostasis in 
preparation for an upcoming wave of protein synthesis. Our results are in line with earlier 
observations demonstrating that ER in pancreatic acinar cells becomes dilated within 2–4 
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h refeeding (Slot and Geuze, 1979; Slot et al., 1979). Nonetheless, it is quite surprising 
that ER stress in pancreatic cells fluctuates with the fasting-feeding cycle because acute 
mild UPR would expectedly reset proteostasis upon each fasting-feeding cycle, leading to 
the expansion of the proteostasis network and adaptation (Powers et al., 2009). Hence, we 
postulate that the proteostasis network in acinar cells is very flexible in order to respond 
to many variables in the feeding process. The same is likely to be true for pancreatic islet 
cells. 
 
There are several potential applications for our method in both basic and clinical 
research. First, our method may help elucidate the activation mechanisms for IRE1! and 
PERK. The effect of critical residues or inter-/intra-molecular interactions on sensor 
activation as well as branch-specific activation of non-canonical UPR pathways can now 
be accurately measured and quantitated. Second, our method may aid in the diagnosis of 
UPR-associated diseases by providing a more sensitive tool for detecting ER stress. The 
knowledge of the extent of ER stress in a given tissue of a patient may help assess disease 
progression. Finally, our method may assist in drug development and design. The 
efficacy of drugs such as chemical chaperones or antioxidants on ER stress can be 
quantitatively measured based on sensor activation, circumventing the complications 
associated with crosstalk among various pathways. 
 
As ER stress is being implicated in an increasing number of physiological processes as 
well as human diseases such as cancer, liver diseases, neurodegeneration and type-1 
diabetes (Kim et al., 2008; Ron and Walter, 2007), new strategies and approaches 
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enabling a comprehensive understanding of UPR in physiological and disease settings are 
urgently needed to facilitate drug design targeting UPR in conformational diseases (Kim 
et al., 2008). The ability to directly visualize and quantitate UPR activation is an 
important step towards gaining novel insights into physiological UPR and improving 
therapeutic strategies targeting UPR in vivo. 
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CHAPTER 3. PHENFORMIN ACTIVATES UNFOLDED 
PROTEIN RESPONSE IN AN AMP-ACTIVATED PROTEIN 
KINASE (AMPK)-DEPENDENT MANNER !
Published as: Yang, L., Sha, H., Davisson, R.L., and Qi, L. (2013). Phenformin Activates 
the Unfolded Protein Response in an AMP-activated Protein Kinase (AMPK)-dependent 
Manner. J Biol Chem 288, 13631–13638. 
 
3.1 ABSTRACT 
Activation of unfolded protein response (UPR) is associated with the disruption of 
endoplasmic reticulum (ER) homeostasis and has been implicated in the pathogenesis of 
many human metabolic diseases, including obesity and type-2 diabetes. However, the 
nature of the signals activating UPR under these conditions remains largely unknown. 
Using a method that we recently optimized to directly measure UPR sensor activation, 
here we screen the effect of various metabolic drugs on UPR activation and show that an 
antidiabetic drug phenformin activates UPR sensors IRE1! and PERK via both ER-
dependent and -independent manners. Mechanistically, AMPK activation is required but 
not sufficient to initiate phenformin-mediated IRE1! and PERK activation, suggesting 
the involvement of additional factor(s). Interestingly, activation of the IRE1!, but not the 
PERK pathway, is partially responsible for the cytotoxic effect of phenformin. Together, 
our data show the existence of a noncanonical UPR whose activation requires cytosolic 
kinase AMPK, adding another layer of complexity to UPR activation under metabolic 
stress. 
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3.2 INTRODUCTION 
Alteration of ER homeostasis initiates signaling pathways, which allow for the 
communication between ER and other cellular organelles, collectively termed unfolded 
protein response (UPR). Activation of UPR has been associated, causally in some 
instances, with various physiological and pathological conditions such as cancer, obesity, 
type-1 diabetes and cardiovascular diseases (Sha et al., 2011; Wang and Kaufman, 2012). 
The expansion of ER folding capacity and the reduction of nascent peptide load by UPR 
assist the recovery and reset of ER homeostasis. However, UPR can act as a double- 
edged sword as prolonged UPR activation may induce apoptosis (Walter and Ron, 2011). 
 
Upon accumulation of misfolded proteins in the ER lumen, canonical UPR in mammals 
is initiated by the activation of three major ER- transmembrane sensors IRE1!, PERK 
and ATF6 (Walter and Ron, 2011). Under ER stressed conditions, binding of misfolded 
proteins and/or the dissociation of chaperone GRP78 results in IRE1! dimerization, 
trans-autophosphorylation, oligomerization with the help of actin cytoskeleton (He et al., 
2012) and the activation of its RNase activity (Korennykh et al., 2009; Shamu and 
Walter, 1996). Activated IRE1! splices 26 nucleotides from the Xbp1 mRNA to generate 
Xbp1s (spliced) transcript, which encodes a transcription factor XBP1s responsible for 
the induction of various ER chaperones (He et al., 2010; Liou et al., 1990). The activation 
mechanism for PERK may be similar to that of IRE1! since their luminal domains are 
inter-changeable (Liu et al., 2000). However, unlike IRE1!, PERK has only a kinase 
domain, which trans-autophosphorylates itself and phosphorylates eukaryotic translation 
initiation factor 2! (eIF2!) upon activation (Harding et al., 1999). Phosphorylation of 
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eIF2! attenuates global translation while paradoxically increases the expression of ATF4 
and CHOP (Lu et al., 2004a). Unlike IRE1! and PERK, ATF6 translocates to the Golgi 
and undergoes proteolysis to release its N-terminal domain, which encodes an active 
transcription factor. N-terminal ATF6 may be responsible for the upregulation of genes 
involved in protein folding, trafficking and degradation (Chen et al., 2002a). 
 
Many of the mechanistic insights into UPR activation were garnered from the use of 
pharmacological drugs, such as dithiotheitol (DTT) that blocks disulfide bond formation 
(Tatu et al., 1993), thapsigargin (Tg) that inhibits ER calcium pump (Thastrup et al., 
1990) and tunicamycin (Tm) that impairs ER protein glycosylation (Dennis et al., 1999). 
Physiologically, UPR has been detected in various metabolic status changes such as in 
obese liver and adipose tissues (Ozcan et al., 2004) and in refeeding pancreas (Yang et 
al., 2010). Interestingly, glucagon-induced IRE1! activation is dependent on protein 
kinase A (PKA), supporting the possibility of direct regulation of UPR by cytosolic 
metabolic pathways (Mao et al., 2011). However, how metabolic stress activates UPR is 
poorly understood. 
 
To address whether and how metabolic signals crosstalk with UPR pathways and 
facilitate UPR activation, we take advantage of a recently developed Phos-tag-based 
method. This method allows for visual assessment and quantitative detection of UPR 
activation at the sensor level (Qi et al., 2011; Sha et al., 2009; Yang et al., 2010). We 
tested the effect of several metabolic drugs to mimic physiological energy deprivation 
conditions on UPR. To our surprise, among all the tested drugs, only the hypoglycemic 
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agent phenformin potently activated IRE1! and PERK pathways. In addition, 
overexpression of chaperone GRP78 attenuated phenformin- mediated UPR activation 
while translational inhibition had no effect. Mechanistically, phenformin-induced UPR 
required kinase activities of both UPR sensors as well as AMPK, but not liver kinase B1 
(LKB1). Interestingly, an AMPK agonist AICAR was not sufficient to activate UPR, 
suggesting the involvement of additional factor(s) in phenformin-mediated UPR 
activation. Thus, our study implicates the requirement of AMPK in phenformin-mediated 
UPR activation and provides a framework for further studies to understand the crosstalk 
between metabolic signals and UPR activation. 
 
3.3 MATERIALS AND METHODS 
Cell lines 
HepG2, 266-6, 3T3-L1, MEFs, and phoenix cells were maintained in DMEM 
supplemented with 10% FBS and 1% penicillin/streptomycin. PERK null 
(PERK-/-) and WT control MEFs were gifts from Dr. Douglas Cavener, Penn State 
University. AMPK!1!2-/- and AMPK+/+, LKB1-/- and LKB1+/+ MEFs (gifts from Dr. 
Reuben Shaw, Salk Institute) were previously described (Gwinn et al., 2008). IRE1!-/- 
MEFs stably expressing WT and mutant IRE1! were generated as previously described 
(Xue et al., 2011). XBP1i- or luciferase RNAi (CONi)- expressing 3T3L1 cells were 
previously described (Sha et al., 2009). 
 
Reagents 
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Tunicamycin (Tm) and thapsigargin (Tg) (EMD Calbiochem, Billerica, MA) were 
dissolved in DMSO and used at 5 µg/ml and 75~300 nM, respectively. AICAR ((5-
aminoimidazole-4-carboxamide ribonucleotide, Toronto Research Center, Toronto, 
Ontario, Canada) was used at 2 mM. Phenformin, 2-deoxy- D-glucose (2DG), rotenone 
and rapamycin (Sigma Aldrich, St. Louis, MO) were used at 5 mM, 2 mM, 1 µM and 80 
µM, respectively. CHX from EMD Calbiochem was dissolved in ethanol and used at 50 
µg/ml. Selection drugs puromycin and G418 were purchased from Sigma and EMD 
Calbiochem, respectively. Phos-tag was purchased from the NARD Institute (Amagasaki, 
Japan). 
 
Drug treatment 
106 cells were plated in 6-well plates in culture medium and incubated overnight. Before 
experiments, medium was changed to serum-free DMEM supplemented with 0.05% BSA 
and 1% penicillin/streptomycin. Half an hour later, drugs were added for the indicated 
time. For CHX treatment, cells were pre-treated with 50 µg/ml CHX for 30 min and 
throughout the drug treatment. At the end of experiments, cells were snap-frozen in liquid 
nitrogen before analysis. 
 
Plasmids 
WT and K618A mouse PERK cDNA (gifts from Dr. David Ron) (Harding et al., 1999) 
were subcloned into the pBabe-puro vector. WT human IRE1! cDNA in the pMSCV 
retroviral vector was provided by Dr. Claudio Hetz (University of Chile) (Hetz et al., 
2006). pMSCV-K599A IRE1! was generated by mutagenesis (Xue et al., 2011). 
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Stable cell line generation 
PERK-/- MEFs stably expressing pBabe-WT and mutant PERK, and 3T3-L1 fibroblasts 
stably expressing PERKi and its control (CONi) were generated using retroviral 
transduction as previously described (Sha et al., 2009). pSuper- neo vectors (Dr. Lee 
Kraus, UT Southwestern Medical Center) encoding CONi (gatatgggctgaatacaaa) or 
PERKi (agtggaaagctgaggtata) were used for retroviral transduction and stable cell line 
generation. 
 
Adenoviral infection 
HepG2 cells in 12-well plates were infected with 5 µl of 1012 particles/ml adenoviruses 
encoding LacZ or GRP78 (Young et al., 2012). After overnight incubation, cells were 
incubated in DMEM with 0.05% BSA and 1% penicillin/streptomycin for 0.5h and then 
treated with mock, Tg, Tm or phenformin. 
 
Western blot 
Cell nuclear fractionation, whole cell lysate preparation and Western blot analysis were 
performed as described (Sha et al., 2009). Phosphatase treatment of whole cell lysates 
and Phos-tag gel was performed as described (Qi et al., 2011; Yang et al., 2010). 
Quantification of Western blots was done using the ChemiDoc XRS+ system with 
ImageLab software (Biorad, Hercules, CA) or by ImageJ. 
Antibodies  
GRP78 (goat, 1:1000), ATF4 (rabbit, 1:1,500), CHOP10 (mouse, 1:500), XBP1 (rabbit, 
1:1,000) and HSP90 (rabbit, 1:5,000) were purchased from Santa Cruz (Santa Cruz, CA). 
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(p-T172) AMPK (rabbit, 1:1,000), (p-S79) ACC (rabbit, 1:1,000), (p-S51) eIF2! (rabbit, 
1:1,000), IRE1! (rabbit, 1:1,000), (p-T980) PERK (rabbit, 1:1,000), and (p-S240/244) S6 
(rabbit, 1:1,000) antibodies were purchased from Cell Signaling (Beverly, MA); CREB 
antibody (rabbit, 1:6,000) was from Dr. Marc Montminy (Salk Institute). Secondary 
antibodies were goat anti-rabbit and anti-mouse IgG HRP and donkey anti-goat HRP 
used at 1:10,000 (Biorad). 
 
Quantitative PCR (qPCR) and RT-PCR 
Total mRNA extractions were carried out using Trizol- based protocol (Molecular 
Research Center, Inc.) and reverse transcribed using Superscript III kit (Invitrogen, 
Calsbad, CA). qPCR was performed with primers described in (Yang et al., 2010). RT-
PCR analysis of spliced and unspliced Xbp1 was performed as described (Sha et al., 
2009). RT-PCR products were separated by electroporesis on a 2% agarose gel 
(Invitrogen) containing ethidium bromide and visualized using Bio-Rad ChemiDoc 
XRS+ system. 
 
Survival assay 
2-5x104 3T3-L1 fibroblasts stably expressing control RNAi, XBP1i or PERKi were 
plated in each well of a 24-well plate, incubated for overnight and treated with 5 mM 
phenformin for the indicated time. Cells were snap-frozen in liquid nitrogen and thawed 
at room temperature (25°C). DNA content was measured using CyQuant kit (Invitrogen) 
per supplier’s protocol as an indication of relative cell numbers. 
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Statistical analysis 
All experiments have been repeated at least twice. Results are expressed as mean ± s.e.m. 
Comparisons between groups were made by unpaired two-tailed Student t-test, except 
that in the cell survival assay ANOVA was used. P<0.05 was considered as statistically 
significant. 
 
3.4 RESULTS 
3.4.1 Phenformin induces IRE1" and PERK phosphorylation 
To study the link between metabolic pathways and UPR, we tested the effect of various 
metabolic drugs on UPR sensor activation in hepatoma cell line HepG2. Several drugs 
with capacity to affect cellular metabolic state were selected, such as inhibitors of 
mitochondrial electron transport phenformin (Davidoff, 1968) and rotenone (CHANCE et 
al., 1963), a nonmetabolizable glucose analog 2DG that blocks glycolysis (SOLS and 
CRANE, 1954), and an inhibitor of mTOR complex rapamycin (Brown et al., 1994). 
Following 2 h treatment, whole cell lysates were prepared and separated on Phos-tag-
containing or regular SDS-PAGE gels to visualize IRE1! and PERK phosphorylation, 
respectively. The slower- migrating bands of IRE1! and PERK represent their 
phosphorylated forms as they are sensitive to phosphatase treatment (Fig. 3.1A). Detailed 
characterization of UPR activation using the Phos- tag-based methods has been 
previously described (Qi et al., 2011; Sha et al., 2009; Yang et al., 2010). Of note, we 
were not able to assess the activation of the ATF6 pathway due to the lack of a reliable 
antibody for endogenous ATF6 proteins. 
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As expected, most metabolic drugs affected cellular metabolic state within the 2-hour 
treatment as reflected by the decreased phosphorylation of ribosomal protein S6 (Fig. 
3.1B). However, only phenformin, a derivative of biguanides, significantly elevated 
IRE1! and PERK phosphorylation, to a level comparable to that of classical ER stressor 
such as Tg or Tm (Fig. 3.1C-D, and data not shown). The effect of phenformin on UPR 
sensors was not merely due to the inhibition of mitochondrial electron transport as 
rotenone, another mitochondrial respiration inhibitor, had the opposite effect on IRE1! 
phosphorylation (Fig. 3.1C-D). 
 
To further characterize the nature of phenformin- mediated activation of IRE1! and 
PERK, we performed the following two experiments to attenuate ER stress. First, cells 
were pre-treated with a protein translation inhibitor CHX. As expected, inhibition of 
protein translation greatly reduced both basal and Tg-induced IRE1! and PERK 
phosphorylation (Fig. 3.1C-D). By contrast, phenformin-mediated IRE1! and PERK 
activation remained unaffected by CHX (Fig. 3.1C-D).  
 
Second, we infected HepG2 cells with an adenovirus encoding the ER chaperone GRP78, 
which is known to increase ER folding capacity and thereby alleviate UPR activation 
(Wang et al., 1996; Young et al., 2012). Overexpression of GRP78 significantly 
attenuated phenformin-mediated IRE1! and PERK phosphorylation compared to the 
controls (Fig. 3.1E-F). The effect of GRP78 on Tg-induced ER stress in HepG2 cells was 
modest likely due to the expression level of GRP78, as more dramatic effect of GRP78 
was observed in HEK293T cells where viral infection was more efficient (Fig. 3.1G). 
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Thus, we conclude that the accumulation of unfolded/misfolded proteins at least in part 
responsible for phenformin-mediated UPR activation. 
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Figure 3.1 Phenformin treatment activates UPR sensors IRE1! and PERK. (A) Phos-tag 
(PT) analysis of IRE1! and Western blot analysis of PERK in HepG2 cells treated with 
75 nM thapsigargin (Tg) for 2 h. Whole cell lysates were treated with or without $ 
phosphatase (PP). HSP90, a loading control. (B) Western blot analysis of (p-)S6 in 
HepG2 cells treated with phenformin (Ph, 5 mM), 2-deoxy-D-glucose (2DG, 2 mM), 
rotenone (Rot, 1 %M), or rapamycin (Rap, 80 %M) and tunicamycin (Tm, 5 %g/ml) for 2 
h. (C) Western blot analysis of IRE1! and PERK in HepG2 cells treated with various 
drugs as in A and B. In the cycloheximide (CHX) group, HepG2 cells were pre-treated 
with 50 %g/ml CHX for 30 min and throughout the drug treatments. (D) Quantitation of 
the percent of phosphorylated IRE1! in total IRE1! (hereafter referred to as %IRE1!) in 
(C). (E-F) Western blot analysis of IRE1! and PERK in HepG2 (E) and HEK293T cells 
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(F) infected with adenoviruses overexpressing LacZ or GRP78 followed by drug 
treatment; and quantitation of two independent experiments of E shown in (F). Data are 
representative of at least two independent experiments. Values as mean ± s.e.m with three 
repeats. Statistical analysis was done by t-test (*, p<0.05). 
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3.4.2 Phenformin-mediated IRE1" and PERK activation is a general phenomenon 
To determine whether this is a general phenomenon, we examined in detail the effect of 
phenformin on UPR in various cell types. In MEFs, phenformin treatment increased 
AMPK phosphorylation and decreased S6 phosphorylation as expected (Fig. 3.2A). 
Consistently with the data in HepG2 cells shown in Fig. 1, phenformin induced IRE1! 
phosphorylation (Fig. 3.2A) and Xbp1 mRNA splicing (Fig. 3.2B). Similarly, phenformin 
increased PERK and eIF2! phosphorylation and CHOP protein levels (Fig. 3.2C). 
Moreover, the activation of IRE1! and PERK pathways was supported by the increased 
transcript levels of UPR target genes, including Grp78, Erdj4, Chop and Gadd34 (Fig. 
3.2D). Similar observations were obtained in pancreatic acinar 266-6 cells (Fig. 3.2E), " 
cell line INS-1 and macrophage cell line RAW (not shown). Thus, our data show that 
phenformin- induced UPR activation is a general phenomenon regardless of cell types. 
 
 
!,'!!!
 
Figure 3.2 Phenformin effect on UPR activation is a general phenomenon. (A) Western 
blot analysis of IRE1! in MEFs treated with 75 nM Tg for 2 h or 5 mM Ph at the 
indicated times. (B) RT-PCR analysis of Xbp1 mRNA splicing in MEFs treated as in (A). 
Ribosomal gene L32, a loading control. (C) Immunoblots of the PERK pathway in MEFs 
treated as in (A). (D) qPCR analysis of UPR targets in MEFs treated as in (A). mRNA 
levels of each gene were normalized to L32. (E) Western blot analysis of IRE1! and 
PERK in pancreatic acinar cell 266-6 treated with 5 mM Ph for 2h. HSP90 and CREB, 
loading controls. Data are representative of three independent experiments. Quantitation 
from one experiment shown below the gel. Statistical analysis was done by t-test 
comparing each treatment with non-treated control (*, p<0.05. **, p<0.01. *** p<0.001) 
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3.4.3 AMPK is required for phenformin-mediated IRE1" and PERK activation 
Phenformin effect is partially mediated by AMPK (Zhou et al., 2001). We next asked 
whether AMPK is required for the phenformin-mediated UPR activation. To this end, we 
examined UPR activation in AMPK-/- MEFs lacking both AMPK!1 and !2 catalytic 
domains. Indeed, the activation of the IRE1! pathway, including IRE1! phosphorylation 
and Xbp1 mRNA splicing, was completely abolished by the loss of AMPK (Fig. 3.3A-B). 
This was not due to intrinsic defects of UPR activation in AMPK-/- cells as Tg-induced 
IRE1! activation was not blocked (Fig. 3.3A-B). At the mRNA level, AMPK deficiency 
blocked phenformin- but not Tg- induced Erdj4 expression (Fig. 3.3C). Similarly, 
activation of the PERK pathway by phenformin, but not Tg, were significantly reduced in 
AMPK-/- MEFs as shown by Thr980 PERK phosphorylation (Fig. 3.3D) and induction of 
CHOP at both mRNA and protein levels (Fig. 3.3C and 3.3E). Of note, lack of 
phosphorylation of ACC, a direct AMPK target, in AMPK-/- MEFs in response to 
phenformin confirmed the complete loss of AMPK activity (Fig. 3.3D). Thus, our data 
suggest that AMPK is required for phenformin-mediated IRE1! and PERK activation. 
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Figure 3.3 AMPK is required for phenformin-mediated UPR activation. (A) Western blot 
analysis of IRE1! in AMPK-/- or WT MEFs treated with 75 nM Tg or 5mM Ph for 6 h. 
(B) RT-PCR analysis of Xbp1 mRNA splicing in AMPK+/+ and AMPK-/- MEFs treated 
with 75 nM Tg and 5 mM Ph for the indicated times. (C) qPCR analysis of mRNA level 
changes of Erdj4 and Chop in AMPK+/+ and AMPK-/- MEFs treated as in (B). (D-E) 
Western blot analysis of the PERK pathway, p-T980 PERK (D) and CHOP (E), in 
AMPK+/+ and AMPK-/- MEFs treated as in (A). HSP90 and CREB, loading controls. 
Data are representative of three independent experiments. Quantitation from one 
experiment shown below the gel. Statistical analysis was done by t-test between 
AMPK+/+ and AMPK-/- MEFs for each treatment (*, p<0.05. **, p<0.01. *** p<0.001). 
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3.4.4 LKB1 is dispensable for phenformin effect 
LKB1 is an upstream kinase of AMPK in some settings (Hawley et al., 2003; Lizcano et 
al., 2004). We next asked whether LKB1 is required in phenformin-mediated UPR 
activation. Comparable levels of IRE1! and PERK hyperphosphorylation were observed 
in LKB1-/- and wildtype cells treated with phenformin (Fig. 3.4A). This was further 
supported by the similar induction of CHOP protein (Fig. 3.4A). Thus, LKB1 is 
dispensable for phenformin-mediated UPR activation. Indeed, phenformin-induced ACC 
phosphorylation did not require LKB1 (Fig. 3.4B), suggesting the presence of other 
AMPK upstream kinase(s). 
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Figure 3.4 LKB1 is dispensable for phenformin-mediated UPR activation. (A) Western 
blot analysis of IRE1! and PERK pathways in LKB1+/+ and LKB1-/- MEFs treated with 
75 nM Tg or 5mM Ph for 6 h. (B) Immunoblots of (p)-ACC in LKB1+/+ and LKB1-/- 
MEFs treated with drugs for 8 h. HSP90 and CREB, loading controls. Data are 
representative of three independent experiments. Quantitation from one experiment 
shown below the gel. Of note, the blots shown in this figure were derived from the same 
exposure of the same gels with the irrelevant lanes cut off. 
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3.4.5 AMPK activation is not sufficient to activate IRE1" and PERK 
We are next asked whether AMPK is sufficient to induce UPR using another AMPK 
agonist AICAR (Sullivan et al., 1994). Treatment of AICAR expectedly increased AMPK 
phosphorylation at Thr172 and decreased S6 phosphorylation (Fig. 3.5A). However, no 
increase of IRE1! and PERK phosphorylation was observed even with prolonged 
treatment (Fig. 3.5B), arguing that AMPK activation was not sufficient to promote IRE1! 
and PERK activation. Rather, we noticed that IRE1! phosphorylation was decreased with 
time, suggesting that AMPK activation alone may downregulate ER stress, likely through 
the inhibition of protein translation (reduced p-S6). This observation is consistent with 
previous reports showing that AMPK activation alone alleviates ER stress in various cell 
types (Dong et al., 2010; Gomez et al., 2008; Lee et al., 2012; Lu et al., 2012; Mayer and 
Belsham, 2010; Terai et al., 2005). 
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Figure 3.5 AMPK activation is not sufficient to activate UPR. Western blot analysis of 
(p-) AMPK and (p)-S6 (A) and IRE1! and PERK (B) in WT MEFs treated with 2 mM 
AICAR for the indicated times. Note the suppressive effect of AICAR on IRE1! 
activation in B. Data are representative of three independent experiments. Quantitation 
from one experiment shown below the gel. HSP90, the loading control. 
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3.4.6 Kinase activities of both IRE1" and PERK are indispensable for their 
activation by phenformin 
In canonical UPR, kinase activities of IRE1! and PERK are required for the 
transautophosphorylation and activation. To test the involvement of kinase activities of 
IRE1! and PERK in phenformin-mediated activation, we generated PERK knockout 
(PERK-/-) MEFs stably expressing empty vector pBabe, WT PERK or kinase-dead 
K618A PERK (Bertolotti et al., 2000), and measured phenformin-induced 
phosphorylation. The kinase-dead K618A mutation specifically prevented PERK from 
auto-phosphorylation and activating downstream targets ATF4 and CHOP under both Tg 
and phenformin treatment (Fig. 3.6A). Similarly, only WT but not kinase-dead K599A 
IRE1! was responsive to phenformin treatment (Fig. 3.6B). In conclusion, intact IRE1! 
and PERK kinase domains are required for the phenformin effect, suggesting that 
phenformin effect is mediated through the kinase activities of IRE1! and PERK. 
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Figure 3.6 Kinase activities of IRE1! and PERK are required for the phenformin effect. 
(A) Western blot analysis of the PERK pathway in PERK-/- MEFs stably expressing 
empty vector, WT or K618A kinase-dead PERK treated with 300 nM Tg and 5mM Ph for 
2 h. Wild type MEFs as control. ATF4 and CHOP were detected using nuclear extracts of 
the same cells. (B) Western blot analysis of IRE1! phosphorylation in IRE1!-/- MEFs 
stably expressing WT or K599A IRE1! treated with phenformin (5 mM) for the indicated 
times. HSP90, loading/position controls. CREB, a loading control for nuclear fraction. 
Data are representative of at least two independent experiments. 
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3.4.7 Activation of IRE1"-XBP1 pathway partially mediates the cytotoxicity of 
phenformin 
Prolonged treatment of phenformin has cytotoxicity as its potential side effect (Heishi et 
al., 2008). As UPR is a key determinant of cell fate, we next asked whether IRE1! and 
PERK activation accounted, at least in part, for the cytotoxicity of phenformin. To this 
end, we generated 3T3-L1 fibroblasts stably expressing RNAi against PERK (PERKi) or 
the major target of IRE1! XBP1 (XBP1i) (Fig. 3.7A-B). Cell survival upon prolonged 
phenformin treatment was revealed by the CyQuant assay measuring the amount of DNA 
as the indicator of cell numbers. Cell numbers started to decline after 7h phenformin 
treatment in CONi cells while cells expressing XBP1i showed slower cell loss rate (Fig. 
3.7A). On the other hand, knockdown of PERK had no significant effects on cell survival 
compared to the control group (Fig. 3.7B). Thus, the IRE1!-XBP1 pathway, but not 
PERK, is in part responsible for the cytotoxicity of phenformin. 
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Figure 3.7 Activation of the IRE1! pathway in part mediates the cytotoxicity of 
phenformin and the model. (A-B) Cell survival assay in 3T3-L1 cells stably expressing 
CONi, XBP1i (A) or PERKi (B) treated with 5 mM Ph for the indicated times with 
immunoblots showing the levels of XBP1s and PERK on left. In (A), Western blot 
analysis of XBP1s were done using nuclear extracts of cells treated with 300 nM 
thapsigargin for 3 h as XBP1s protein levels at basal condition was very low. Values as 
mean ± s.e.m with three repeats. Statistical analysis was done by ANOVA (***, 
p<0.001). (C) Schematic model for the phenformin-induced IRE1! and PERK activation. 
Phenformin treatment leads to AMPK activation, which together with signals from the 
ER activates UPR. Upregulation of the IRE1! target XBP1s, but not the PERK pathway, 
in part accounts for the cytotoxicity of phenformin. 
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3.5 DISCUSSION 
Our study demonstrates the phenformin-induced UPR activation in an AMPK-dependent 
manner. The downstream outcomes of this phenformin- induced UPR highly resemble 
those of the UPR triggered by traditional ER stress inducers, including the activation of 
downstream canonical events of IRE1! and PERK pathways, such as the requirement of 
kinase activities of IRE1! and PERK, Xbp1 splicing, eIF2! phosphorylation and 
induction of ER chaperones. However, the activation mechanism appears to be distinct: 
The phenformin-mediated UPR activation is resistant to cycloheximide treatment and 
requires the cytosolic energy sensor AMPK. Based on these findings, we conclude that 
activation of UPR sensors can be facilitated by metabolic signals from outside of the ER 
lumen under metabolic challenges. 
 
In addition to the activation mechanism, our data show that phenformin-mediated UPR 
activation may be responsible for the cytotoxic effect of phenformin. It has been shown 
that IRE1! and PERK pathways differentially regulate cell survival in response to ER 
stress (Wang and Kaufman, 2012). While the PERK pathway promotes cell death in part 
via CHOP-mediated induction of pro-apoptotic genes such as Bim (Puthalakath et al., 
2007), the IRE1!-XBP1 pathway may promote cell survival via the induction of ER 
folding capacity (Hetz, 2012; Lin et al., 2007; 2009). On the other hand, several recent 
reports showed that high levels of XBP1s can also be pro-apoptotic (Allagnat et al., 2010; 
Zeng et al., 2009). Here, our data showed an improved cell survival rate in XBP1-
deficient cells treated with phenformin while no difference in PERK-deficient cells, 
suggesting that the IRE1!-XBP1 pathway is pro- apoptotic in this context. In line with 
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our study, in a previous report, another biguanide derivative metformin selectively 
upregulating PERK pathway results in no cell apoptosis (Quentin et al., 2011). Thus, the 
role of UPR branches in cell fate decision is likely to be cell type- and context-specific. 
 
Phenformin has been removed from the anti- diabetic drug market due to its liver-toxicity 
and potency for inducing lactic acidosis while its analog metformin remains on the 
market (Assan et al., 1975). Recently, phenformin starts to re-attract interests for its 
greater anti-tumor efficacy than metformin in mouse models (Appleyard et al., 2012). 
Enhanced cell cycle inhibitor p21 has been suggested as one of the mechanisms 
underlying the inhibition of cell proliferation and induction of apoptosis in phenformin-
treated cancer cells (Caraci et al., 2003). However, the detailed mechanisms of its 
cytotoxicity are still not fully understood. Our data suggest UPR as a potential 
mechanism for the cell fate determination of phenformin. Whether the liver toxicity or 
the anti-cancer effect of phenformin is mediated by the IRE1!-XBP1 pathway requires 
further investigations using in vivo models. 
 
Several recent studies have shed light on the emerging crosstalks between UPR and 
metabolic signaling pathways such as AMPK or mTOR pathways (Appenzeller-Herzog 
and Hall, 2012). For example, a recent study showed that the RNase activity of IRE1! 
may be required for nitric-oxide-mediated activation of AMPK (Meares et al., 2011), 
while UPR activation downregulates the mTOR pathway to enhance autophagy, 
presumably to provide amino acids by degradation of unnecessary proteins (Qin et al., 
2010). Conversely, AMPK activation reduces translation and attenuates ER stress and 
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UPR (Dong et al., 2010; Gomez et al., 2008; Lee et al., 2012; Lu et al., 2012; Mayer and 
Belsham, 2010; Terai et al., 2005), similar to our observation. Nonetheless, our data 
showed that phenformin activates UPR in an AMPK-dependent manner and AMPK 
deficiency completely abolishes the phenformin-induced UPR while having no effect on 
Tg-induced UPR. Thus, these new data suggest that AMPK is required but not sufficient 
to activate UPR. We speculate that additional phenformin-responsive factor(s) may be 
required in this process (Fig. 3.7C). We speculate that signals from inside the ER may act 
as the additional factor, exert synergistic effect with AMPK to activate UPR sensors 
under phenformin treatment as overexpression of GRP78 attenuated the phenformin 
effect on UPR. Possible mechanisms include the interruption of folding, maturation and 
secretion of ER proteins. 
 
Our study reveals the complexity of mammalian UPR activation, which seems to be 
tightly regulated by multiple signaling pathways in addition to stress in the ER. We 
recently showed the involvement of non-muscle myosin II ad actin cytoskeleton in the 
activation of IRE1! in response to ER stress (He et al. 2012). Thus, together with this 
study, we postulate that UPR sensors not only sense the ER environment, but also are 
able to integrate cytosolic signals such as actin cytoskeleton and metabolic status. 
The challenge that lies ahead is to determine the nature of physiological signals triggering 
ER stress and activating UPR as well as quantitating the amount of ER stress under 
physiological setting. We recently demonstrated the importance and efficacy of a Phos-
tag-based approach to quantitating and visualizing ER stress (Qi et al., 2011; Sha et al., 
2009; Yang et al., 2010). This approach takes advantage that IRE1! is separated into two 
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bands on a Phos-tag gel, with the slower-migrating band representing the phosphorylated 
form which tightly correlates with IRE1! and UPR activation. Many laboratories have 
successfully used this approach to detect IRE1! activation under more physiological 
conditions in various cell and tissue types. With the aid of this method, this study reports 
a case of UPR activation facilitated by metabolic signals in the cytosol. Understanding of 
the alternate modes of UPR activation will be pivotal and instrumental for the 
development of therapeutic strategies that modulate ER stress and homeostasis in human 
health and diseases. 
 
3.6 ACKNOWLEDGEMENT 
We thank Drs. Douglas Cavener (Penn State University), Claudio Hetz (University of 
Chile), Lee Kraus (UT Southwestern Medical Center), Marc Montminy (Salk Institute), 
David Ron (University of Cambridge), and Reuben Shaw (Salk Institute) for reagents. 
We also thank Dr. Stipanuk (Cornell University) and the Qi lab members for helpful 
discussions. L.Y. was supported in part by the American Heart Association Founders 
Affiliate Predoctoral Fellowship 12PRE9400033. This work was supported by NIH 
R01DK082582, R21AA020351 and American Diabetes Association 7-08-JF-46 and 1-
12-CD-04 (to L.Q.). 
 
 
 
 
 
!-,!!!
CHAPTER 4. SEL1L, A CORE ERAD COMPONENT 
MAINTAINS THE PRE-BCR CHECKPOINT AND IS 
INDISPENSIBLE FOR B CELL DEVELOPMENT 
 
4.1 ABSTRACT 
B cell development relies heavily on signaling pathways mediated by various surface 
receptors, which are synthesized in ER (endoplasmic reticulum). However the importance 
of ER homeostasis and ER quality control system in B cell development is under-
appreciated. To dissect the role of ERAD, the housekeeping ER quality control 
machinery, in this process, we generated a conditional knockout mouse model in which 
SEL1L, a key ERAD component, is selectively deleted in B cell linage. Loss of SEL1L 
resulted in B cell developmental defect and systemic B cell reduction. No ER stress or 
UPR activation was detected in B precursors, which ruled out UPR-mediated apoptosis as 
a causal factor for B cell loss. Remarkably, we observed unusual ER accumulation of a 
preBCR subunit VpreB, which may mediate the reduction of surface preBCR expression, 
impair the signaling pathways in differentiation and proliferation, and ultimately 
influence B cell maturation. In summary, our study of SEL1L null B cells reveals a novel 
role of ERAD in B lymphocyte checkpoint maintenance, establishing the significance of 
ER quality control in the delicate developmental control process. 
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4.2 INTRODUCTION 
The terminally misfolded ER proteins are eliminated by machineries organized on the ER 
membrane, which are collectively termed as ER-associated degradation (ERAD) 
pathway. Depending on the topology (luminal protein or transmembrane protein) and the 
location of lesion (in the luminal, transmembrane or cytosolic domains), substrates can be 
sorted by adaptors for different ERAD pathways (Smith et al., 2011). Distinct ERAD 
pathways are defined by specific E3 ubiquitination complexes including Hrd1p and 
Doa10p in yeast, and many more in metazoans, such as HRD1, GP78, TRC8, RMA1 and 
TEB4.  
 
The most well characterized E3 core organizer is the HRD1/SEL1L complex, which is 
evolutionally conserved from yeast to mammals. At the center of this complex is the 
ubiquintin ligase HRD1, a six transmembrane protein with a catalytic ring domain in the 
cytosolic side(Kikkert et al., 2004). HRD1 receives ubiquitin units from E2 ubiquintin-
conjugating enzymes and passes the ubiquitin chains onto the ERAD substrates retro-
translocated from ER for further degradation by cytosolic proteasome (Kikkert et al., 
2004; Mueller et al., 2008). Another critical component in HRD1 E3 complex is the 
central adaptor SEL1L (Mueller et al., 2006). SEL1L is a interaction hub protein featured 
by multiple tetratricopeptide repeats on its luminal domain, a single transmembrane 
segment and a small cytosolic proline-rich tail (Biunno et al., 2006) (Mittl and Schneider-
Brachert, 2007). SEL1L has been proposed to nucleate the whole E3 complex 
(Christianson et al., 2012; Mueller et al., 2006; 2008), maintaining complex 
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stability(Gardner et al., 2000)while serving as the loading dock for substrate-binding 
lectins such as mammalian OS-9 and XTP3-B (Christianson et al., 2008). 
 
The indispensable housekeeping function of HRD1/SEL1L ERAD pathway has been 
indicated by the overt ER stress and the embryonic lethality observed in animals lacking 
of HRD1 or SEL1L (Francisco et al., 2010; Yagishita et al., 2005). However, the 
embryonic lethality hinders our understanding of the tissue-specific physiological 
functions of HRD1/SEL1L ERAD pathway. In this project, we are particularly interested 
in the role of ERAD in B cell development, a process that requires a high ER capacity. 
During B cell development, ER produces a large amount of surface receptors, such as 
SCF receptor cKIT, cytokine interleukin-7 (IL-7) receptor (IL-7R) and premature B cell 
receptor (preBCR), to communicate with the bone marrow microenvironment, providing 
important survival and differentiation signals, (Herzog et al., 2009; Nagasawa, 2006).  
 
preBCR (premature B cell receptor) is a key checkpoint expressed specifically at 
precursor-B cell (pre-B) stage, critical for the transition from pre-B to immature B stage 
(Herzog et al., 2009). preBCR is a tetramer consisted of a pair of Igµ heavy chains and 
two surrogate light chains, with more structural complexity compared to the other dimer 
receptors such as IL-7R (Interleukin 7 receptor) or cKIT (stem cell factor receptor) 
(Nishimoto et al., 1991). The surrogate light chains (the non-variable light chain-like 
structure) are composed by non-variable peptides VpreB and $5, and are required for 
membrane expression and downstream signaling of preBCR (Papavasiliou et al., 1996). 
Upon preBCR activation, Src-family protein tyrosine kinases such as LYN and SYK 
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phosphorylate preBCR-associated adaptors Ig! and Ig". Phosphorylated adaptors in turn 
recruit Src-tyrosine kinases for differentiation signaling transduction (Flaswinkel and 
Reth, 1994). Another target of Src-tyrosine kinases is the co-receptor CD19, which 
activates the PI3K-AKT pathway for proliferation (Aiba et al., 2008). In addition, IL-7R 
senses IL-7 secreted by the stromal cells activates AKT in an ERK-dependent manner to 
enhance proliferation synergistically with preBCR derived signals (Milne and Paige, 
2006). preBCR and IL-7R-controlled differentiation and proliferation, and thus serve as 
the checkpoints to ensure suitable environment and functional heavy chain before further 
development. 
 
Of note, assembly of both conventional and premature BCR is under tight control by the 
ER folding machinery (Hendershot, 1990; Minegishi et al., 1999). A considerable amount 
of unassembled Igµ is retained in ER by BIP (Cohen et al., 2013; Hendershot, 1990; Hsu 
and Betenbaugh, 1997) and delivered to ERAD for degradation upon prolonged ER 
retention (Fagioli and Sitia, 2001). In fact, only a small percentage of preBCR complexes 
can exit ER even after successful assembly (Brouns et al., 1996). This restricted 
transportation implies a positive selection for functional preBCR as quality control. 
However, how ER machinery contributes to this quality control is poorly understood and 
often taken for granted.  
 
To understand the physiological importance of ERAD and ER homeostasis in B cells, we 
generated a conditional ERAD knockout mouse model. Our data show that loss of the 
key ERAD component SEL1L severely impairs B cell development before the immature 
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B cell stage. In contrast to our expectation, this phenotype is not the result of ER stress-
induced apoptosis. Rather, we observed dysregulation of the pre-BCR signaling pathway, 
which may be the direct cause of developmental blockage. An unusual intracellular 
accumulation of surrogate light chain VpreB due to loss of SEL1L, likely disrupts normal 
preBCR assembly, leads to decreased surface expression of other pre-BCR components, 
and may be the fundamental reason for the phenotypic defects.  From these observations, 
we derive the hypothesis that ERAD contributes to the regulation of preBCR production 
and maintains the essential checkpoint for B cell development.  
 
4.3 MATERIALS AND METHODS 
Mice 
Agouti mice on C57BL/6N background with two loxP cassettes flanking the 6th exon of 
SEL1L (Sel1L f/f) were backcrossed with C57B6/L mice for 6 generations for a pure 
C57B6/L background. The resulted C57B6/L Sel1L f/f mice and C57B6/L CD19-Cre 
mice from Jackson laboratory (B6.129P2(C)-Cd19tm1(cre)Cgn/J) were used to generate 
the animals for experiments. Adult (8-20 weeks) Sel1L f/f; CRE+/- offspring is used as B 
cell specific knockout (BKO), while Sel1L f/f; CRE-/- littermates of similar ages as wild 
type control (WT). Genotyping was performed with PCR primers as the following: Sel1L 
F: 5’-CTGACTGAGGAAGGGTCTC-3’ and R: 5’-
GCTAAAAACATTACAAAGGGGCA-3’ (325 bp as wild-type allele, 286 bp as floxed 
allele). CD19-CRE (oIMR 1084:!GCG GTC TGG CAG TAA AAA CTA TC/ oIMR1085: 
GTG AAA CAG CAT TGC TGT CAC TT) and CD19-wt (oIMR1589: CCT CTC CCT 
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GTC TCC TTC CT/1590: TGG TCT GAG ACA TTG ACA ATC A) primer sets are 
purchased from Jackson laboratory.  
 
Flow cytometry 
Flow cytometry was performed as previously described in (Xia et al., 2011). BD 
permeablization and fixation kit was used for intracellular staining. Fluorochrome 
antibodies against B220 (RA3-6B2), CD43 (1B11), CD19 (6D5), CD138 (281-2), VpreB 
(R3), cKIT (ACK2), IL-7R! (A7R34), Ig!, Ig" (HM79-12), IgM (RMM-1), IgD (11-
26c.2a), BP-1 (6C3), HAS (M1/69), CD4 (GK1.5), CD8 (YTS169), CD5 (53-7.3), 
CD11b (M1/70), CD45 (30-F11) and BrdU-FITC (PRB-1) and isotype control antibodies 
were purchased from Biolegend. Igµ was from Jackson Immunoresearch. Antibodies 
(except BrdU-FITC) were used at 1:150 - 1:200 dilution for surface staining and 1:100 
dilution for total staining in 50 %l system. BrdU-FITC was used at 1:20 dilution. 
 
Splenic B cell purification (negative selection)   
B-cell purification from spleens was carried out using the BD IMagTM Cell Separation 
System (BD Biosciences). Spleens were gently pushed through 70 %m nylon mesh 
(Fisher Scientific 22363548) to yield single cell suspension. Red blood cells were lysed 
on ice for 1 min in ACK lysis buffer (0.15 M NH4Cl ,1 mM KHCO3 ,0.1 mM Na2EDTA, 
pH 7.2).  After two washes with 10 ml PBS (137mM NaCl, 2.7mM KCl, 4.3mM 
Na2HPO4, 1.4mM KH2PO4, pH 7.4), 108 splenocytes were incubated with 5 %l biotin-
conjugated anti mouse CD3 antibody and 3 %l biotin-conjugated anti mouse CD11b 
antibody (UCSF Monoclonal Antibody Core Facility, 0.5 mg/ml) with a total volume of 
!%.(!!!
100 %l at 4°C for 20 min followed by incubation with 60 %l Streptavidin Particles Plus 
(BD Biosciences 557812) with a total volume of 300 %l at 4°C for 20 min. Then cells 
were transferred to a 12 & 75 mm tube which was inserted into a Cell Separation Magnet 
Apparatus (BD Biosciences) for 5 min.  Cells from the flow-through, i.e. the CD3- and 
CD11b-negative portion, were collected, washed with PBS and then resuspended in 1 ml 
DMEM culture medium. Of note, CD3 antibody targets T cells while CD11b antibody 
recognizes monocytes, macrophages, eosinophils, granulocytes and NK cells. Purity was 
determined using flow cytometry. 
 
Bone marrow CD19+ B cell purification (positive selection)  
Bone marrow cells were flushed out from freshly harvested bones by PBS with 10% FBS 
and 1% penicillin/streptavidin, and filtered through 70 %m nylon mesh (Fisher Scientific 
22363548) to yield single cell suspension. 2-3x108 cells were incubated with 30 %l anti-
CD19-biotin in 500ul PBS/10%FBS/1%PS for 20 min at 4°C, followed by incubation 
with 70 %l Streptavidin Particles Plus (BD Biosciences 557812) with a total volume of 
200 %l at 4°C for 20 min. CD19+ cells are enriched by 7 min incubation in Cell 
Separation Magnet Apparatus (BD Biosciences) twice and were snap frozen in liquid 
nitrogen. Purity was determined using flow cytometry. 
 
B cell differentiation into plasma cells   
The procedure was adopted from (Iwakoshi et al., 2003)with some modifications.  
Briefly, purified B cells were diluted in DMEM containing 10% FBS at a concentration 
of 5&106/ml, cultured in 24-well plate (1 ml per well) and stimulated with 20 %g/ml LPS 
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(Calbiochem 437627) and 20 ng/ml murine IL-4 (Peprotech 214-14). Cells were collected 
and snap-frozen in liquid nitrogen for western blots.  Proliferating B cells were diluted to 
5&106/ml with the fresh medium containing IL-4 and LPS every 48 h as described 
(Iwakoshi et al., 2003). 
 
BrdU incorporation assay 
Mice were injected with 20 %l BrdU in PBS (10mM) per g body weight for 2h, which 
enables incorporation into bone marrow cells. Saline injection was used as control. Bone 
marrows were flashed out from freshly collected bones. After red blood cell lysis, 106 
cells were staining against surface CD19 (Biolegend, 1:100 in PBS) at 4°C for 20min. 
Cells were permeablized and fixed using BD Fixation and Permeabilization kit, followed 
by incubation in 200 %l DNaseI (50U/ml) at room temperature for 30min. Then cells 
stained with BrdU-FITC (1:20 in 100 %l BD Permeabilization/Wash Buffer), and 
incubated at room temperature for 45min before flow cytometry.   
 
Western blot 
Cells were lysed in Tris-based lysis buffer (150 mM NaCl, 50 mM Tris, pH7.5, 1 mM 
EDTA and 1% Triton X-100) supplemented with 1%M DTT and 1x protease inhibitors 
(Sigma).   Supernatant was collected after microcentrifugation at 4°C for 10 min (Yang et 
al., 2010). Equal amount of supernatant was used for regular western blot on mini SDS-
PAGE gels or Phos-tag gels as described in (Yang et al., 2010). Bone marrow cells from 
3-4 mice were pooled together for either WT or BKO groups.  
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Antibodies 
GRP78 (goat, 1:1000) and HSP90 (rabbit, 1:5,000) were purchased from Santa Cruz 
(Santa Cruz, CA). p-S51 and total eIF2! (rabbit, 1:1,000), IRE1! (rabbit, 1:1,000), p-
S473 and total AKT (rabbit, 1:1,000), p-ERK42/44 (rabbit, 1:2000), p-LYN (rabbit, 
1:2000) and CD79A(Ig!) (rabbit, 1:1,000) antibodies were purchased from Cell 
Signaling; SEL1L (rabbit, 1:1000) and CD79B(Ig") (rabbit, 1:1000) was purchased from 
Abcam; Calnexin (rabbit, 1:10000) and ERP57 (rabbit, 1:2000) were from Assay Design; 
HRD1 (rabbit, 1:2000) was from Novus Biologicals. Secondary antibodies were goat 
anti-rabbit and anti-mouse HRP, and donkey anti-goat HRP used at 1:10,000 (Biorad). 
 
RNA extraction and semiquantitative PCR 
Cells from 3-4 mice were pooled together for each group after freshly purified by CD19-
biotin beads and magnetic isolation. RNA extraction and cDNA preparation were 
performed as described previously (Yang et al., 2013). Primer sequences for PCR were 
adopted from (Maeda et al., 2006; Reynaud et al., 2008; Zhang et al., 2005) and listed as 
below: 
Pax5 F:CGGGTCAGCCATGGTTGTG, R:GTGCTGTCTCTCAAACACG; VpreB1 
F:CGTCTGTCCTGCTCATGCTGC, R:ACGGCACAGTAATACACAGCC; Rag1 
F:TGCAGACATTCTAGCACTCTGGCC, R:ACATCTGCCTTCACGTCGATCCGG; 
Ebf1 F:CAAGACAAGAACCCTGAAATG, R:GTAACCTCTGGAAGCCGTAGT; Ig!  
F: TCAGAAGAGGGACGCATTGTG, R:TTCAAGCCCTCATAGGTGTGA; VDJ-Cµ 
F:CGCGCGGCCGCTGCAGCAGCCTGGGGCTGAG, 
R:GGAATGGGCACATGCAGATCTC; Igµ F:TGTGTGTACTGTGACTCACAGGGA, 
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R:AGGGAGACATTGTACAGTGTGGGT; L32 F:GAGCAACAAGAAAACCAAGCA, 
R:TGCACACAAGCCATCTACTCA.  
The PCR conditions are: 94°C for 5min, 94°C for 1min, 58°C for 20sec and 72°C for 
30sec repeated for 25 to 30 cycles according to the different abundance of individual 
template, and followed by 72°C for 10min.  
 
Statistics 
Results are expressed as mean ± s.e.m.  Comparisons between non-treated group and 
groups from each time point were made by unpaired two-tailed Student t-test.  P<0.05 
was considered as statistically significant. 
 
4.4 RESULTS 
4.4.1 Sel1L BKO mice exhibit systemic B cell reduction.  
To study the physiological importance of SEL1L in B cells, we generated B cell-specific 
Sel1L knockout mice on C57BL/6 background using CD19 promoter, expressing as a 
commitment marker specifically in B cell lineage (Rickert et al., 1997). Deletion of the 
6th exon of Sel1L caused frame-shift and generated a premature stop codon. The resulting 
truncated SEL1L protein with only a short ER luminal fraction of 232 amino acids was 
considered non-functional. Therefore, these mice were defined as B cell-specific Sel1L-/- 
mice (BKO). Genotyping was performed to distinguish WT and BKO animals (Fig. 4.1).  
 
BKO mice were born normally with similar body sizes and weights as WT littermates 
(Data not shown). The first phenotypic difference we observed in the BKO mice is the 
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smaller spleen size. Both spleen weights and the ratios between spleen and body weight 
in BKO mice were significantly lower than those in WT mice (Fig. 4.2 A). To investigate 
the cellular basis of this phenotype, we analyzed the immune cell composition in WT and 
BKO spleens by flow cytometry-based immunotyping.  The percentage of IgM+IgD+ or 
B220+IgM+ B cells decreased from 40% to around 10%, while the percentages of 
CD4+CD8- T cells and CD4-CD8+ T cells doubled in the spleens of BKO mice 
compared to WT controls (Fig. 4.2B), indicating a loss of B cells and corresponding 
increase of T cell occupation. The absolute cell numbers per spleen were also calculated 
for CD4+CD8- and CD4-CD8+ T cells, CD11b+ myeloid cells and IgM+IgD+ B cells. 
BKO mice showed an 8 fold-reduction of B cell number while having comparable cell 
numbers for the other immune cell types (Fig. 4.2C). Thus, B cell Sel1L deficiency 
specifically reduced B cell in spleen leaving other population intact.  
 
Similar decreases of B220+IgM+ B cell percentages and increases of CD4+ or CD8+ T 
cell percentages were also detected in other peripheral lymph organs such as lymph nodes 
and blood (Fig. 4.2D). Both numbers and sizes of Peyer’s patches in the gut immune 
system decreased dramatically (Fig. 4.2E and data not shown). The cellular reduction was 
due to loss of both naïve B cells (B220+CD138-) and activated B cells (B220+CD138+) 
(Fig. 4.2F). Peyer’s patches consisted of two B cell subtypes: bone marrow-generated 
CD5-B220+ B2 cells and fetal liver-originated CD5+B220+ B1 cells. Immunotyping 
CD5 indicated that the population shrinkage of B2 cells was the major reason for peyer’s 
patch B cell deficiency (Fig. 4.2F). Taken together, the data indicated a systemic 
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reduction of B cells in BKO mice, pointing to possible B cell developmental defect in the 
bone marrow.  
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Figure 4.1 Mouse genotyping examples. SEL1Lf/f; CRE+/- and SEL1Lf/f; CRE-/- 
parents generate SEL1Lf/f; CRE+/- (BKO) and SEL1Lf/f; CRE-/- (Wild type) offsprings. 
On the left panel, PCR product of LoxP flanked SEL1L migrate faster on agarose gel 
compared to product from wild type allele. On the right panel, only CRE positive mice 
result in a PCR product of 100bp.  
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Figure 4.2 Impairment of B cell development in bone marrow leading to decrease of B 
cellularity in peripheral tissues. (A) Comparison of spleen weight (left) and the ratio 
between spleen (SpW, mg) and whole body weight (BW, g) (right) in WT and BKO 
mice. (B) Immunotyping of splenic B and T cell population in WT and BKO mice. 
Upper: CD4 versus CD8 flow cytometry profiles of T4 (CD4+CD8-) and T8 cells (CD4-
CD8+). Middle: IgM versus IgD flow cytometry profiles of mature B cells (IgM+IgD+). 
Bottom: IgM versus B220 profiles of B cells (B220+IgM+). The numbers indicate the 
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percentages of each gated population out of total splenocytes.  (C) Absolute cell numbers 
of CD4+ T cell, CD8+ T8, myeloid (CD11b+) and B (IgM+IgD+) cells in WT (open 
circles) and BKO (solid circles) spleens. (D) CD4 versus CD8 and IgM versus B220 flow 
cytometry profiles of T cells and B cells in lymph nodes (LN) and peripheral blood 
(PBL). The numbers indicate the percentages of each gated population out of total cells. 
(E) The peyer’s patch (PP) number per mice. WT (white bar) and BKO (black bar). (F) 
Upper: B220 versus CD138 immunotyping profiles for activated B cells (plasma cells, 
B220+CD138+) and naive B cells (B220+CD138-). Bottom: B220 versus CD5 profiles 
for B2 (B220+CD5-) and B1 (B220+CD5+) B cells. The numbers indicate the 
percentages of each gated population out of total CD45+ lymphocytes in peyer’s patches. 
(G) Bone marrow immunotyping. Upper: B220 versus CD43 reveals pro-B 
(B220+CD43+), pre-B (B220+CD43-) and immature B (B220hiCD43-, also contains a 
small fraction of mature B). Quantification as shown at the bottom of (G). Middle: B220 
versus IgM profiles show B cell receptor IgM+ bone marrow B cells (B220+IgM+). The 
numbers indicate the percentages of B220+IgM+ in gated bone marrow cells. (H) HSA 
versus BP-1 flow cytometry profiles of gated B220+CD43+ B cell progenitors. Data are 
representative of two to four independent experiments with n=3-5 mice per group. 
Quantification is shown as mean ± s.e.m.. *, p<0.05. ***, p<0.001. 
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4.4.2 B cell development is defective in BKO bone marrows  
Since BKO mice had fewer peripheral B cells, we next examined the B cell development 
in bone marrows of both groups. The B220+CD43+ B cell progenitors (pro-B) and the 
B220+CD43- precursors (pre-B) were comparable between BKO and WT mice.  
However, there was a significant drop for B220hiCD43- immature B cells (Fig. 4.2 G). 
Immature B is the first population in the development to express complete B cell 
receptors and can be stained as IgM+. The developmental blockage before immature B 
cell stage was confirmed by the 50% reduction of B220+IgM+ cells (Fig. 4.2G). 
B220+CD43+ progenitors can be further divided into three subsets by BP-1 and HSA 
according to Hardy’s standard (Hardy and Hayakawa, 2001; Hardy et al., 1991). Thus, 
we analyzed the sub-population composition by flow cytometry, but found similar 
patterns for the three early progenitors between the two genotypes (Fig. 4.2H). Thus, we 
concluded that SEL1L plays an indispensable role in B cell development. SEL1L 
deficiency blocks relatively late development before the immature B cell stage.  
 
Interestingly, the residual peripheral B cells remained responsive to antigen stimulation 
and differentiated into plasma cells normally ex vivo. Same numbers of splenic B cells 
were purified by negative magnetic purification from either WT or BKO spleens, with the 
purity of 90% (data not shown), and plated in culture media supplemented with 
lipopolysaccharide and Interleukin 4 (LPS/IL4). Stimulation of both WT and BKO naïve 
B cells yielded similar amount of B220+CD138+ plasma cells (Fig. 4.3A). Previous 
studies indicated the successful recombination rate for CD19-Cre mice was not 100%, 
which may potentially cause phenotypic leakage in conditional knockout mice (Rickert et 
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al., 1997). It was possible that the B cell progenitors with unsuccessful CRE-dependent 
Sel1L deletion managed to develop and partially popularize the peripheral lymph organs. 
Indeed, we observed same levels of SEL1L protein in purified BKO and WT splenic B 
cells, confirming that the residual B cells in BKO spleen were in fact “WT” B cells (Fig. 
4.3B). If not the conditional knockout leakage, we might expect even more severe B cell 
loss in BKO mice.   
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Figure 4.3 The residual B cells in BKO spleen are normal B cells resulted from 
unsuccessful CRE recombination. (A) After negative purification, same numbers of B 
cells from WT or BKO spleens were stimulated with 20 %g/ml LPS and 20 ng/ml murine 
IL-4. B220 versus CD138 flow cytometry profiles show B220+CD138+ plasma cells 
after 51h stimulation. The numbers represent percentages of plasma cells out of total 
cells. (B) Western blot against SEL1L in WT and BKO B cells. Each sample contains the 
same amount of purified splenic B cells from either WT or BKO mice. eIF2! as loading 
control.  
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4.4.3 ER stress is not the cause for developmental defect in SEL1L null B cells.  
ERAD removes and degrades terminally misfolded peptides from ER, and is required to 
maintain ER homeostasis. Accumulation of misfolded proteins activates multiple a 
cascade of stress responses - unfolded protein response (UPR), which not only restore ER 
homeostasis by enlarging ER folding capacity and reducing nascent peptide loading, but 
also promote apoptosis under prolonged or severe ER stress (Tabas and Ron, 2011; 
Walter and Ron, 2011).  
 
In previous studies, loss of SEL1L leads to multiple pathological outcomes including 
embryonic lethality, pancreas development defect, diet-induced pancreas dysfunction and 
neuron diseases, presumably mediated by cell death signaling pathways under prolonged 
ER stress (Francisco et al., 2010; 2011; Kyöstilä et al., 2012; Li et al., 2010b). To 
investigate the apoptosis level in our case, we examine the phosphatidylserine (PS) 
externalization levels and plasma membrane integrity by Annexin V and 7AAD 
respectively. Neither increased cell death (7AAD+Annexin V+) nor early apoptotic cells 
(7AAD-Annexin V+) was detected in BKO bone marrow B220+ population (Fig. 4.4A). 
We also performed BrdU proliferation assay and observed even a slight increase of 
actively duplicating BrdU+ B cells in BKO mice (Fig. 4.4B). Thus, dysregulated 
apoptosis or proliferation was unlikely the direct development obstacle for BKO B cells. 
 
To test the whether there is overt ER stress in SEL1L-/- B cell precursors, we performed 
CD19-biotin beads-based magnetic isolation to enrich bone marrow B cell precursors 
(Fig. 4.5) and screened for UPR markers.  SEL1L knockout efficacy was demonstrated 
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by the dramatic reduction at protein level in CD19+ bone marrow BKO B cells compared 
to WT B cells (Fig. 4.4C). Remarkably, SEL1L and a UPR sensor IRE1! are only highly 
expressed in CD19+ cells but not other immune progenitors in the bone marrow, as they 
are barely detectable in total bone marrow or the flow-through lysates, suggesting a 
particular high demanding for ER capacity in B cell lineage (Fig. 4.4C). HRD1 protein 
also decreased in CD19+ cells with SEL1L deficiency (Fig. 4.4C), which is consistent 
with the previous report that Hrd3p, the yeast SEL1L maintains the stability of hrd1p 
(Gardner et al., 2000). Surprisingly, we observed no increase of common ER stress 
markers, including UPR downstream targets phospho-eIF2!, chaperones GRP78 (Fig. 
4.4C), ERP57, CXN (Fig. 4.6) and PDI (data not shown). Xbp1 mRNA splicing by 
IRE1! activation also remained the same between BKO and WT CD19+ cells (Fig. 4.4D). 
The Phos-tag gel assay showed no phosphorylated IRE1! band, indicating that the IRE1! 
was inactive during B cell development (Fig. 4.6). These data together showed that ER 
homeostasis remained unchanged in despite of ERAD deficiency, and may not be 
responsible for the B cell developmental defect.  
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Figure 4.4 No ER stress in BKO mice compared to WT mice. (A) AnnexinV versus 
7AAD flow cytometry profiles of B220+ bone marrow B cells. The numbers are 
percentages of early apoptotic cells (AnnexinV+7AAD-) and dead cells 
(AnnexinV+7AAD+) out of total bone marrow B cells. (B) Histogram of BrdU 
incorporation in B220+ bone marrow B cells. Percentage quantification on the right. 
White bar: WT; Black bar: BKO. *, p<0.05. (C) Western blot against SEL1L, HRD1 and 
UPR components after positive magnetic purification. Whole cell lysates from total bone 
marrows (tBM), enriched CD19+ B cells (CD19+) and flow-through cells (FL). HSP90, 
loading control. (D) RT-PCR reveals the Xbp1 splicing levels in total bone marrows 
(tBM), enriched CD19+ B cells (CD19+) and flow-through cells (FL). Mouse embryonic 
fibroblast (MEF) cells treated with 300nM ER stress inducer thapsigargin as positive 
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control. Xbp1u: PCR product from unspliced Xbp1 mRNA. Xbp1s: PCR product from 
spliced Xbp1 mRNA. Cells isolated from 3-4 mice were pooled together for each sample 
group in (C) and (D). 
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Figure 4.5 Bone marrow CD19+ B cell purification efficiency. Flow cytometry of B cells 
freshly isolated by positive purification from mouse bone marrow. The number indicates 
the percentage of CD19+ B cells out of total purified cells. 
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Figure 4.6 Western blots against additional UPR markers. Whole cell lysates from total 
bone marrows (tBM), and enriched CD19+ B cells (CD19+) were run on Phos-tag gel 
(PT) or regular SDS-PAGE gels. Cells from 3 mice were pooled for each sample. 
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4.4.4 Loss of SEL1L leads to dysregulated preBCR signaling pathways  
Surface expression of many receptors is crucial for B cell development, as the receptors 
are responsible for coordinating signals from niche environment with intercellular 
development events. Particularly, there are two key checkpoints to determine the B cell 
differentiation before the immature B cell stages. One of them is IL-7R receptor 
maintaining early lymphocyte expansion (Peschon et al., 1994). The other is the preBCR 
mediated signaling pathways for differentiation and proliferation. Disruption of either 
checkpoint strongly impairs maturation of B cells in bone marrows, a phenotype highly 
reminiscent of the observation in our mice.  An immunotyping screen was performed at 
the two checkpoint receptors as well as cKIT, the receptor for stem cell growth factor 
(SCF), which also plays indispensable role in B cell development.  The data showed 
unchanged IL-7R ! chain (IL-7R!), and surrogate light chain VpreB on the surface of 
B220+ cells in WT and BKO mice.  Heavy chain Igµ and adaptor protein Ig", two 
preBCR and BCR components showed about 50% decreases on B220+ cells and almost 
80% reduction on B220hi cells, while common adaptor Ig! also dropped from 1.8% to 
0.8% (Fig. 4.7A).   
 
As SEL1L participates in ER protein degradation, we also investigated total proteins of 
above-mentioned receptors at both surface and intracellular levels. The most striking 
difference was the 4-fold increase of total VpreB (Fig. 4.7B). The induction was mostly 
attributed to intracellular accumulation, as very few VpreB was detected on the plasma 
membrane (Fig. 4.7A). IL7R level was also higher in BKO, but to a much less extent 
(~50% increase). On the contrary, Ig!, Ig", and Igµ all decreased, with more dramatic 
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reduction for Ig" and Igµ. The percentages of cKIT+ cells were quite small and showed 
no difference between two genotypes. Together, the surface and total staining indicated 
that SEL1L deficiency has the greatest influence on the surface production of preBCR 
receptors. Of note, transcriptional expression of surrogate light chains starts at pro-B and 
can be detected intracellularly (Wang et al., 1998). The preBCR abnormality in SEL1L 
BKO mice became obvious as early as the B220+CD43+ progenitor stage (Fig. 4.8). 
 
The preBCR defect was also confirmed at the downstream signaling pathway. CD19+ 
bone marrow B cells were separated into three fractions via positive purification. Same 
amount of lysate from total bone marrow, CD19- flow-through and enriched CD19+ cells 
were run on the SDS PAGE gels (Fig. 4.9A). Consistent with the flow cytometry data, 
intensity of Ig" and Igµ bands were much weaker in BKO CD19+ cells. The flow through 
showed some Igµ heavy, suggesting residual CD19+ cells in this fraction after 
purification. However, the general efficiency was satisfactory as no Ig" was detected in 
FL. Src-family protein tyrosine kinase LYN is one of the immediate preBCR effector 
interacting with the cytosolic domains of adaptors Ig! and Ig" (Gauld and Cambier, 
2004). LYN-/- mice also exhibits decreased peripheral B cells (Chan et al., 1997). 
Compared to WT, BKO B cell progenitors have less phosphorylated LYN, the active 
form of LYN, and reduced phospho-AKT and phospho-ERK, supporting the idea of 
impaired preBCR signaling pathways. Interestingly, total AKT also decreased in BKO, 
the reason of which remained unknown (Fig. 4.9A).  
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In addition, we performed RT-PCR and detected reduced mRNA levels of RAG1, a key 
recombinase required for functional light chain synthesis, and less VDJ-Cu products (Fig. 
4.9B). preBCR signaling induces downregulation and subsequential re-expression of 
RAG recombinases. Re-expression of RAGs is critical for light chain gene rearrangement 
and BCR production. Thus, the low surface expression of BCR (IgM) (Fig. 4.2G lower 
panel) suggests lack of light chain recombination, which may be the direct cause blocking 
the transitions from pre-B to immature B. The mRNA levels of other B development 
genes such as B cell transcription factors PAX and EBF1, adaptor Ig!, immunoglobulin 
heavy chain Igµ, and surrogate light chain VpreB remained unchanged in BKO cells. Of 
note, the unchanged VpreB mRNA levels demonstrated that the cellular accumulation of 
VpreB protein was not due to the transcriptional induction. 
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Figure 4.7 Loss of SEL1L leads to dysregulated preBCR signaling pathways.  (A) Flow 
cytometric profiles showing B220 versus surface levels of receptor components cKIT, IL-
7R!, VpreB, Ig!, Ig" or Igµ in bone marrow B cells on WT and BKO bone marrow cells. 
(B) Flow cytometric profiles showing B220 versus total (surface and intracellular) levels 
of receptor components cKIT, IL-7R!, VpreB, Ig!, Ig" or Igµ in bone marrow B cells on 
WT and BKO bone marrow cells. The numbers are percentage of gated cells, as mean ± 
s.e.m.. 
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 Figure 4.8 surface expressions of receptors that are critical for B cell development on 
early B cell progenitors. Overlaying histograms showing surface (upper) and total 
(bottom) staining of receptor components cKIT, IL-7R!, VpreB, Ig!, Ig", Igµ and CD19 
on B220+CD43+ pro-B cells from WT (blue) or BKO (red) mice. x axis represents 
different levels of each receptor components (from left to right: low to high). y axis 
represents the % of the highest numbers, and the curves show the relative population 
distribution with different levels of each receptor components.   
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Figure 4.9 preBCR downstream signaling pathways are impaired in BKO.  (A) Western 
blot against preBCR components (Ig!, Ig", Igµ) and downstream signaling effectors 
(phospho-AKT, phospho-ERK, phospho-LYN) after positive magnetic purification. 
Whole cell lysates from total bone marrows (tBM), enriched CD19+ B cells (CD19+) and 
flow-through cells (FL). HSP90, loading control. *: non-specific bands. (B) 
Semiquantitative PCR of cDNA from freshly isolated WT and BKO CD19+ bone 
marrow B cells (CD19+BM).Wedges indicate 1:3 serial dilution of cDNA. Data are 
representative of at least two independent experiments.    
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4.5 DISCUSSION 
preBCR is the key checkpoint signaling guiding B cell precursors to the next stage for an 
immature B cell repertoire. This positive selection by functional preBCR serves as 
quality control ensuring functional heavy chain before light chain production. Our study 
of Sel1L in B cell reveals an unexpected and remarkable role of ERAD in B cell 
development. ERAD pathway facilitated by core adaptor SEL1L may degrade surrogate 
light chain VpreB to delicately control the normal surface expression of preBCR and 
maintains normal preBCR signaling pathways, which is critical for B cell development.  
 
SEL1L was first linked to development in a C.elegans study as a suppressor of Notch 
signaling pathway (Sundaram and Greenwald, 1993) and was later shown to facilitate and 
organize ERAD complex for protein degradation (Mueller et al., 2006; 2008). The 
phenotype in our study is more closely related to SEL1L’s role in ERAD rather its 
suppression of Notch signaling. There are four Notch isoforms – Notch1-4. Notch4 is 
barely detected in lymphocytes (Saito et al., 2003), while Notch2 expression is 
particularly restricted in mature B cells. Targeted Notch2 deletion impairs marginal zone 
B cell formation but has no influence on the early development in the bone marrows 
(Saito et al., 2003). The expression patterns of Notch1 and Notch3 in B cell lineage are 
similar, with the highest level in pro-B stage (Saito et al., 2003). Transcriptional 
repression of Notch 1 is a prerequisite for B cell linage commitment, likely mediated by 
an early B-lineage commitment factor Pax5 (Souabni et al., 2002). However, we detected 
even lower Notch1 mRNA level in BKO B cells, which is almost beyond detection (Data 
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not shown). Thus, Notch1 induction may not be the underlying mechanism bridging the 
SEL1L deficiency to the B cell developmental defects.  
 
On the other hand, the components of preBCR are highly misfolding-prone. Complicated 
regulation is necessary for its correct folding, assembly and surface expression. 
Coordinated folding of surrogate light chain is tightly controlled by the split 
immunoglobulin domain between VpreB and $5, while $5 contains a unique region as an 
intramolecular chaperone to prevent aberrant folding before paired with VpreB 
(Minegishi et al., 1999). Paired surrogate light chain escorts Igµ to the plasma membrane 
to enable the association with heterodimer Ig!/Ig" for full preBCR complex. Loss of 
preBCR due to surrogate light chain deficiency significantly impairs pre-B cell expansion 
(Mundt et al., 2001; Shimizu et al., 2002).  Interestingly, compared to BCR, a larger 
fraction of preBCR fail to exit ER for surface localization even after assembly, which is 
likely attributed to the intrinsic property of surrogate light chain (Brouns et al., 1996). 
Unlike conventional light chain, surrogate light chain promotes low levels of Igµ 
maturation and high level of ER retention, indicated by the accumulation of EndoH 
sensitive deglycosylated forms of Igµ (Fang et al., 2001). As no overt ER stress was 
detected in our case, it is highly likely that the overwhelmed VpreB specifically holds Igµ 
in the ER and prevents migration of preBCR to Golgi for further modification. It seems 
that a quantitative balance between VpreB and the rest of the components is of 
comparable importance as the presence of VpreB per se. However, future studies are in 
need to dissect the detailed mechanism by which VpreB accumulation blocks preBCR 
surface expression. 
!%'.!!!
One of the remaining questions is the role of HRD1 in VpreB quantity control. SEL1L 
mainly associates with HRD1 among all the ERAD E3 ubiquitin ligases; and SEL1L and 
HRD1 share similar the substrate profiles (Christianson et al., 2012). In addition, 
misfolded client proteins can be categorized as ERAD-L (lumen), ERAD-M (membrane) 
and ERAD-C (cytosol), based on their topology and lesion location. VpreB is a soluble 
ER luminal substrate belonging to the ERAD-L pathway, which is dominantly mediated 
by HRD1 specific ERAD (Bernasconi et al., 2010). Taken together, HRD1 is the top-1 
candidate E3 ligase for VpreB degradation. However, only SEL1L but not HRD1 null 
mice showed retarded growth besides embryonic lethality, suggesting an HRD1-
independent function of SEL1L at the development stage (Francisco et al., 2010; 
Yagishita et al., 2005). It would be interesting to examine the immune system in HRD1 
knockout mice to confirm whether it is the E3 ligase responsible for VpreB degradation.  
 
Another intriguing question raised by this study is whether SEL1L and quantity control 
are also required for other (earlier or later) stages in B cell life history. Our inducible 
SEL1L knockout mice showed even earlier B cell maturation blockage starting at pro-B, 
while the mechanism is still under investigation (Data not shown).  In addition, the 
differentiation from naïve B cells to plasma cells stimulates class-switch and production 
of humongous secretory immunoglobulin such as IgA, IgD, IgE, and IgG, which may 
require elevated folding capacity as well as degradation machinery. We indeed observed 
increased SEL1L at both mRNA and protein levels in B cells activated by LPS/IL4. A 
plasma cell-specific SEL1L conditional knockout model will provide us more 
!%'%!!!
mechanistic and physiological insights into the role of SEL1L protein and ERAD in the 
control of immunoglobulin production and function.  
 
Taken together, our study for the first time establishes a novel role of ER degradation 
machinery in the maintenance of B cell development checkpoints. Sel1L related ERAD 
pathway contributes to not only quality but also quantitative control of preBCR 
checkpoint complex. Most previous studies of B cell development have only focused on 
the receptor-initiated signaling network and transcriptional switch of key differentiation. 
However, animals with dysregulated maintenance machinery phenotypically can copy 
those in deficiency of B cell specific receptors or transcription factors, indicating that 
regulation of checkpoint receptor and checkpoint receptor per se are of comparable 
physiological importance. Our model of ERAD-dependent VpreB quantitative provides 
another posttranslational regulation mechanism of checkpoint maintenance. More 
mechanistic studies are required to enhance our understanding of the significance of ER 
homeostasis in lymphocyte development.  
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CHAPTER 5. SUMMARY AND FUTURE DIRECTIONS 
 
Previous studies using pharmacologically induced ER stress models gain us precious 
knowledge on the mechanisms and molecular outcomes of the UPR activation. On the 
other hand, increasing in vivo investigations report participation of ER stress and UPR 
under various physiological or physiological stimuli, even though the conclusions can 
sometimes be inconsistent and even controversial.  We believe multiple measuring 
methods especially those at the sensor level are highly recommended for better 
understanding of the physiological UPR. In Chapter 2, I developed Phos-tag based SDS-
PAGE gels that separate phosphorylated IRE1! and PERK from their non-
phosphorylated inactive forms. This method sensitively monitors the IRE1! and PERK 
activation in cells transfected with misfolded protein, and reveals interesting patterns of 
basal IRE1! in various mouse tissues and its activation in pancreas in response to fast-
refeeding. In addition, it can be used for quantitation of the ER stress levels, evident by 
the IRE1! phosphorylation changes corresponding to the time or concentration increases 
of thapsigargin treatment.  
 
Chapter 3 and Appendix A and C showed several application of this new measuring tool. 
Together with the detection of downstream events, Phos-tag gel allows us to identify a 
novel crosstalk between AMPK and the UPR sensors in a screen of metabolic drugs. In 
the screen, the anti-diabetic reagent phenformin stimulates IRE1! and PERK as well as 
their downstream targets in both AMPK- and ER stress-dependent manners. However, 
activation of AMPK is not sufficient to trigger IRE1! and PERK activation. The nature 
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of the crosstalk remains mysterious. One possibility is that AMPK directly 
phosphorylates IRE1! and PERK, leading to structural changes and enhanced activities. 
However, we didn’t detect any interaction in co-immunoprecipitation assay between 
AMPK catalytic domain and IRE1!/PERK. Alternatively, AMPK may modulate other 
signaling pathways, which may elevate the ER stress levels. In vitro phosphorylation of 
kinase-dead IRE1!/PERK by AMPK may be needed to test the hypothesis of direct 
modulation. Impairment of IRE1!-XBP1 pathway protects cells against phenformin 
toxicity, suggesting the potential physiological significance of the UPR activation in anti-
cancer biguanide treatment.  
 
In the case of Chapter 2, examinations on both proximal and distal parts of the UPR 
reache the same conclusions regarding to the activation status of the UPR. Remarkably, 
Appendix A shows an interesting situation in which IRE1! phosphorylation disagrees 
with XBP1 protein and chaperone induction. B cell to plasma cell differentiation was 
thought to be ER-stress dependent given the induction of XBP1 and chaperones. 
However, our study for the first time clearly indicates constant IRE1! phosphorylation 
and decreased PERK phosphorylation through out the differentiation process, even after 
dramatic XBP1 protein increase is observed. This evidence strongly argues against the 
stress response model of plasma cell ER expansion while supporting the anticipation 
model in which programed Xbp1 transcriptional induction enhances the ER capacity 
before immunoglobulin synthesis. Another example of inconsistency is presented in 
Appendix C. Xbp1 mRNA oscillates with constant IRE1αphosphorylation in the heart, 
while mRNA expression profiles of the XBP1 targets Grp78 and Erdj4 mRNA exhibit 
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circadian rhythm in liver and WAT without circadian oscillation of Xbp1s. This 
preliminary data also point to the complexity of the in vivo physiological UPR compared 
to those in in vitro cell culture models.  
 
Chapter 4 was designed to study the possible role of chronic ER stress in B cell 
development. Defective ERAD machinery is a common cause of misfolded protein 
accumulation and leads to several conformational diseases. Thus we generated B cell-
specific SEL1L-knockout mice, expecting disruption of ER homeostasis and impaired B 
cell development. Indeed, we observed systemic loss of B cells and defective B cell 
genesis in bone marrow in mice lacking of SEL1L. To our surprise, no ER stress is 
detected at both upstream and downstream levels of the UPR, as indicated by both our 
method and traditional measurements. Current progress suggests the abnormal 
accumulation of the preBCR component VpreB as the direct cause of developmental 
blockage. Accumulated VpreB may disrupt normal assembly and/or modification of the 
key development receptor preBCR, and thus blocks signaling for differentiation. More 
studies are warranted to dissect the detailed mechanisms by which the ERAD modulates 
the pre-B cell checkpoints and B cell genesis. The investigation of the ERAD will also 
add to our understanding of the intimate relation between ER and tissue functions.  
 
Besides investigating the physiological significance of UPR, I also carried on a 
mechanistic study on a novel IRE1! interacting protein, FARP1. Unfortunately, data 
showed no functional importance of FARP1 in IRE1! and PERK activation, even though 
the physical interaction was confirmed (Appendix B). 
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Taken together, my thesis dissertation reports the development and application of a Phos-
tag based method for better understanding the physiological ER quality control 
machineries, especially the UPR. However, many interesting questions are raised from 
the dissertation such as the unexpected discovery in Chapter 3. More efforts to 
characterize the role of ERAD at different stages of B cell development are required for 
thorough understanding of the ER protein quantity and/or quality control in B 
lymphocyte maturation. First of all, in vitro mechanistic studies will help us better 
understand how the SEL1L complex interacts, modifies and degrades the surrogate light 
chains, as well as how the surrogate light chain accumulation affects the preBCR 
complex assembly. Secondly, It would be interesting to compare the HRD1 CD19-CRE 
mice with our SEL1L deficient animal. The possibility of different immunotyping results 
in the two models remains. In another word, even though the phenotype we observe in 
SEL1LCD19-CRE is highly likely to originate from disruption of HRD1 E3 complex, an 
HRD1-independent SEL1L function is still not impossible. An HRD1 conditional 
knockout mouse model would reveal the standing of HRD1 in the picture of B cell 
development. Last but not the least, based on another preliminary study, the role of 
SEL1L in B cell development is not restricted in the pre-B stage. Inducible whole body 
SEL1L knockout greatly affects pro-B cell population, although we have no clue for the 
underlying mechanism yet. In addition, surrogate light chains are rapidly replaced by 
conventional light chains, which generate the mature BCR before the naïve B cell stage. 
Thus, we hypothesize that there is similar requirement for SEL1L for quality/quantity 
control of mature BCR in naïve B cells. To this end, ex vivo B cell-to-plasma cell 
differentiation needs to be analyzed using Tamoxifen-driven conditional Sel1l deletion in 
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B cells. I anticipate that the induced SEL1L loss would greatly impair plasma cell 
differentiation. Besides the inducible knockout mouse model, specific SEL1L deletion in 
plasma cell will be another valuable tool for both physiological and mechanistic studies. 
B cell activation upon antigen immunization as well as BCR (light chain, particularly) 
modification, localization, secretion and degradation should also be closely examined. 
Accumulation of conventional light chains might occur, affecting expression and 
secretion of antibodies.   
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APPENDIX A. TRANSCRIPTION UPREGULATION OF 
XBP1 RESETS PROTEOSTASIS BOUNDARY DURING 
PLASMA CELL DIFFERENTIATION WITH NO OVERT 
UPR ACTIVATION 
 
A.1 INTRODUCTION 
Homeostasis in the endoplasmic reticulum (ER) is tightly monitored by the ER-to-
nucleus signaling cascades, called unfolded protein response (UPR) (Ron and Walter, 
2007).  B cell differentiation into immunoglobulin (Ig)-secreting plasma cells has been 
long considered to be the best example of UPR activation under physiological settings 
(Iwakoshi et al., 2003; Reimold et al., 2001; Todd et al., 2008; Zhang et al., 2005).  
Plasma cells produce large amounts of secreted IgM and IgG whereas naïve B cells 
express the membrane-bound IgM at a much lower level.  Cells or mice deficient in 
IRE1! or XBP1 exhibit severe defects in ER homeostasis and plasma cell formation 
(Iwakoshi et al., 2003; Reimold et al., 2001; Zhang et al., 2005). Intriguingly, unlike the 
IRE1!-XBP1 branch, the PERK branch of UPR is dispensable for B cell differentiation 
(Gass et al., 2008; Ma et al., 2009), leading to the speculations of either a selective 
activation (Rutkowski and Kaufman, 2007) or repression (Ma et al., 2009; Wu and 
Kaufman, 2006) of UPR branches.  Here our data show that ER homeostasis was not 
breached by massive Ig biosynthesis in differentiating B cells, but was rather 
progressively reset to a new homeostasis through XBP1s transcriptional activity prior to 
the oncoming waves of antibody load. Thus, in contrast to the current dogma, overt UPR 
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activation is bypassed during B cell differentiation to antibody-secreting plasma cells, 
representing a novel scenario for physiological processes associated with changes in 
demands of protein synthesis and folding in the ER.   
 
A.2 MATERIALS AND METHODS 
Animals 
Wildtype C57BL/6 mice were either purchased from the Jackson Laboratory or bred in 
the Cornell Weill Mouse Facility. 8-12 mice at age of 6-8 weeks were used in every B 
cell differentiation experiment. 
  
Magnetic beads purification (negative selection)   
B-cell purification from spleens was carried out using the BD IMagTM Cell Separation 
System (BD Biosciences). Spleens were gently pushed through 70 %m nylon mesh 
(Fisher Scientific 22363548) to yield single cell suspension. Red blood cells were lysed 
on ice for 1 min in ACK lysis buffer (0.15 M NH4Cl ,1 mM KHCO3 ,0.1 mM 
Na2EDTA, pH 7.2).  After two washes with 10 ml PBS (137mM NaCl, 2.7mM KCl, 
4.3mM Na2HPO4, 1.4mM KH2PO4, pH 7.4) containing 2% BSA, 108 splenocytes were 
incubated with 5 %l biotin-conjugated anti mouse CD3 antibody and 3 %l biotin-
conjugated anti mouse CD11b antibody (UCSF Monoclonal Antibody Core Facility, 0.5 
mg/ml) with a total volume of 100 %l at 4°C for 20 min followed by incubation with 60 
%l Streptavidin Particles Plus (BD Biosciences 557812) with a total volume of 300 %l at 
4°C for 20 min. Cells were transferred to a 12 & 75 mm tube which was inserted into a 
Cell Separation Magnet Apparatus (BD Biosciences) for 5 min.  Cells from the flow-
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through, i.e. the CD3- and CD11b-negative portion, were collected, washed with PBS 
and then resuspended in 1 ml DMEM culture medium.  Purity was determined using flow 
cytometry. Normally over 90% cells were B220+ cells (Fig. A1).  Of note, CD3 antibody 
targets T cells while CD11b antibody recognizes monocytes, macrophages, eosinophils, 
granulocytes and NK cells. 
 
B cell differentiation into plasma cells 
The procedure was adopted from (Iwakoshi et al., 2003; Shaffer et al., 2004) with some 
modifications.  Briefly, purified B cells were diluted in DMEM containing 10% FBS at a 
concentration of 5&106/ml, cultured in 24-well plate (1 ml per well) and stimulated with 
20 %g/ml LPS (Calbiochem 437627) and 20 ng/ml murine IL-4 (Peprotech 214-14). Cells 
were collected and snap-frozen in liquid nitrogen at different time points.  Proliferating B 
cells were diluted to 5&106/ml with the fresh medium containing IL-4 and LPS every 48 h 
as described (Iwakoshi et al., 2003). 
 
Protein lysates 
Cells were lysed in Tris-based lysis buffer (150 mM NaCl, 50 mM Tris, pH7.5, 1 mM 
EDTA and 1% Triton X-100) supplemented with 1 %M DTT and 1x protease inhibitors 
(Sigma).   Supernatant was collected after microcentrifugation at 4°C for 10 min. 
 
Nuclear-cytosolic fractionation  
Nuclear extraction for cells were performed as we previously described (Sha et al., 2009).  
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Western blot and Phos-tag gels 
Bradford assay (BioRad) was used to measure protein concentrations of whole cell lysate 
or nuclear extraction. 15-30 %g of whole cell lysates or 5-10 %g of nuclear extracts were 
used for regular western blot on mini SDS-PAGE gels.  Phosphorylated IRE1! were 
separated from non-phosphorylated proteins using Phos-tag gels as previously described 
(Yang et al., 2010).   
 
Antibodies 
XBP1 (XBP1u/s-specific, rabbit, 1:1,000), and HSP90 (rabbit, 1:5,000) were purchased 
from Santa Cruz; p-eIF2!, IRE1! and PERK (rabbit) antibodies were purchased from 
Cell Signaling and used at 1:1,000–2,000. CREB antibody (rabbit, 1:6,000) was from Dr. 
Marc Montminy (Salk Institute). Primary antibodies were diluted in 5% milk/TBST or 
2% BSA/TBST and incubated with PVDF membrane overnight at 4°C. Secondary 
antibodies were goat anti-rabbit IgG HRP (Jackson ImmunoResearch) used at 1:10,000. 
 
RNA extraction, Q-PCR and RT-PCR 
RNA extraction and Q-PCR were performed as described previously (Sha et al., 2009). 
All Q-PCR data were normalized to ribosomal l32 gene in the corresponding sample.  
Primer sequences as listed below: L32 F: 5’-GAGCAACAAGAAAACCAAGCA-3’, R: 
5’-TGCACACAAGCCATCTACTCA-3'; Xbp1 F: 5’-ACATCTTCCCATGGACTCTG-
3’, R: 5’-TAGGTCCTTCTGGGTAGACC-3'; Sel1L F: 5’-
TGGGTTTTCTCTCTCTCCTCTG-3’, R: 5’-CCTTTGTTCCGGTTACTTCTTG-3'; 
P58ipk F: 5’-GTGGCATCCAGATAATTTCCAG-3’, R: 5’-
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GAGTTCCAACTTCTGTGGAAGG-3'; Grp94 F:5’-
CTCAGAAGACGCAGAAGACTCA -3’, R: 5’-AAAACTTCACATTCCCTCTCCA-3'; 
Myc F:5’-TGAGCCCCTAGTGCTGCAT-3’, R: 5’-
TCAATTTCTTCCTCATCTTCTTGCT-3'; Blimp-1 F: 5’-
GGGAAACCCAAGAGCCTTAC-3’, R: 5’-GCTTGCTAGCATGTGTGGAA-3'; Chop 
F: 5’-TATCTCATCCCCAGGAAACG-3’, R: 5’-GGGCACTGACCACTCTGTTT-3'; 
Gadd34 F: 5’-AGGACCCCGAGATTCCTCTA-3’, R: 5’-
CCTGGAATCAGGGGTAAGGT-3'.  
RT-PCR analysis of spliced and unspliced Xbp1 was performed as described (Sha et al., 
2009) 
 
Measurement of ER/Golgi size 
To measure ER/Golgi size, 2x105 B cells at different stages of differentiation were 
collected and incubated in 200%l of culture medium containing 0.4 %g/ml Brefeldin A 
BODIPY (Invitrogen) for 30 min at 4°C. Then cells were washed once and suspended in 
200 %l PBS for immediate flow cytometry analysis. 
 
Measurement of intracellular IgG levels 
For intracellular staining, stimulated B cells were collected as indicated and incubated in 
200 %l of 70% ethanol for 20 min at 40°C.  Following three washes with PBS, cells were 
kept in 1% formaldehyde until all time points were collected. Cells were washed three 
times with PBS, incubated with 20 %l of antibodies diluted at optimal concentrations for 
45 min at 4°C, and resuspended in 400 %l PBS for analysis using the FACSCalibur flow 
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cytometer (BD Biosciences).  Data were analyzed using the CellQuest software (BD 
Biosciences).  Antibodies used for flow cytometry in this study with final concentrations 
were:  5 %g/ml PE anti-mouse CD45R/B220 antibody (BD Biosciences 103207), 5 %g/ml 
PE- Rat IgG2b, kappa isotype control (BD Biosciences 553989), and 6 %g/ml FITC-
conjugated anti-mouse IgG (Jackson ImmunoResearch 715-095-151). Of note, anti-IgG 
antibody recognizes both IgG heavy chain and the common light chain shared by other Ig 
such as IgM expressed in mature B cells. 
 
Statistics 
Results are expressed as mean ± s.e.m.  Comparisons between non-treated group and 
groups from each time point were made by unpaired two-tailed Student t-test.  P<0.05 
was considered as statistically significant. All experiments were repeated at least twice 
and representative data or data on average are shown. 
 
A.3 RESULTS 
We purified splenic B220+ B cells (Fig. A1) and differentiated them to plasma cells 
using standard LPS and IL-4 stimulation (Iwakoshi et al., 2003; Shaffer et al., 2004). In 
keeping with previous observations (Federovitch et al., 2005; Gass et al., 2002; Iwakoshi 
et al., 2003; Reimold et al., 2001; van Anken et al., 2003; Zhang et al., 2005), cells 
progressively exhibited characteristic changes such as enlarged cell size (not shown), 
reciprocal regulation of Blimp and c-Myc genes (Fig. A2-A). While the induction of total 
Xbp1 mRNA occurred early during differentiation starting at 2h (Fig. A2-A), the increase 
of active XBP1s protein was detected at 16h following LPS/IL-4 treatment (Fig. A2-B). 
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Q-PCR revealed induction of ER chaperone genes such as well known XBP1-targets 
p58ipk, Grp94 and Sel1l, but not PERK targets (Fig. A2-C,D). Accordingly, expansion of 
ER-Golgi mass started at 16 h (Fig. A3-A), an event that is known to be XBP1s-
dependent (Shaffer et al., 2004). The extent of ER-Golgi expansion at 16 h of B cell 
differentiation was comparable to that of MEFs treated with 75 nM thapsigargin (Tg), an 
ER-stress-inducing drug, for 7 h (Fig. A3-B). 
 
Levels of intracellular Ig significantly increased at around 24 h (Fig. A3-C), preceded by 
XBP1s protein accumulation and ER-Golgi expansion. Strikingly, no activation of IRE1! 
was observed during the differentiation, even after 16 h of LPS treatment (Fig. A4-A, B). 
Of note, LPS per se didn’t suppress IRE1!, as tunicamycin (Tm) was able to increase 
IRE1! phosphorylation in presence of LPS (Fig. A4-C). Further supporting the lack of 
IRE1! activation, there was no increase in Xbp1 mRNA splicing during the 16 h and 24 h 
periods (P>0.05) (Fig. A4-D). When both intracellular Ig levels and ER/Golgi mass 
peaked at 72 h, IRE1! hyperphosphorylation and Xbp1 mRNA splicing, i.e. IRE1! 
activation, reached nadir (Fig. A4-B, D). Finally, neither PERK nor its target eIF2! 
showed increased phosphorylation (Fig. A4-E, F). The inactivation of PERK pathway 
and the IRE1! phosphorylation status together argue that ER homeostasis has been reset 
to readily accommodate the protein load in fully differentiated plasma cells without 
undergoing ER stress.  
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Figure A1 Flow cytometric analysis of purified splenic B cells.   
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Figure A2 Increases of XBP1s and its targets during B cell to plasma cell differentiation. 
(A) Q-PCR analyses of Xbp1 total, Blimp and c-Myc mRNA in splenic B cells stimulated 
with LPS and IL-4 at different time points. (B) Immunoblots for XBP1s protein from 
nuclear extracts of differentiating B cells. CREB, a loading control. Q-PCR analyses was 
also performed to show the mRNA changes of IRE1!-XBP1 targets (C) and PERK 
targets (D). Values are mean ± s.e.m. Q-PCR data were normalized to ribosomal L32 
gene. a.u.: arbitrary units. 
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Figure A3 Expansion of ER capacity precedes immunoglobulin synthesis. (A) Flow 
cytometric analysis of the ER-Golgi mass during B cell differentiation. Cells were stained 
with ER/Golgi-specific dye brefeldin A-Bodipy. The 4 h time points are used as the 
control point (to eliminate the possible artifact at 0 h generated in purification procedure) 
overlaid in red. (B) Flow cytometric analysis of intracellular immunoglobulin (Ig) 
expression during B cell differentiation, overlaid with 4 h time point. (A-B) are 
representatives of four independent experiments. Numbers in each histogram of panels A-
B refer to the mean channel fluorescence of each peak, i.e. fluorescent intensity. (C) Flow 
cytometric analysis of the ER-Golgi mass in Tg treated MEF cells. Red line: control, 
Purple line: treatment. 
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Figure A4 No overt UPR activation during B cell to plasma cell differentiation. (A) 
Immunoblots of IRE1! using Phos-tag gel (indicated by a bar at the left-hand side). 0- 
non-phosphorylated, p- phosphorylated. (B) Quantitation of the percent of 
phosphorylated IRE1! out of total IRE1! in panel A.  (C) Immunoblots of IRE1! from 
LPS/IL4 or Tm treated purified B cells, using Phos-tag gel.  (D) RT-PCR analysis of 
Xbp1 mRNA splicing (bottom) and quantitation of the ratio of Xbp1s to total Xbp1 from 
three independent experiments (top).  L32, a loading control. Values are mean ± s.e.m.. 
NS, not significant; *, P<0.05 using unpaired two-tailed Student’s t-test.  Representatives 
of at least two independent experiments shown.  (E) Immunoblots of PERK using Phos-
tag gels (indicated by a bar at the left-hand side). Two additional controls, MEF either 
mock (-) or 75 nM Tg treated for 4 h, included for the PERK blot. (F) Immunoblots of 
PERK downstream target p-eIF2! on regular SDS PAGE gel. Hsp90, a loading control. 
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Figure A5 Event dynamics during plasma cell differentiation (Summary of Figure A2-4). 
(A) Event dynamics of the IRE1!-XBP1 pathway. (B) Event dynamics related to ER 
volume and protein synthesis. *, P<0.05; **, P<0.01, ***,P<0.001; using unpaired two-
tailed Student’s t-test. 
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A.4 DISCUSSION 
Our results lead us to conclude that, in contrast to the current dogma, massive Ig 
synthesis does not cause overt ER stress during differentiation; rather, an increase in 
Xbp1 mRNA (the substrate) induced by differentiation signals at early stages of 
differentiation (Iwakoshi et al., 2003; Todd et al., 2008) results in accumulation of 
XBP1s protein via basal IRE1! RNase enzymatic activity. Elevated XBP1s protein is 
responsible for the augmented ER mass/chaperones and thereby ER homeostasis for the 
subsequent Ig biosynthesis (Fig A5). The lack of ER stress and subsequent UPR during 
plasma cell differentiation circumvents the consequences of PERK activation on 
blockade of protein synthesis. Our model provides another explanation of the functional 
disparities between the IRE1!-XBP1 and PERK pathways in plasma cell 
differentiation(Gass et al., 2008; Iwakoshi et al., 2003; Ma et al., 2009; Reimold et al., 
2001; Zhang et al., 2005). This scenario seems to be reminiscent of the situation in 
hormone-stimulated thyrocytes (Christis et al., 2010), where ER chaperones were 
dramatically increased ahead of large protein load. 
 
XBP1s activation depends on the differentiation signals provided by LPS and IL-4, rather 
than Ig biosynthesis. Indeed, several recent studies show that XBP1 activation occurs 
normally in IgM-deficient cells (Hu et al., 2009; McGehee et al., 2009) and precedes an 
increase in Ig synthesis (Gass et al., 2002).  Thus, XBP1s activation is a differentiation- 
and transcriptional-dependent and UPR-independent event during plasma cell 
differentiation. As many cell or tissue types have basal levels of IRE1! activity (Yang et 
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al., 2010), hence Xbp1 mRNA can be spliced to generate XBP1s protein even in the 
absence of an overt UPR. 
Our data show that, in a choreographed sequence of events, B cells differentiate into 
plasma cells without the activation of an overt UPR. This represents an alternative model 
of UPR activation in physiological settings. Previously, we have shown the UPR 
activation in fasting-refeeding pancreas (Yang et al., 2010), which we speculate may 
allow the secretion of pancreatic zymogens directly correlated with the amount of food 
intake and content of nutrients in a more acute setting. As chronically UPR is associated 
with cell death, we propose that in some physiological events ER stress may be 
circumvented by the XBP1-mediated upregulation of ER chaperones and capacity and 
thereby reset of ER homeostasis. This mechanism seems to be evolutionally conserved as 
a similar mode of transcriptional upregulation of XBP1 homolog Hac1 without overt 
IRE1 activation has been reported in yeast (Leber et al., 2004).  
 
In summary, our results challenge the notion that plasma cell differentiation is associated 
with overt ER stress and UPR activation. As cells have high stress adaptability and 
flexibility in ER homeostasis (Federovitch et al., 2005; Sha et al., 2011), the on/off 
switch provided by ER stress may not be the only regulatory step of IRE1!-XBP1 
pathway in mammals; rather, a transcriptional program-triggered XBP1s induction may 
provide an alternative molecular mechanism underlying homeostatic regulation of the ER 
and allow the cell to differentiate and survive. From evolution perspective, this intriguing 
mechanism may be preferentially selected for specialized secretory cell types such as B 
cells to fulfill their functional requirement. 
!%)%!!!
APPENDIX B. FARP1, A NOVEL IRE1! INTERACTING 
PROTEIN !
B.1 INTRODUCTION  
Under ER stress conditions, IRE1! is activated by direct binding of unfolded protein, 
and/or disassociated of BIP from IRE1! luminal linker region, which leads to 
autophosphorylation and oligomerization. Recent studies point out that the activation of 
IRE1! can be fine-tuned by additional binding proteins, which are together termed as 
IRE1! interactome or “UPRosome” (Hetz et al., 2011). Reported IRE1! accessory 
proteins include BAX, BAK, PUMA and BIM, loss of which significantly influence 
IRE1! activation (Hetz et al., 2006). In addition to the regulatory effects on IRE1! 
activity, some adaptor proteins initiate a variety of physiological outcomes in responsible 
to ER stress. For instance, activation of IRE1! leads to phosphorylation of the binding 
partner TRAF2 and thus activates caspase-12, JNK, ERK, p38 and NF#B, which regulate 
apoptosis, autophagy and inflammation (Hetz and Glimcher, 2009). 
 
One of the research directions in our lab is to define the detailed mechanism of IRE1! 
activation. To this end, our lab performed a proteomic screening. The screening 
successfully identified multiple previously unknown IRE1! interacting proteins. One of 
the novel adaptor proteins, the non-muscle myosin heavy chain IIB (NMHCIIB), has 
been proved to be critical for full IRE1! activation including IRE1! foci formation, Xbp1 
splicing and downstream upregulation of XBP1 targets (He et al., 2012). However, how 
NMHCIIB mediates the activation of IRE1! remains to be unclear.  
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The fact that NMHCIIB is associated with actin filaments and migrates along the 
filament network for cargo transportation suggests a potential role of the cytoskeleton 
system in precise control of IRE1! foci formation and activation.  Interestingly, the 
proteomic screening identified another putative IRE1!- interacting factor, FARP1 
(FERM, RhoGEF and pleckstrin domain-containing protein 1), which also involve in 
cytoskeletal dynamics and organization. FARP1 belongs to the Rho GEF (guanine 
nucleotide exchange factor) family with a cytoskeleton-associating ezrin-like domain 
(Koyano et al., 1997). It has been shown to be important for trans-synaptic organization, 
axonal repulsion and dendritic growth of neurons (Cheadle and Biederer, 2012; Toyofuku 
et al., 2005; Zhuang et al., 2009). Here, we tested whether FARP1 is physically 
associated with UPR sensors IRE1! and PERK, and regulates the UPR signaling 
pathways. 
 
B.2 MATERIALS AND METHODS 
Cells 
Mouse embryonic fibroblast (MEF) cells were maintained in DMEM supplemented with 
10% FBS and 1% penicillin/streptomycin. 
 
Immunoprecipitation  
Cells were lyzed in lysis buffer (150 mM NaCl, 1% Triton X-100, 1mM EDTA, 50 mM 
Tris HCl, pH 7.5) supplemented with protease inhibitor cocktail (Sigma) and 1 mM DTT. 
Immunoprecipitation was recovered by anti-HA agarose beads for overnight at 4°C. 
Beads were washed with washing buffer (137 mM NaCl, 1% Triton X-100, 20mM 
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EDTA, 20 mM Tris HCl, 10% glycerol, pH 7.5) for 5 min at room temperature for a total 
of four times, and eluted with 2X SDS sample buffer for future Western blot. 
 
Western blots 
Bradford assay (BioRad) was used to measure protein concentrations of whole cell lysate 
or nuclear extraction. 20 %g of whole cell lysates or 5-10 %g of nuclear extracts were used 
for regular western blot on mini SDS-PAGE gels. GRP78 (goat, 1:1,000), XBP1 
(XBP1u/s-specific, rabbit, 1:1,000), CHOP (mouse, 1:500), HA-HRP (1:1000) and 
HSP90 (rabbit, 1:5,000) were purchased from Santa Cruz; (p)-eIF2!, IRE1! and PERK 
(rabbit) antibodies were purchased from Cell Signaling and used at 1:1,000–2,000. 
SEL1L (rabbit, 1:2000) was from Abcam. GAPDH (mouse, 1:20,000) was from Novus 
Biologicals. CREB antibody (rabbit, 1:6,000) was from Dr. Marc Montminy (Salk 
Institute). Primary antibodies were diluted in 5% milk/TBST or 2% BSA/TBST and 
incubated with PVDF membrane overnight at 4°C. Secondary antibodies were goat anti-
rabbit IgG HRP, goat anti-mouse IgG HRP (Biorad) and donkey anti-goat IgG HRP 
(Jackson ImmunoResearch), all of which were used at 1:10,000. 
 
RNA extraction and Q-PCR 
RNA extraction and Q-PCR were performed as described previously (Sha et al., 2009). 
All Q-PCR data were normalized to ribosomal L32 gene in the corresponding sample.  
Primer sequences as listed below: L32 F: 5’-GAGCAACAAGAAAACCAAGCA-3’, R: 
5’-TGCACACAAGCCATCTACTCA-3'; Xbp1s F: 5’-
TGCTGAGTCCGCAGCAGGTG-3’, R: 5’-ACTAGCAGACTCTGGGGAAG-3’ 
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 Sel1L F: 5’-TGGGTTTTCTCTCTCTCCTCTG-3’, R: 5’-
CCTTTGTTCCGGTTACTTCTTG-3'; Chop F: 5’-TATCTCATCCCCAGGAAACG-3’, 
R: 5’-GGGCACTGACCACTCTGTTT-3'; Erdj4 F: 5’- 
CTTAGGTGTGCCAAAGTCTGC-3’, R: 5’-GGCATCCGAGAGTGTTTCATA-3’; 
Pdia6 F: 5’- TGGTTCCTTTCCTACCATCACT-3’, R: 5’- 
ACTTTCACTGCTGGAAAACTGC-3’; FARP1 F: 5’-
ATCACAGAGATGGTGGCACA-3’; R 5’-AGAACATGCGCTGCTGAAG-3’. 
 
Plasmids and transfection 
Plasmid expressing HA-tagged mouse FARP1 was a gift from Dr. Shan Sockanathan 
(John Hopkins University). Plasmids were transfected into MEFs via lipofectamine2000 
according to the supplier’s protocol. Tg treatment was performed 24 h post-transfection 
followed by Western blot or immunoprecipitation. 
 
RNAi 
Retroviral transduction and stable knockdown were performred as described previously 
(Sha et al., 2009). Stable cell lines with shRNA expressing were selected in media with 
5ug/ml puromycin.  
 
FARP1 shRNA were designed online using Thermo-Scientific siDESIGN center. 
Sequences of the three shRNA constructs are as followed: FARP1.14/FARP1.18 are two 
different clones resulted from the same shRNA constract: 5’-
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GGATAAGGAGTAAGATGTA-3’; FARP2 target to sequence: 5’-
GGTTCTAAGTACTAACAAA-3’. 
 
B.3 RESULTS 
FARP1 interacts with IRE1" and PERK in an ER stress-independent manner. 
First of all, semi-endogenous immunoprecipitation (IP) was carried out to confirm the 
proteomic screen result. HA-tagged mouse FARP1 or GFP proteins were overexpressed 
in MEF cells.  To our surprise, IP against HA-FARP1 pulled down not only endogenous 
IRE1! but also PERK when HA-FARP1 is expressed, indicating a physical interaction 
between FARP1 and both UPR sensors IRE1! and PERK (Fig. B1). As elevated 
interaction between NMHCIIB and IRE1! was observed upon ER stress-inducer Tg 
treatment, immunoprecipitation against FARP1 was also performed under 300nM Tg 
treatment for 2 hours. However, Tg treatment didn’t increased interaction between 
FARP1 and either IRE1! or PERK (Fig. B1). Thus, FARP1 interacts with UPR sensors 
independently of ER stress.  
 
Overexpression of FARP1 is not sufficient to promote UPR activation by ER stress. 
To determine whether the interaction of FARP1 and UPR sensors is important for UPR 
activation, we checked the Tg-induced upregulation of UPR downstream targets in MEF 
cells expressing EGFP control plasmid or plasmid expressing FARP1. We observed 
similar levels of phosphorylation on PERK target eIF2! as well as XBP1s and CHOP 
proteins in the nuclei (Fig. B2-A). At the mRNA level, Xbp1s and other UPR genes 
including GRP78, Erdj4 and Chop are comparable between the two cell lines (Fig. B2-B). 
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The dramatic increase of Farp1 mRNA and western blot against HA demonstrated the 
high transfection efficiency (Fig. B2-A,B). 
 
FARP1 is not required for UPR activation 
We next tested whether FARP1 deficiency impaired UPR activation under ER stress. The 
knockdown is highly efficient as indicated by the over 80% reduction of FARP1 mRNA 
(Fig. B3-A). However, we observed no changes of UPR mRNA induction by Tg in 
control knockdown (CONi) and three different FARP1i cell lines (Fig. B3-A).  Both 
CONi and FARP1i exhibited similar dynamic patterns of phosphorylation increase on 
IRE1! and PERK, protein induction of GRP78, and nuclear transcription factors CHOP 
and XBP1s by Tg treatment. Neither p-eIF2! nor SEL1L increase much in either cell 
lines (Fig. B3-B). Thus, we concluded that FARP1 is not necessary for the upregulation 
of UPR under ER stress conditions. 
 
!%)+!!!
  
Figure B1 FARP1 interacts with both IRE1! and PERK independently of ER stress. 
Western blots against HA-FARP and UPR sensors – IRE1! and PERK from input and 
immunoprecipitates (IP) with anti-HA agarose. MEF cells transfected with GFP control 
or HA-FARP1 were treated with or without 300nM Tg for 2h. 
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Figure B2 Over-expression of FARP1 doesn’t promote UPR activation. (A) Western 
blots against UPR genes in MEF cells overexpressing EGFP control or mouse FARP1 
under 300nM Tg for indicated time. Cell fractionation was performed to separate the 
cytosolic (Cyto) and nuclear fractions (NX). HSP90: the loading control for the cytosolic 
fraction. CREB: the loading control for the nuclear extraction. Quantification of XBP1s 
protein level normalized to CREB was shown below the gel. (B) Q-PCR showing the 
mRNA levels of UPR genes and Farp1 in the cells as in (A). Ribosomal L32 gene as 
control.   
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Figure B3 Knockdown of FARP1 doesn’t impair UPR activation. (A) mRNA levels of 
UPR genes including Xbp1s (spliced), Grp78, Erdj4, Chop, Sel1L, Pdia6 in MEF cells 
stabling expressing control shRNA (CONi) or three different FARP1 shRNA (FARP1i 
1.14(red)/1.18(yellow)/2.6(blue)). (B) Western blots against UPR genes in cytosolic 
fraction (Cyto) or nuclear extraction (NX). IRE1! was separated on phos-tag gels 
indicated by the bar on the right with PT. p-: phosphorylated, 0-: non-phosphorylated. 
GAPDH: the loading control for cytosolic fraction. CREB: the loading control for nuclear 
extraction.   
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B.4 DISCUSSION 
Here our data show that the FARP1 interacts with both IRE1! and PERK in basal and 
stressed conditions. The strength of interaction is not affected by ER stress. In addition, 
neither overexpression nor knockdown of FARP1 affects UPR activation. It is possible 
that the nature of FARP1 binding to IRE1! and PERK is non-specific, when FARP1 is 
highly overexpressed. Co-immunoprecipitation of endogenous FARP1 and IRE1! /PERK 
may help to clarify the possibility of non-specific binding. Nevertheless, the regulatory 
role of cytoskeleton networks in UPR activation remains to be an interesting future 
direction, which is worth of more investigation. 
 
 !!!!!!!!!!!!!!!
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APPENDIX C. CIRCADIAN EXPRESSION OF UPR GENES 
IN MULTIPLE ORGANS 
 
C.1 INTRODUCTION 
Mammalian circadian rhythm orchestrates the temporal cycling of many physiological 
activities including metabolism, thus allowing organisms to adjust to the environmental 
cycles of light and nutrients caused by the 24 h rotation of the earth (Green et al., 2008). 
Dysregulation of circadian clock has been linked to a number of human diseases, such as 
sleep disorder, obesity, diabetes, and cardiovascular diseases (Maury et al., 2010). 
Mammalian circadian clock is composed of a master clock located in the suprachiasmatic 
nucleus (SCN) of the hypothalamus as well as peripheral clocks in various tissues 
(Kohsaka et al., 2007; Ralph et al., 1990). Despite tissue specificity, circadian rhythm is 
generated and maintained by the same master regulatory transcription factors, CLOCK 
and BMAL1. Heterodimeric CLOCK/BMAL1 binds to the E-box motif (CACGTGA) at 
the promoter regions of four other core clock transcription factors, PERIOD (PER), 
CRYPTOCHROME (CRY), nuclear receptors ROR! and REV-ERB!, and activates their 
transcription. Heterodimeric PER/CRY suppresses their own expression by inhibiting 
CLOCK/BMAL1 activity, while ROR! and REV-ERB! activate and suppress BMAL1 
transcription respectively. The two interlocking regulatory loops trigger the oscillation of 
these core clock genes and orchestrate the periodic expression of a wide range of 
downstream genes involved in various biological pathways and are especially relevant in 
lipid and glucose metabolism (Green et al., 2008). 
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A large portion of metabolic genes (Pdk4, Pepck, Pgc-1a, Hmgcr, Fasn, Ldlr) have been 
shown to cycle with a period of 24h in key metabolic tissues such as liver and fat, many 
of which encode rate-limiting enzymes (Kohsaka et al., 2007; Panda et al., 2002; Storch 
et al., 2002). Disruption of circadian clock dampens the oscillation of those genes and 
thus interrupts metabolic homeostasis. For example, inactivation of BMAL1 and CLOCK 
impairs gluconeogenesis and suppresses the diurnal variations of serum metabolites such 
as glucose, triglycerides, and corticosterone (Rudic et al., 2004). Interestingly, circadian 
rhythm can also be influenced by metabolic status. Food restriction and high fat diet are 
known to affect the period and persistence of circadian rhythm (Kohsaka et al., 2007). 
However, despite the recent identification of several metabolic genes such as Retinoid X 
receptor alpha (RXR!), peroxisome-proliferation-activator-receptor alpha (PPAR!) and 
PPAR' coactivator-1 alpha (PGC-1!), as potential modulators of BMAL and CLOCK 
expression, the mechanisms by which different physiological challenges and metabolic 
stress contribute to the regulation of circadian clock remains largely unknown (Canaple et 
al., 2006; Liu et al., 2007; McNamara et al., 2001). 
 
Several reports have suggested a potential reciprocal regulation between UPR and 
circadian rhythm. ER dilation, a common outcome of UPR activation has been reported 
to exhibit a diurnal pattern, implying a link between UPR and circadian rhythm 
(Uchiyama and Watanabe, 1987). Moreover, the potential link between these two 
pathways may also be reflected by the functional similarities shared between them. Both 
UPR and circadian rhythm have pivotal roles in lipid metabolism, gluconeogenesis, and 
are implicated in the pathogenesis of obesity, diabetes, and cardiovascular diseases 
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(Hotamisligil, 2010; Maury et al., 2010). Interestingly, the E-box motif also contains the 
core CRE site “-ACGT-“, the binding site for XBP1, suggesting a possible regulation of 
clock genes and clock-controlled genes by XBP1. In addition, the recent report hinted at 
the existence of a cycling canonical UPR without Xbp1 mRNA change in mouse liver 
(Cretenet et al., 2010) directly links UPR to circadian rhythm. Thus we are interested in 
the regulation of UPR by circadian rhythm, and the physiological importance of the 
oscillating UPR in various tissues. This study is a pilot investigation describing the 
phenotypic UPR circadian rhythm in metabolic tissues as the first step.  
 
C.2 MATERIALS AND METHODS 
Animals 
Wildtype C57BL/6 mice were either purchased from the Jackson Laboratory or bred in 
the Cornell Weill Mouse Facility. 4 mice were used for each time point. Tissues were 
frozen immediately in liquid nitrogen and stored at -80°C for later protein or RNA 
extraction. 
 
Cell lines 
HEK293T, 3T3L1 and Macrophage cell line RAW267.4 cells were maintained in DMEM 
supplemented with 10% FBS and 1% penicillin/streptomycin.  
  
Western blots 
Western blotting against IRE1! was performed according to previously published paper 
(Yang et al., 2010). IRE1! antibody (rabbit 1:1000) was purchased from Cell Signaling 
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while XBP1 antibody (rabbit 1:1000) from Santa Cruz. Secondary antibodies were goat 
anti-rabbit IgG HRP was used at 1:10,000 
 
RNAi 
Stable knockdown was performred as described in (Sha et al., 2009). To knockdown 
XBP1, shRNA were designed targeting to the mouse XBP1 sequence 
(GGATTCATGAATGGCCTTA) at 3’ UTR.  Stable cell lines with shRNA expressing 
were selected in media with 5ug/ml puromycin. XBP1i 3T3L1 as described in (Yang et 
al., 2013) while XBP1i RAW267.4 cells as in (He, 2013). 
 
RNA extraction and Q-PCR  
RNA extraction and Q-PCR were performed as described previously (Sha et al., 2009; 
Yang et al., 2010). All Q-PCR data were normalized to ribosomal l32 gene in the 
corresponding sample.  Primer sequences as listed below: L32 F: 5’-
GAGCAACAAGAAAACCAAGCA-3’, R: 5’-TGCACACAAGCCATCTACTCA-3'; 
Xbp1 F: 5’-ACATCTTCCCATGGACTCTG-3’, R: 5’-TAGGTCCTTCTGGGTAGACC-
3'; Xbp1s F: 5’-TGCTGAGTCCGCAGCAGGTG-3’, R: 5’-
ACTAGCAGACTCTGGGGAAG-3’; Chop F: 5’-TATCTCATCCCCAGGAAACG-3’, 
R: 5’-GGGCACTGACCACTCTGTTT-3'; Erdj4 F: 5’- 
CTTAGGTGTGCCAAAGTCTGC-3’, R: 5’-GGCATCCGAGAGTGTTTCATA-3’;  
 Grp78 F: 5’-TGTGGTACCCACCAAGAAGTC-3’, R: 5’-
TTCAGCTGTCACTCGGAGAAT-3’; p58ipk F: 5’- 
GTGGCATCCAGATAATTTCCAG-3’, R: 5’-GAGTTCCAACTTCTGTGGAAGG-3’; 
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Dgat2 F: 5’-TTCCTGGCATAAGGCCCTATT-3’, R: 5’-
AGTCTATGGTGTCTCGGTTGAC-3’; Acc2 F: 5’-CACCATCCGTGAAAACATCA-
3’, R: 5’-AGCAGCTGAGCCACCTGTAT-3’; Per1 F: 5’-
AACGGGATGTGTTTCGGGGTGC-3’, R: 5’-AGGACCTCCTCTGATTCGGCAG-3’; 
Per2 F: 5’-TGTGCGATGATGATTCGTGA-3’, R: 5’-
GGTGAAGGTACGTTTGGTTTGC-3’; Clock F: 5’-ACCACAGCAACAGCAACAAC-
3’, R: 5’- GGCTGCTGAACTGAAGGAAG-3’; Bmal1 F: 5’- 
CCACCTCAGAGCCATTGATACA-3’, R: 5’-
GAGCAGGTTTAGTTCCACTTTGTCT-3’; RXR! F: 5’-
CACCCTGCTTGGAGATTCAT-3”, R: 5’-CCCTGTGGTCATCTTCGTTT-3’; Rev-
erb! F: 5’-ATGCCCATGACAAGTTAGGC-3’, R: 5’-GGGCTACCTGATGCATGATT-
3’; Rev-erb" F: 5’-CGCACATTGCCGATATAGGAGG-3’, R: 5’-
GAGACTGCCACCACCACGTACT-3’; Cry1 F: 5’-
AGCGCAGGTGTCGGTTATGAGC-3’, R: 5’-ATAGACGCAGCGGATGGTGTCG-3’; 
Pgc1! F: 5’-TGTACTTTTGTGGACGGAAGC-3’, R: 5’-
TCCCATGAGGTATTGACCATC-3’; Pgc1" F: 5’-GCCAGAAGCACGGTTTTATC-3’, 
R: 5’-GAAGGGACTCCTCAGATGTG-3’; aP2 F: 5’-AGCATCATAACCCTAGATGG-
3’, R: 5’-TCACGCCTTTCATAACACAT-3’; AdipoQ F: 5’-
GGAACTTGTGCAGGTTGGAT-3’, R: 5’-GCTTCTCCAGGCTCTCCTTT-3’.  
 
Luciferase assay 
Luciferase assay was performed in HEK293T cells with PEI-based transfection of 
PGC1! or control construct as in (Sha et al., 2009).   
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Statistics 
Results are expressed as mean ± s.e.m.  Comparisons between groups from each time 
point were made by unpaired two-tailed Student t-test.  P<0.05 was considered as 
statistically significant. All experiments were repeated at least twice and representative 
data or data on average are shown. 
 
C.3 RESULTS 
Xbp1 and its downstream targets’ mRNA levels exhibit circadian rhythm in the 
heart, liver and WAT. 
Quantitative PCR (qPCR) was used to analyze UPR gene expression patterns in wild type 
C57BL/6J mouse hearts during a 24h period. Mice were accommodated under 12 hour 
light: 12 hour dark conditions. The mice were active during the dark period, which lasted 
from ZT12 to ZT0.  
 
Total Xbp1 mRNA and Xbp1s oscillated with a peak around ZT8, started to decrease at 
ZT 12 (start of active phase), and reached nadir at ZT16- ZT20, suggesting a circadian-
clock-dependent transcriptional regulation of Xbp1 mRNA.  In addition, PERK 
downstream target Chop and XBP1 downstream targets Erdj4, Grp78 and P58ipk 
exhibited 24-hour cycles with peaking time around ZT8-ZT12. Per2, and Clock are used 
as control here and exhibits dramatic mRNA level changes as expected (Fig. C1).  
 
As ER stress and IRE1 activation are the upstream events of XBP1 activation in most 
known cases, I applied a Phos-tag based method previously developed to sensitively 
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assess the phosphorylation status of IRE1! as an indicator of ER stress level (Yang et al., 
2010). Unexpectedly, the Phos-tag based western blot showed no obvious oscillation of 
phospho-IRE1! (p-IRE1!) level. The lack of diurnal variation in IRE1! phosphorylation 
indicates unchanged IRE1 activity. It also suggests that the splicing rate of Xbp1 mRNA 
by IRE1! is constant and that the force driving UPR oscillation in heart may be ER 
stress-independent (Fig. C2).  
 
Interestingly, the oscillation of Xbp1 and Xbp1s is very unique in heart, while in liver and 
white adipose tissue (WAT), the chaperone genes such as Grp78, Erdj4, and P58ipk, as 
well as Chop exhibit significant circadian patterns, even without cycling of Xbp1/Xbp1s 
mRNA levels (Fig. C3, C4). Metabolic genes (Dgat2, Acc2, AdipoQ, aP2 and Pgc-1") 
and circadian clock genes (Per2 and Clock) showed circadian clock with 24-hour cycling 
period as expected in liver and WAT (Fig. C3, C4).  
 
XBP1 may transcriptionally regulate circadian clock components. 
The relationship between XBP1s and clock components was further tested in a cell line 
stably expressing shRNA against XBP1 (XBP1i). In Xbp1-deficient 3T3L1 cells, an ER 
stress agent, thapsigargin (Tg), failed to induce XBP1s protein, confirming very high 
knockdown efficiency (data in Chapter 3 and (Yang et al., 2013)). Intriguingly, core 
clock gene Bmal1 as well as Rxr! was significantly reduced in XBP1i (Fig. C5-A). 
Furthermore, we observed that a similar circadian phase was shared between hepatic 
Xbp1s and Pgc1!, the Bmal1 activator (Fig. C5-B). To confirm the link between XBP1 
and PGC1!, we performed a luciferase reporter assay in which XBP1s elevated the 
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expression of a luciferase construct driven by mouse PGC1! promoter for four fold (Fig. 
C5-C). Influences of XBP1 on circadian clock were also observed in macrophages with 
XBP1 knockdown, arguing against cell specificity (Fig. C6). Taken together, these data 
suggest that XBP1 may not only be controlled by circadian clock but may also feedback 
into circadian clock maintenance.  
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Figure C1 Circadian rhythm of UPR genes in heart. Hearts were harvested every 4 hours 
from 9 week-old male B6 mice. 4 mice per time point. Q-PCR showing the mRNA levels 
of Xbp1t (total), Xbp1s (spliced), Grp78, Erdj4, P58ipk, Chop, Per2, Clock. mRNA 
levels were normalized to ribosomal L32. a.u.: arbitrary unit. Values are mean ± s.e.m.  
White bar: light period. Black bar: dark period. ZT: Zeitgeber time. ZT0: start of light 
period. ZT 12: start of dark period. 
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 Figure C2 Activity of ER stress sensor IRE1! remains constant in heart. (A) Levels of 
phosphorylated- (P) and non-phosphorylated IRE1! revealed via Phos-tag based western 
blot. Same samples are used as in Fig.C1. Duplicates are shown for each time point. (B) 
Quantitation of percent of phosphorylated IRE1! (pIRE1!). Values are mean ± s.e.m 
(n=4 per time point). 
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Figure C3 Circadian rhythm of UPR genes in liver. Livers were harvested every 4 hours 
from 9 week-old male B6 mice. 4 mice per time point. Q-PCR showing the mRNA levels 
of Xbp1t (total), Xbp1s (spliced), Erdj4, Grp78, P58ipk, Chop, Per2, Clock, Pgc-1", 
Dgat2, Acc2. mRNA levels were normalized to ribosomal L32. a.u.: arbitrary unit. 
Values are mean ± s.e.m.  White bar: light period. Black bar: dark period. ZT: Zeitgeber 
time. ZT0: start of light period. ZT 12: start of dark period.  
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Figure C4 Circadian rhythm of UPR genes in white adipose tissue (WAT). WAT were 
harvested every 4 hours from 9 week-old male B6 mice. 4 mice per time point. Q-PCR 
showing the mRNA levels of Xbp1t (total), Xbp1s (spliced), Grp78, Erdj4, Chop, Dgat2, 
aP2, AdipoQ, Per2. mRNA levels were normalized to ribosomal L32. a.u.: arbitrary unit. 
Values are mean ± s.e.m.  White bar: light period. Black bar: dark period. ZT: Zeitgeber 
time. ZT0: start of light period. ZT 12: start of dark period. 
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Figure C5 XBP1 regulates core circadian components at transcriptional level. (A) Q-PCR 
analysis of Clock, Bmal1, Rxr! in Lucii or Xbp1i 3T3-L1 cells. Values are mean ± s.e.m. 
*, p<0.05 (B) Q-PCR analysis of hepatic Xbp1s and Pgc1! mRNA in a 24h period from 
C57BL/6J mice. Values are mean ± s.e.m. (C) Luciferase activity of HEK293T cells 
transiently co-transfected with PGC1! promoter-luciferase construct (-170 to +68) and 
Xbp1s or EGFP control.   
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Figure C6 Knockdown of XBP1 influences multiple circadian genes. Q-PCR showing the 
mRNA levels of Xbp1t (total), and circadian genes including Clock, Rev-erb!, Rev-erb", 
Cry1, and Per1 in RAW267.4 cells with control knockdown (CONi) or XBP1 
knockdown (XBP1i). mRNA normalized to ribosomal L32 level. a.u.: arbitrary unit. 
Values are mean ± s.e.m. 
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C.4 DISCUSSION 
My preliminary data reveal the circadian oscillation of total Xbp1 mRNA, Xbp1s in 
hearts, and other UPR downstream targets in multiple tissues with a 24hour-circadian 
period.  The Xbp1 circadian rhythm is independent of IRE1! activation in mouse hearts. 
This is indicative of a unique circadian UPR under basal physiological conditions. 
Strikingly, our results also showed that knockdown of XBP1 significantly affects the 
mRNA level of several clock genes in multiple cell models. Furthermore, a luciferase 
reporter assay demonstrated that XBP1 transcriptionally activated PGC1! (peroxisome 
proliferator activated receptor coactivator-1 alpha), a transcription cofactor critical for 
maintaining rhythmic oscillations of both clock and metabolic genes. Considering the 
link between disrupted circadian rhythm and multiple diseases, it is of great interest to 
investigate whether UPR maintains tissue homeostasis in a circadian manner to allow 
appropriate and rapid adaptation of the organ to environmental changes, and how the 
circadian rhythm of UPR is regulated.  
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